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PREFAC E 
This thesis describes the results of research 
carried out in the Department of Biochemistry, John Curtin 
School of Medical Research, Australian National University, 
from February, 1977, to September, 1980. These studies 
were carried out while in receipt of a Commonwealth 
Postgraduate Award. 
Abbreviations used in this thesis without definition: 
S.E. 
SDS 
EDTA 
TPCK 
CNBr 
PTH 
tRNAf-met 
' 
standard error 
sodium dodecyl sulphate 
ethylenediaminetetraacetic acid 
L-1-(p-toluenesulphonyl)amido-2-
phenylethylchloromethyl ketone 
cyanogen bromide 
phenylthiohydantoin 
ampicillin resistance 
tetracycline resistance 
initiation tRNA 
Various systems of nomenclature have been used in 
the literature for the components of the respiratory chain 
discussed in this thesis . The following nomenclature has 
been adopted which, although not totally satisfactory, has 
been imposed in part by past usage. 
NADH dehydrogenase (1.6.99.1); any enzyme (complex) 
catalyzing the oxidation of NADH by artificial electron 
acceptors . Primary dehydrogenase; the first enzyme in the 
putative respiratory complex containing the catalytic site 
for NADH oxidation. Respiratory NADH dehydro genase 
lV. 
complex; the putative complex catalyzing the transfer of 
electrons between NADH and ubiquinone in vivo . Where 
specific enzyme catalyzed reactions or the enzymes 
catalyzing these reactions are meant, they are named 
according to I . U. B. rules, e . g. NADH:ubiquinone oxido-
reductase (1.6 .5.3 ). 
v. 
ABSTRACT 
Membrane particles prepared from wild-type strains 
of E. coli were solubilized with 3% (w/v) potassium 
cholate and lM KCl. Chromatography of the solubilized 
material on hydroxylapatite revealed a single major peak 
of NADH : ubiquinone oxidoreductase activity. This peak of 
activity was identified as the respiratory NADH dehydro-
genase since it is absent from chromatograms of cholate-
solubi l ized membrane particles prepared from the ndh mutant 
s train IY12 , which possesses an inactive NADH dehydro-
genase complex (Young , I . G. & Wallace, B.J. (1976) Biochim. 
Bi ophys . Acta 449 , 376 - 385) . Several other NADH dehydro-
genases , assayed with potassium ferricyanide as electron 
acceptor , were also resolved by hydroxylapatite column 
chromatography , but their presence in IY12 column profiles 
s uggests that they are not derived from the respiratory 
enzyme . 
The hybrid plasmid pIYl (Young, I . G., Jaworowski, A. 
& Poul i s , M. I . (1978) Gene 4 , 25 - 36) was shown to carry the 
gene coding for the respiratory NADH dehydrogenase. Strains 
carrying this plasmid were found to possess amplified levels 
of NADH : ubiquinone oxidoreductase and NADH oxidase activity 
in their cell membranes. Methods were developed to further 
amplify the levels of membrane-bound NADH:ubiquinone oxido-
reductase , in strains carrying pIYl, over fifty-fold 
relative to wild-type levels . These methods should prove 
generally applicable to the amplification of membrane enzyme 
levels in v ~vo , being of value both in facilitating the 
purification of minor membrane components, and in metabolic 
Vi. 
studies where being able to modulate the levels of 
enzymes in vivo should give valuable information on 
the metabolic pathways they are involved in. 
The respiratory NADH dehydrogenase was purified to 
homogeneity from amplified membrane particles as a 
lipoprotein complex. This preparation possesses the 
highest reported NADH:ubiquinone oxidoreductase activity; 
. -1 530 units mg . It is postulated that this enzyme contains 
all the components associated with electron transfer 
between NADH and ubiquinone in vivo and, if so, this is 
the first highly purified preparation of the NADH: 
ubiquinone oxidoreductase segment of the respiratory 
chain, from any source. The enzyme consists of a single 
subunit of MW - 45,000 with one molecule of FAD per poly-
peptide chain. No Fe or acid-labile S was detected. The 
enzyme is in a reconstitutively active form, and a cyanide-
sensitive NADH oxidase can be reconstituted from the pure 
enzyme and ndh mutant membrane particles. 
In preliminary protein chemical studies, the sequence 
of the first 20 amino acid residues was determined; data 
which was subsequently used to locate the structural gene 
in the complete nucleic acid sequence of the cloned DNA 
fragment containing the ndh gene. Evidence was obtained 
for the existence of unprocessed enzyme in the preparation 
having an amino-terminal formyl-methionine; this has 
important implications with respect to initiation of 
translation of this particular gene product. 
The hybrid plasmid pIY2 (Young, I.G., Jaworowski, A. 
& Poulis, M.I. (1978) Gene 4, 25-36) was shown to probably 
carry the gene coding for the respiratory D-lactate 
vii. 
dehydrogenase flavoprotei n , and strains carrying pIY2 
possess amplified levels of D-lactate oxidase. A novel 
pathway for NADH oxidation in strains carrying pIY2 is 
proposed to explain how this plasmid is able to 
complement ndh mutants. 
This work illustrates new genetic and molecular 
biological approaches which will help to solve difficult 
problems in the enzymology of membrane-bound systems. A 
system has been characterized and developed which, by its 
simplicity and flexibility, should be an excellent model 
system for probing questions concerning membrane-bound 
enzymes and membrane proteins in general. 
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CHAPTER 1. 
Introduction 
1. 
Organisation of Thesis. 
In this thesis the purification and properties of 
the respiratory NADH dehydrogenase complex from E. coli 
is presented. Chapter 2 details the attempts to purify 
the complex as a ubiquinone reductase following 
solubilization of wild-type membrane particles. Although 
this was not achieved, it was possible to identify the 
NADH:ubiquinone oxidoreductase which was solubilized, as 
the respiratory NADH dehydrogenase by the use of an ndh 
mutant strain. To facilitate the purification of the 
NADH:ubiquinone oxidoreductase, techniques were developed 
to amplify the levels of the respiratory dehydrogenase in 
the membrane by using gene-cloning techniques. These 
experiments are described in Chapter 3. With the use of 
the genetically-amplified membrane particles, developed 
in Chapter 3, and the purification procedures described 
in Chapter 2, it was possible to purify the respiratory 
NADH dehydrogenase to homogeneity and characterize the 
preparation. These results are presented in Chapter 4. 
Some protein chemical studies on the pure enzyme are 
presented in Chapter 5; though not complete, they point 
to the. existence of unique properties in the initiation of 
translation of this particular gene product. 
In this introduction, the details of the respiratory 
pathway, that this enzyme is an important part of, are 
presented. The properties of the mitochondrial NADH and 
succinate dehydrogenase complexes are discussed since 
these two systems are the only well -studied respiratory-
chain-linked ubiquinone reductases. There has been little, 
2 . 
if any , enzymology on the qu inone reductase components of 
the E. coli respiratory chain: however a survey on the 
work done in purifying soluble dehydrogenase preparations 
active with artificial electron acceptors, and derived 
from respiratory components, is presented, concentrating 
on those attempts to purify the respiratory NADH 
dehydrogenase . An associated reaction of the NADH 
dehydrogenase complex in E. coli is thought to be that of 
energy conservation coupled to quinone reduction, although 
this has not been universally accepted at present. A 
summary of the experimental evidence for such a reaction 
is presented . 
The Aerobic Respiratory Chain of E. coli. 
Escherichia coli is a facultative anaerobe. It 
derives most of its energy from respiration by using o2 
as terminal electron acceptor, under conditions of 
aerobic growth , and fumarate or N0 3 under conditions of 
' 
anaerobic growth (Haddock & Jones, 1977). The respiratory 
chain can be seen as a more complicated system compared to 
that of the mitochondrion due to the variety of terminal 
electron acceptors and the larger number of various 
dehydrogenases (inducible and non-inducible) which feed-in 
to the respiratory chain. Only the aerobic respiratory 
chain will be considered here. 
Despite obvious differences in detail, the aerobic 
respiratory chain of E. coli is basically similar to that 
of the mitochondrion in that in both cases there are a 
series of substrate-specific dehydrogenases which catalyze 
the transfer of electrons to a quinone pool, and 
3. 
ultimately to molecular o2 via a cytochrome chain (see 
Figure 1-1). The major non-inducible respiratory-linked 
dehydrogenases are the NADH, succinate and D-lactate 
dehydrogenases . In addition, growth on certain carbon 
sources induces the synthesis of specific respiratory-
linked dehydrogenases capable of metabolizing that 
substrate , e . g . L-lactate (Kline & Mahler, 1965; Futai & 
Kimura , 1977) , D-alanine (Raunio & Jenkins, 1973; 
Olsiewski et al.~ 1980) ·, praline (Frank & Rybicki, 1961; 
Scarpulla & Soffer , 1978) and glycerol (Lin et al .~ 1962; 
Ki stler et al . ~ 1969 ; Schryvers et al.~ 1978) . 
There are five major ~ytochromes synthesized 
aerobically wh i ch are membrane - bound and thought to be 
i nvolved in respiration. These are cytochromes b 556 , 
b 558 ~ b 562 , o and d (Shipp , 1972) . Cytochrome · b 562 
. is 
only partially membrane-bound , and a considerable 
proportion of th i s cytochrome is found in the cytoplasm 
(Ashcroft & Haddock, 1975; Hagaki & Hager, 1966) . Its 
' 
involvement in respiration is uncertain . Cytochromes 
o and b 556 are the major cytochromes found under 
conditions of vigorous aeration . Cytochrome o , which is 
a b-type cytochrome , acts as a terminal oxidase (Haddock 
et al . ~ 1976) . It exhibits a high affinity for KCN 
(Pudek & Bragg , 1974) and has been shown to be kinetically 
competent to act as a terminal o x idase under conditions of 
high o2 tension (Haddock et al .~ 1976). 
There have been reports that under conditions of 
low o2 tension , when cultures approach late exponential 
and stationary phases, the content of cytochromes b 558 and 
d increase in the membrane (Pudek & Bragg, 1975; Shipp, 
4 . 
FIGURE 1 - 1 . The Aerobic Respira tory Chain of E. c o li . 
D-locfote 
dehydrogenase 
...... 
. . . 
..-a MK 
. 
succinate 
dehydrogenase -
J 
. 
. 
. Q · .. 
. 
. b.562 
NADH : : 
dehydrogenose ----•~\~ j __ /l _ __,_L ... ~~ .... ~:=~re b:
5
- ,ytoch,ome ;-02 
· ... Q MK .. • ascorbate 
• 
/'V energy 
coupling 
. · · · ... · ···· - PMS 
-/ 
~ - glycerophosphate 
dehy?rogenose 
• 
A.I energy 
coupling 
A schematic representation of the aerobic r e spiratory 
chain of E. coli showing the postulated sites of energy 
conservation: after Wallace & Young (1977b) . 
5 . 
1972) . It has been pos tulated that under these 
conditions an alternative cytochrome chain is synthesized 
consisting of these two cytochromes, with cytochrome d 
acting as a terminal oxidase. How this may function as 
a response to lowered o2 tension is suggested by the 
higher affinity of cytochrome d , compared to cytochrome o , 
for o2 , as indicated by its lower sensitivity to KCN 
(Haddock & Jones , 1977; Pudek & Bragg, 1974; Pudek & 
Bragg, 1975) . 
Increased synthesis of cytochromes b 558 and d have 
also been observed under conditions of sub-optimal aerobic 
growth, e . g . sulphate limitation (Poole & Haddock, 1975) 
and ~n the presence of sub-lethal concentrations of 
potassium cyanide (Ashcroft & Haddock, 1975). 
The E. col~ respiratory chain differs from that of 
the mitochondrion in that it is a multiple quinone system. 
The three major species of quinone found in E. coli are 
ubiquinone - 8 and the two naphthoquinones, menaquinone-8 
and demethylmenaquinone-8 (see Figure 1-2; Pandya & King, 
1966; Wallace & Young, 1977(b)) . Ubiquinone-8 is the 
predominant quinone species present in aerobically grown 
E. coli , whereas the levels of the two napthoquinones are 
higher in anaerobically-grown cells (Bishop et al .~ 1962; 
Wallace & Young, 1977(b); Alexander & Young, 1978(a) & 
(b)). The levels of menaquinone-8 have been observed to 
increase when cells are grown in the presence of sub-
lethal concentrations of KCN (Ashcroft & Haddock, 1975) 
and where there exists an impairment in the activity of 
the respiratory chain, e . g . in ubiquinone-def icient (Co x 
et al . ~ 1970) or haem-deficient (Haddock & Schairer, 1973) 
strains . 
6 . 
FIGURE 1-2 . Structure of the Major Quinone Species in 
E . coli . 
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The Involvement of Qui none s in Electron Transport . 
There was some early doubt concerning the 
involvement of ubiquinone as an obligatory electron 
carrier in mitochondrial respiration. Using chemical 
extraction methods to determine the ext~nt of reduction 
of endogenous ubiquinone by succinate and NADH, Redfearn 
and Pumphrey (1960) concluded that the rate of reduction 
was less than the overall oxidase rate. Similar 
conclusions were reached by Chance and Redfearn (1961) 
and Storey and Chance (1967) using direct spectrophoto-
metric determination of the extent of reduction of the 
quinone pool. Using improved chemical extraction and 
spectrophotometric techniques, Kr~ger and Klingenberg 
(1966) obtained rates of reduction of the endogenous 
ubiquinone which were high enough to be consistent with 
a role in oxidation. The involvement of ubiquinone as ~n 
obligatory electron carrier in mitochondrial respiration 
was demonstrated by the extraction/reactivation studies 
of Lester and Fleischer (1959) for the succinate oxidase 
system and Szarkowska (1966) and Ernster et al .~ (1969(a) 
& (b)) for the NADH oxidase. In the case of E. coli~ 
demonstration of the involvement of ubiquinone in 
respiration has been achieved in elegant experiments with 
the use of quinone-deficient strains (Cox et al .~ 1970; 
Wallace & Young, 1977(b); Gibson & Cox, 1973). Ubiquinone 
has been shown to be involved in the NADH, succinate and 
D-lactate oxidase systems (Cox et al .~ 1970; Wallace & 
Young, 1977(b)), whereas both ubiquinone and menaquinone 
may participate in electron transport from a - glycero -
phosphate and, to a lesser extent, D-lactate (Wallace & 
8 • 
Young , 1977(b)) . These sL dies have discounted earlier 
reports that ubiquinone is not involved in NADH 
oxidation in E. coli . Irradiation of membrane particles 
at 360nm led to destruction of endogenous quinone and 
loss of NADH and succinate oxidase activity (Kashket & 
Brodie, 1963(b)). Reactivation experiments with 
vitamin K2 and ubiquinone-10 led to the conclusion that 
ubiquinone is involved in succinate oxidase and mena-
quinone in NADH oxidase. Bragg & Hou (1967(b)) prepared 
membrane particles which contained a very low level of 
endogenous ubiquinone. From these particles they 
extracted two menadione redQctases. One of these enzymes 
was not active towards ubiquinone and was assumed to be 
the respiratory NADH dehydrogenase (see below). They 
concluded that the major pathway of NADH oxidation in 
E. coli is not quinone dependent. 
Two models of quinone involvement in E. coli 
respiration have been proposed. Cox et al . (1970) ·and 
Downie and Cox (1978) have postulated that ubiquinone 
functions at two sites; between the NADH dehydrogenase and 
cytochrome b 562 and at a second site between cytochrome 
b 556 and the terminal oxidases (Downie & Cox, 1978). In 
a model based upon that of Kr6ger & Klingenberg (Kr6ger 
et al .~ 1973(a) & (b); Kr6ger & Klingenberg, 1970), 
Wallace and Young (1977(b)) have proposed that the 
quinones act as a pool of mobile electron carriers between 
the dehydrogenases and a common cytochrome chain. The 
specificity of each oxidase system with respect to the 
various quinones would reside with the substrate-
specificity at the active site of each dehydrogenase 
9 . 
complex. Both models i nclude the concept of an NADH 
dehydrogenase complex capable of reducing ubiquinone 
in vivo . 
Mitochondrial Respiratory Dehydroqenases. 
There has been a substantial amount of work carried 
out on the various respiratory-linked dehydrogenases of 
the mitochondrion: e.g . L-gJ.ycerol-3-phosphate 
dehydrogenase , choline dehydrogenase, yeast D and L-
lactate dehydrogenases , succinate dehydrogenase and 
NADH dehydrogenase (Hatefi & Stigall, 1976). By far the 
majority of this work has been carried out on the latter 
two enzymes , and these will be considered in detail here. 
The pioneering work of Hatefi and his co-workers 
resulted in the resolving of the mitochondrial respiratory 
c hain into a series of lipoprotein complexes capable of . 
i nteracting stoichiometrically to form a particulate unit 
with similar activities and inhibition characteristics to 
' 
the intact respiratory chain (Hatefi & Rieske, 1967). 
These complexes represent the NADH:ubiquinone oxido-
reductase (complex 1), succinate : ubiquinone oxidoreductase 
(complex 2) , ubiquinol:cytochrome c oxidoreductase 
(complex 3) and cytochrome c oxidase (complex 4) segments 
of the respiratory chain . They have not only proven 
valuable in studying the various partial reactions of the 
respiratory chain, but have also served as the starting 
material for further purification of respiratory 
components . 
10. 
A. Succinate Dehydrogen ase Complex. 
Complex 2 catalyzes the transfer of electrons 
between succinate and ubiquinone (Zeigler & Doeg, 1959; 
Ziegler & Doeg, 1962; Hatefi et al .~ 1961) with a 
specific activity of 45 to 55 µmol min-l mg-l (at 38 ° ) 
using ubiquinone-2 as electron acceptor. It contains 
5nmoles of covalently-bound flavin per mg protein, and 
7 to 8 g-atoms of iron and 7 to 8moles of acid-labile S 
per ' mole of flavin. In addition, complex 2 contains a 
b - type cytochrome in approximately equimolar amount to 
the flavin . This cytochrome, b 557 _5 (Davis et al .~ 
1973) is found exclusively in complex 2 following 
fractionation of the respiratory chain into its constituent 
complexes . It is not detectably reduced by succinate in 
either complex 2 or respiratory particles, and its 
significance is unknown (however, see below). 
Complex 2 has been used as the starting material 
for the preparation of soluble succinate dehydrogenase 
using various chao~ropic agents (Davis & Hatefi, 1971). 
The soluble succinate dehydrogenase (assayed with 
phenazine methosulphate as electron acceptor) has a 
molecular weight of 97 , 000 and consists of two distinct 
subunits of molecular weights - 70,000 and -2 7,000. The 
preparation contains - lOnmoles of covalently-bound FAD 
-1 . 
mg protein (located on the larger subunit) with a 
flavin:iron:acid-labile S ratio the same as for complex 2 
(Davis & Hatefi, 1971; Hatefi & Stigall, 1976). 
The FAD was found to be covalently linked to the 
N-3 nitrogen of a histidyl residue via the methyl group 
at position 8 on the isoalloxazine ring (Hemmerich et al .~ 
11. 
1969; Salach et al .) 19 7 2) . The sequence of a penta-
peptide containing the histidyl-8- a -FAD has been 
obtained (Singer et al .) 1973): ser-his-thr-val-ala. 
The exact number and the nature of the iron-sulphur 
prosthetic groups in succinate dehydrogenase and 
succinate:ubiquinone oxidoreductase is still a matter of 
controversy (Ohnishi et al .) 1976; Coles et al .) 1979; 
Albracht , 1980). 
The structure of the soluble succinate dehydrogenase 
from mitochondria is very similar to that purified from 
R. rubrum (Davis & Hatefi, 1971; Hatefi et al .) 1972). 
Recently, a preparatiDn of succinate:ubiquinone 
oxidoreductase was purified following triton X-100 
solubilization of N. crassa mitochondrial particles 
(Weiss & Kolb, 1979). This preparation contained three 
subunits (molecular weights 72,000, 28,000 and - 14,000); 
two subunits analogous to those of the soluble succinate 
dehydrogenase from mammalian mitochondria and R. rubrum) 
and · one b~type cytochrome. A similar preparation has 
been purified from the cytoplasmic membrane of B. subtilis 
(Hederstedt et al .) 1979) by immunoprecipitation of 
triton X-100 solubilized membranes. It is suggested that 
succinate dehydrogenase is attached to the membrane -
bound cytochrome b via the smaller (molecular weight 
28 , 000) iron-protein subunit (ibid.). 
The scheme of electron transport between succinate 
and ubiquinone is complicated by the reports of Yu et al . 
(1977 (a) & (b) ), who have isolated a protein from mammalian 
mitochondria (QPs) (molecular weight, 15,000), which 
reconstitutes a thenoyltrifluoroacetone (TTFA)-sensitive 
12. 
succinate:ubiquinone ox i doreductase activity when added 
to soluble succinate dehydrogenase. This protein is 
assumed to act as a ubiquinone binding protein (ibid.), 
and possibly even to allow electron transport to occur 
between the soluble succinate dehydrogenase and ubiquinone 
outside of the lipid phase (Yu & Yu, 1980). However, the 
preparation of QPs does not contain iron or haem and is 
thought to be distinct from cytochrome b . 
Succinate:ubiquinone oxidoreductase is the best-
characterized respiratory-linked enzyme catalyzing the 
reduction of ubiquinone, having all of the polypeptides 
and prosthetic groups involved in catalysis close to 
being identified. 
B. The NADH dehydrogenase Complex. 
Complex 1 (see above) catalyzes the transfer of 
electrons between NADH and ubiquinone; the specific 
activity with ubiquinone-1 as electron acceptor is 
-1 -1 25 wmoles min mg (Merola et al .~ 1963). The complex 
' 
contains non-covalently-bound FMN, non-haem iron, acid-
labile S, ubiquinone and lipid (Table 1-1). 
The reduction of ubiquinone, catalyzed by complex 1, 
is sensitive to rotenone and piericidin (Hatefi et al .~ 
1962; Hatefi & Stigall, 1976) and, by this criterion, is 
similar to the NADH-dependent reduction of ubiquinone-1 
by mitochondrial particles and to the reduction of 
endogenous ubiquinone during NADH oxidation. 
Complex 1 has been reconstituted with artificial 
phospholipid vesicles and shown to couple protein gradien t 
formation to the reduction of exogenous ubiquinone-1 
(Ragan & Hinkle, 1975). The reconstituted vesicles could 
13. 
TABLE 1-1. Composition of Complex 1 
Component Content 
-
-1 FMN (acid extractable) . 1.4-1.Snmoles mg 
non-haem 23-26ng atoms -1 iron mg 
acid-labile sulphide 23-26nmoles -1 mg 
ubiquinone-10 4.2-4.Snmoles -1 mg 
-
lipid 0.22mg -1 mg 
' 
(Hatefi et al .~ 1962) 
14. 
also support the uptake of a lipophilic ion, tetraphenyl-
boron . This complex is therefore an intact preparation 
of the NADH:ubiquinone oxidoreductase segment of the 
respiratory chain and the energy conservation site 
associated with it. 
SDS-polyacrylamide gel electrophoresis reveals the 
presence of at least 10 different polypeptides (Hatefi & 
Stempel , 1969). The polypeptide composition of complex 1 
has recently been extensively studied (Ragan, 1976(b); 
Crowder & Ragan, 1977; Heron et al.~ 1979) and up to 26 
different polypeptides have been resolved. This entity 
has been assumed to be a definite stoichiometic complex 
(Heron et al . ~ 1979; Ragan, 1976(b)) but as to how many 
of these polypeptides are actually involved in electron 
transport , or even the associated energy conservation 
reaction, is unclear. 
Complex 1 has been shown, by EPR spectroscopy, to 
possess four distinct iron-sulphur prosthetic groups 
(Orme-Johnson et al .~ 1974). All four centres are 
rapidly reduced by NADH: the order of this reduction was 
obtained kinetically by measuring the rate of appearance 
of the various signals using 3-acetylpyridine NADH as 
substrate . The number of iron-sulphur prosthetic groups 
is by no means agreed upon, however (Ohnishi et al .~ 1974; 
Ohnishi, 1975). 
Several soluble NADH dehydrogenases have been 
purified from either complex 1 or mitochondrial particles. 
These preparations fall into two groups; the high molecular 
weight (type I) dehydrogenase (Ringler et al .~ 1963) and 
the low molecular weight (type II) dehydrogenases (Mahler 
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et al.~ 1952; Pharo e t 1 a v , ~ 1966; King & Howard, 1962; 
Mahler, 1961; Kumar e t al.~ 1968; Hatefi & Stempel, 1969). 
The former preparation has a molecular weight of ~800,000, 
and was obtained by phospholipase digestion of membrane 
0 particles at 30 . Solubilization with phospholipase at 
37° or by exposure to 9% ethanol at 43°, pHS (heat-acid-
ethanol) produces the latter which has a molecular weight 
of ~80 ,000. Exhaustive work by Singer and co-workers has 
demonstrated that apparently different preparations of the 
latter enzyme are all basically identical. Hatefi and · 
Stempel (1969) and · Galante and Hatefi (1979) have purified, 
and extensively characterized, a type II dehydrogenase 
prepared by chaotropic resolution of complex 1. The latter 
preparation contains three subunits of molecular weight 
51,000, 24,000 and 9-10,000. It contains FMN (13.Snmoles 
-1 -1 
mg protein), non-haem iron (74ng atoms mg protein) 
-1 
and acid-labile S (72 nmoles mg protein). The ratio of 
non-haem iron to flavin suggests the presence of two 
(and possibly three) iron-sulphur clusters. The structure 
is reminiscent of that of succinate dehydrogenase (see 
above). Amino acid compositions have been obtained for 
each subunit (Galante & Hatefi, 1979). 
A controversy has arisen in the literature 
concerning the significance of the type II dehydrogenase 
preparations, especially regards their high ubiquinone 
reductase activity . These arguments are too lengthy to 
consider here, in depth, and the reader is directed to 
various reviews propounding the different points of view 
(Singer & Gutman, 1971; Hatefi & Stigall, 1976; see also 
Ragan, 1976). Basically, the high ubiquinone reductase 
activity of type II dehydrogenase has been considered 
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artifactual, and unrela t ed to the physiological 
ubiquinone reductase activity (Singer & Gutman, 1971). 
The major experimental evidence supporting this is 
(1) The rotenone sensitivity of the ubiquinone reductase 
activity of type II dehydrogenases differs from that of 
membrane particles or complex 1. (2) Transformation 
of type I to type II dehydrogenase occurs under the 
same conditions as the solubilization of type II dehydro-
genase from the membrane: since the type I dehydrogenase 
possesses negligible ubiquinone reductase activity, that 
of the type II dehydrogenase is generated by solubilization. 
The physiological redrrction of ubiquinone has been 
shown to require phospholipid (Ragan & Racker, 1973; · 
Heron et al .~ 1977). The soluble dehydrogenase cannot 
therefore be expected to catalyze this reaction. What 
is more relevant, however, is (1) whether ubiquinone 
accepts electrons from the same catalytic site (i.e. 
prosthetic group) on the dehydrogenase and in the membrane, 
and (2) whether any components involved in electron 
transport between NADH and ubiquinone have been lost or 
denatured during preparation. These questions have yet 
to be answered. 
Respiratory Dehydrogenases from E. coli . 
Comparatively little enzymology has been carried 
out on the enzyme components of the aerobic respiratory 
chain of E. coli compared to those of the mitochondrion. 
D-lactate dehydrogenase has been purified from 
E. coli ML (Futai, 1973; Kohn & Kaback, 1973) and E. coli 
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W (Pratt et a l.~ 1979). Fut ai (1973) solubilized membrane 
particles with sodium deoxycholate and purified the 
solubilized enzyme by a series of ammonium sulphate and 
chloroform precipitations, followed by chromatography on 
DEAE-sephadex and DEAE-cellulose. The purified enzyme 
consisted of a single polypeptide of apparent molecular 
weight 72,000, containing between 0.8 and l.7eq FAD per 
subunit. A similar preparation was obtained by Kohn and 
Kaback (1973), who fractionated crude extracts of E. coli 
with ammonium sulphate, sodium perchlorate and DEAE-
cellulose column chromatography, and solubilized the 
enzyme by DEAE-cellulose column chromatgraphy in the 
presence of triton X-100. The purified enzyme was 
reported to consist of a single subunit of apparent 
molecular weight 73,000 and containing ~leq FAD per 
subunit. Pratt e t a l . (1979) solubilized membrane 
particles with sodium deoxycholate then purified D-
lactate dehydrogenase by DE-52, Sephadex G-200 and 
hydroxylapatite column chromatography in the presence 
of triton X-100 and deoxycholate. The preparation 
consisted of a single subunit of apparent molecular 
weight ~75,000. The preparations of Futai (1973) and 
Kohn and Kaback (1973) were active with D-lactate and, 
to a lesser extent, L-l a ctate (12 and 17 % respe cti vely 
under the standard assay cond itions used). The enzyme 
preparations were assayed by measuring phenazine metho-
sulphate (PMS) mediated reduction of 3, (4,5-dimethyl-
thiazolyl-2-)-2,5-diphenyltetrazolium bromide (MTT); 
in no case was reactivity towards ubiquinone as electron 
acceptor reported. 
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Futai and Kimura (197 7) reported the purification 
of an inducible L-lactate dehydrogenase following 
solubilization of membrane particles with sodium cholate 
and chromatography in the presence of Tween 80. The 
enzyme consisted of a single polypeptide of apparent 
molecular weight 43,000 and existed as an oligomer of 
average molecular weight 480,000 in the presence of these 
detergents . The preparation was shown to contain ~leg FMN 
per subunit . The enzymic activity was assayed by measuring 
the PMS coupled reduction of MTT by L-lactate. D-lactate 
was inactive as a substrate. No reactivity towards 
ubiquinone was reported. 
Scarpulla and Soffer (1978) reported the 
solubilization and purification of an inducible proline 
dehydrogenase which contained a single polypeptide of 
apparent molecular weight ~124,000. The preparation, 
which catalyzed the transfer of electrons from L-proline 
to various artificial dye-acceptors,was shown to have 
~o.24eq FAD per subunit, and required reactivation by 
FAD in the assay for full activity. 
Olsiewski et al . (1980) have recently reported the 
partial purification of an inducible D-amino acid 
dehydrogenase following solubilization of membrane 
vesicles with triton X-100. SDS-polyacrylamide gel 
electrophoresis indicates that the purified enzyme 
consists of two subunits of apparent molecular weights 
45,000 and 55,000. The enzyme contains FAD a nd non-haem 
iron in the ratio of 1:2 to 3, but the distribution of 
these prosthetic groups amongst the two subunits has not 
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been determined. It is n o t known as yet whether 
the iron in the preparation is associated with an iron-
sulphur prosthetic group. The enzyme preparation 
possesses a low activity towards ubiquinone-1 as electron 
acceptor (specific activity= 2.4 units/mg under their 
standard assay conditions, and with D-alanine as electron 
donor) . 
The various attempts to purify the respiratory NADH 
dehydrogenase from E. coli are dealt with elsewhere (see 
below) . 
The Respiratory NADH dehydrogenase of E. coli. 
Various attempts have been made in the past to 
purify the respiratory NADH dehydrogenase from E. coli. 
Wosilait and Nason (1954) reported the partial purification 
of a menadione reductase from crude extracts prepared by 
grinding cells in alumina . This preparation was active 
with both NADH and, to a lesser extent, NADPH,and was 
distinguished from the 'quinone reductase' activity 
(assayed with p - benzoquinone as electron acceptor) also 
found in crude extracts of E. coli . 
Kashket and Brodie (1963(b)) solubilized an NADH 
dehydrogenase from small particles, with deoxycholate. 
The enzyme was not further purified. The preparation 
could reduce vitamin K2 , menadione and, to a lesser extent, 
vitamin K1 . The specific activity of the preparation 
however was very low (0.02lµmol min-l mg-l with vitamin K2 
as electron acceptor). From UV-irradiation/reactivation 
experiments, it was concluded that menaquinone is involved 
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in NADH oxidation in the small particle fraction (see 
above). The enzyme solubilized from small particles was 
differentiated from the quinone reductase activity of 
either large particles or the cytoplasmic fraction. 
Bragg (1965) sonicated E. coli suspensions in the 
presence of deoxycholate, and purified two NADH 
dehydrogenases which catalyzed the menadione-mediated 
reduction of o2 and triphenyltetrazolium chlorid
e (TTC) 
respectively. Bragg and Hou (1967(a)) solubilized a 
small particle fraction of E. coli with deoxycholate and 
resolved two menadione reductases (menadione reductases 
I and II) by calcium phosphate gel chromatography. One 
of these activities (menadione reductase II) was further 
purified by DEAE-cellulose column chromatography (Bragg 
and Hou, 1967(b)) which separated it from a contaminating 
NADH oxidase activity. Menadione reductases I and II 
were active with both NADH and NADPH as electron donor. 
On the basis of sensitivity to various inhibitors, it 
was concluded that menadione reductase I is the major 
respiratory dehydro genase. The small particle fraction, 
used as the starting material for the isolation of these 
enzymes, was found to have very low levels of ubiquinone 
(Bragg & Hou, 1967(a)) and it was concluded that the 
maJor pathway of NADH oxidation is quinone independent. 
Gutman et al . (1968) prepared and l yophilized a 
small particle fraction from E. coli . When the lyophilized 
particles were resuspended in distilled wa ter and 
centrifuged, the yellow supernatant possessed NADH 
dehydrogenase activity with menadione, potassium ferri-
cyanide and dichlorophenolindophenol as el e ctron 
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acceptors . No further purification procedures were 
attempted. The NADH dehydrogenase solubilized in this 
manner was shown to be different to the soluble diaphorase 
activity in the cytoplasm by a nu~ber of criteria: 
differences in the apparent K for NADH and potassium 
m 
ferricyanide , and sensitivity to dicoumarol. The enzyme 
fraction detached from the membrane particles by 
lyophilization was assumed to be the respiratory NADH 
dehydrogenase. The preparation was shown to contain 
approximately equal amounts of both FAD and FMN (0.2 and 
-1 0.3nmol mg protein, respectively) and non-haem iron and 
acid-labile sulphur (14 to lQng atoms and 11 to 13nmoles 
-1 
mg protein, respectively). 
In the early work described above, no evidence as 
to the purity of the various preparations was ever given, 
nor were adequate criter ia to identify the various 
preparations obtained with the respiratory enzyme, even 
when the presence of contaminating dehydrogenase 
activities was demonstrated . 
The first work which seriously attempted to identify 
a purified enzyme preparation with the respiratory NADH 
dehydrogenase, and to give adequate consideration to the 
problem of contaminating activities, was that of Dancey 
et al . ., 1976. They chose osmotically lysed sphero-
plasts as the starting material for their purification, to 
try to overcome the problem of the very high levels of 
NADH dehydrogenase activity in the cytoplasm of E. coli. 
They found that only 10 to 20 % of the NADH dehydrogenase 
activity (measured with dichlorophenolindophenol, DCIP, 
as electron acceptor) is associated with the membrane 
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fraction. Spheroplasts, prepared in this manner, have 
been shown to be substantially free of cytoplasmic 
contamination (Kaback, 1971). The activity present in 
the membrane particles was judged to be different to 
that found in the cytoplasm by the following criteria: 
(1) The membrane-bound activity is completely inhibited 
by lOmM AMP, whereas the cytoplasmic activity is only 10% 
inhibited at this concentration. (2) The membrane-bound 
activity is highly sensitive to triton X-100. (3) The 
cytoplasm has a much higher ratio of dehydrogenase to 
oxidase activity compared to the membranes. (4) There 
a very high NADPH dependent ITCIP reductase activity in 
unfractionated cell extracts, but not in the membrane. 
The leyel of NADPH dehydrogenase activity was used as a 
measure of cytoplasmic contamination of the membrane 
preparation: it was found to be less than 1% of that 
present in unfractionated cell extracts, confirming the 
results of Kaback, 1971. 
. is 
An NADH dehydrogenase was solubilized from sphero-
plasts with triton X-100 and further purified by ethanol 
precipitation and DEAE-cellulose, hydroxylapatite and 
DEAE-agarose column chromatography in the presence of 
triton X-100. A purification of 9 to 16-fold was achieved 
over the activity present after solubilization (this was 
lower, however, when either menadione or potassium 
ferricyanide were used as substrates). Since the recovery 
of activity following solubilization was in the range of 
30 to 50%, the specific activity of the pure enz Jrne was 
only 3 to 8-fold higher than that of the vesicles, in the 
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DCIP reductase assay. The authors attribute the loss 
of activity following solubilization to multiple points 
of interaction of DCIP with the respiratory chain. 
The most highly purified preparations contained a 
single polypeptide of molecular weight 38,000 (estimated 
densitometrically, on SDS-polyacrylamide gels, to 
represent 75% of the material in the preparation). The 
enzyme was estimated to be present at a level equivalent 
to 2% of the total membrane protein or 0.2% of the total 
cellular protein. The preparation was NADH-specific and 
contained no flavin: the enzymic activity showed an 
absolute requirement for FAD - in the assay (Dancey & 
Shapiro, 1976). 
This enzyme was identified as the respiratory NADH 
dehydrogenase on the basis that it is (1) NADH specific, 
(2) it shows similar sensitivity to AMP as the membrane-
bound NADH oxi4ase and (3) since· antibodies elicited 
against the pure enzyme inhibit the membrane-bound NADH 
oxidase. 
Energy Conservation Associated with the NADH:ubiquinone 
Oxidoreductase Segment of the Respiratory Chain. 
The existence of a site of energy conservation 
associated with the NADH :ubiquinone oxidoreductase 
segment of the mitochondrial respiratory chain has long 
been assumed from the difference in P/0 ratios obtained 
with NADH-linked substrates and succinate (e . g . see 
Lehninger, 1964). This site of energy conservation, 
'site -1', has been demonstrated directly by measuring 
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uncoupler-sensitive pho s ha te esterification coupled to 
NADH-dependent ubiquinone-1 reduction in mitochondrial 
particles (Schatz & Racker, 1966). 
The existence of site 1 in E. coli is still a 
matter of some controversy. Due to the very low P/0 
ratios obtained with membrane vesicle preparations (e . g . 
see Butlin et al.~ 1971) no definite statement as to the 
number of energy coupl-ing sites associated with the 
various electron transport chains is possible as is the 
case with mitochondria. 
The existence of multiple sites of energy 
conservation in the E. coli respiratory chain has been 
suggested by measurements of molar growth yields in 
continuous culture (Harrison & Loveless, 1971) and by 
whole - cell measurement of phosphate esterification, 
accompanying o2 addition to anaerobic suspensions of 
bacteria (Hemp£ling, 1970). Both of these approaches 
have been criticized however (Stouthamer & Bettenhaussen, 
' 197·3 ; van der Beek & Stouthamer, 1973). 
Sweetman and Griffiths (1971) reported the preparation 
of a small particle fraction of E. coli which catalyzed 
ATP-dependent reduction of NAD+ by succinate. This 
reaction was sensitive to uncouplers such as pentabromo-
phenol and dicoumarol but not 2,4-dinitrophenol or oligo-
mycin. A similar reaction was demonstrated by Poole and 
Haddock (1974) in a small particle fraction prepared 
from glycerol-grown cells but not glucose-grown cells. 
The activity was sensitive to washing of the particles 
in low ionic strength buffer and could be demonstrated 
in particles prepared from ubiquinone-de f icient mutant 
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strains of E. co l i only af te r addition of ubiquinone-1. 
Its presence in haem-deficient strains suggested that 
this reaction does not involve the cytochrome chain 
(ibid . ). 
Lawford and Haddock (1973) demonstrated the 
presence of two proton translocating segments associated 
with the NADH oxidase from measurements of uncoupler-
sensitive proton translocation in intact, glycerol-grown 
cells. A ~--H+/0 ratio of ~4 was obtained with 
L-malate as a substrate, and ~2 with succinate, D-lactate 
or glycerol as substrates: assuming a +; 't . ~-- H si e ratio 
of 2 , it was concluded that one proton translocation 
' loop ' is associated with the NADH:ubiquinone oxido-
reductase segment of the respiratory chain. From similar 
measurements on sulphate-limited, glycerol-grown cells 
(Poole & Haddock, 1975) it was shown that this activity 
is lost under conditions of sulphate-limitation. It was -
postulated that under these conditions a non-proton-
translocating NADH dehydrogenase is synthesized which may 
be associated specifically with cytochromes b 558 and d 
(ibid ., Haddock & Jones, 1977). 
CHAPTER 2 . 
Identification and Partial Purification 
of the Respiratory NADH dehydrogenase 
from the Wild-Type Strain, IY13 
26. 
INTRODUCTION 
In previous work in this laboratory, a mutant strain 
of E. col i ~ which is defective in electron transport, was 
i solated from amongst strains growing poorly on succinate 
(Young & Wallace , 1976) . This strain, AN589, has less than 
2 % of the -wild-type level of NADH oxidase in the plasma 
membrane , but is unaffected in the levels of D-lactate and 
succinate oxidases . The mutation has been designated ndh 
and a phenotype established based on the inability of AN589 
to grow wi th mannitol as sole carbon source. Reversion 
analysis and transductional mapping experiments (I . G. Young, 
unpublished results, and Young & Wallace , 1976) suggest that 
the lesion is due to a single point mutation located at 
mi nute 22 on the E. coli chromosome (Bachmann & Low, 1980). 
Wi th the above phenotype established , a dozen such mutants 
were isolated . 
The inability of ndh mutant strains to grow with 
succinate as sole carbon source and the fact that they grow 
poorly on glucose, unless the medium is supplemented with 
succinate , acetate or casamino acids (a casein h ydrolyzate), 
i ndicates a defective operation of the tricarboxy lic acid 
cycle . Other evidence indicates that ndh mutants have 
problems in reoxidizing NADH generated mainly during the 
tricarboxylic acid c ycle and glycolysis: 
(1) Their inability to grow on mannitol is assumed 
to be due to the fact that the catabolism of mannitol, 
compared to that of g lucose, generates one extra molecule 
of NADH in the conversion of mannitol-1-p hosp h a t e to 
fructose-6-phosphate, an d , in the absence of the r e spira to ry 
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NADH oxidase, the cell is unable to regenerate NAD+ by the 
subsequent metabolism of fructose-6-phosphate to lactate 
(Young & Wallace, 1976). 
(2) Ndh mutant strains, grown on mannitol plus 
casamino acids, · accumulate high concentrations of D-lactate 
in their culture supernatant (Young, Jaworowski & Paulis, 
unpublished work). This suggests that in the absence of the 
respiratory NADH oxidase the reoxidation of NADH coupled to 
the reduction of pyruvate , and catalyzed by the pyridine 
nucleotide-linked D-lactate dehydrogenase in the cytoplasm, 
becomes an important reaction. 
Since the ndh mutants lack the membrane-bound NADH 
oxi dase activity but not D-lactate or succinate oxidases, 
it was assumed that the mutation is in the gene coding for 
a component of the respiratory chain located on the low 
potential side of the common respiratory components, &.e. 
towards the substrate end of the quinone pool (Young & 
Wallace , 1976) . This was confirmed by experiments showing 
' 
that the endogenous ubiquinone-8 in membrane particles 
prepared from AN589 was not reduced in the steady-state 
after the addit i on of NADH . The respiratory complex which 
transfers electrons from NADH to ubiquinone-8 was defined as 
the NADH dehydrogenase complex (ibid.) and is functionally 
analogous to the complex I isolated from mitochondria 
(Hatefi e t al . ., 1962). 
NADH dehydrogenase rates in the plasma membrane of 
AN589, measured with dichlorophenolindophenol as electron 
acceptor , are 28 % of the wild-type level. It has been 
assumed that because the NADH dehydrogenase activity is not 
completely abolished, as is the NADH oxidase activity, the 
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mutation is not in the gene coding for the primary 
dehydrogenase but in another component of the putative 
complex - possibly that of the polypeptide which interacts 
directly with ubiquinone (Young & Wallace, 1976). 
Studies using quinone-deficient mutants have 
established that the natural electron acceptor for the NADH 
dehydrogenase complex is ubiquinone-8 (Cox e t a l.~ 1970; 
Wallace & Young , 1977) . The enzyme is an intrinsic 
membrane complex in either the inner mitochondrial membrane 
o f eukaryotic cells or the plasma membrane of prokaryotic 
c ells such as E. coli . In order to study the structure of 
the complex which catalyzes tne reduction of ubiquinone 
~n vivo and , wi th the eventual aim of studying the mechanism 
of this and associated reactions, it was decided to try to 
solub i lize the complex , intact , as an NADH : ubiquinone 
o x i doreductase . 
It has not proved possible to study the reaction of 
th i s complex with ubiquinone in highly purified preparations 
from any source . The reactivity towards ubiquinone has been 
found to be very sensitive to the loss of lipid, and is 
easily destroyed during solubilization . Large macro -
molecular aggregates catalyzing the reduction of ubi-
quinones have however been solubilized from mitochondrial 
particles using bile salts as detergent (Hatefi et al .~ 
1962) . The success in solubilizing the enzyme with its 
ubiquinone reductase activity intact is related to the 
fact that the solubilized preparations still retain 20 % 
phospholipid by weight. 
In preliminary studies (M . I . Paulis & I.G. Young, 
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unpublished results) it wa s f ound that the enz yme comp lex 
from E. coli could be solubilized by the use of potassium 
cholate. In the present chapter the NADH:ubiquinone 
oxidoreductase solubilized from E. coli membrane particles 
is verified to be the respiratory NADH dehydrogenase 
complex by comparative studies with ndh mutant strains. 
EXPERIMENTAL 
Chemicals 
Cholic acid was obtained from Fluka (Switzerland). 
Stock solutions (20 % (w/v)) are brownish/orange in colour, 
presumably due to the presence of bile pigments as 
impurities. For some experiments, cholic acid was twice 
recrystallized from 50 % (v/v) ethanol by a procedure 
similar to that of Hatefi (1978). Stock solutions of 
potassium cholate (nominally 20 % (w/v)) were prepared by 
suspending 20g of cholic acid in approx. BOmLof water, 
and slowly titrating the mixture to pH7.5 with concentrated 
KOH . The solution was then adjusted to lOOmL, filtered, and 
stored at room temperature. Solutions of recrystallized 
potassium cholate are completely . colourless. 
Ubiquinone-1 was the generous gift of Drs. O. Isler 
(F. Hoffman - La Roche and Co., Basel, Switzerland) and 
D. Magrath . NADH and NADPH were obtained from P-L Bio-
chemicals (Milwaukee, Wis.) and FAD from Si gma Chemical 
Co . (St. Louis, Mo.). N-tris(hydroxymethyl)methy l-2-amino-
ethanesulphonic acid (TES), sodium salt, was obtained fro m 
Calbiochem (La Jolla, Cal.). 
Bacterial Strains and Plasmids 
All strains used are derivatives of Escherichia coli 
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K-12 . The relevant detai ls are presented 1n Tables 2-1 
and 2-2. 
Stock cultures were maintained at -20 ° as f r o zen 
suspensions in glycerol-Luria broth medium (20 % (w/v) 
glycerol in Luria broth). Freeze dried cultures of each 
strain were kept at 4° c as reserve stock. 
Growth Media 
The mineral-salts medium used has been described 
elsewhere (Stroobant et al.~ 1972), and was used at normal 
strength. The following supplements were sterilized 
separately and added at the indicated final concentrations 
to give the minimal medium: mannitol (30mM), L-histidine-
HCl (0 .l SmM), L-isoleucine (0.3mM), L-valine (0.3mM), 
L- tryptophan (0.2mM) and thiamine-HCl (lµM). Concentrations 
of other additives used were glucose (as carbon source), 
30mM; succinate, 30mM (as carbon source) or 4mM (as 
supplement); casamino acids, 0 . 1% (w/v). The complete 
medium used was brain-heart infusion. 
Solid medium contained 2 % (w/v) agar (Difeo) 1n 
minimal medium, plus the relevant additions at the 
concentrations indicated above. 
Growth of Bacteria and Preparation of Membranes 
All cultures were grown at 37 ° in mannitol-minimal 
medium supplemented with casamino acids unless otherwise 
specified. Culture turbidity was measured using a Klett-
Summerson colorimeter fitted with a blue filter, and is 
measured in Klett units . 
lOL batch cultures were grown 1n 14L New Brunswick 
glass fermenters with aeration (12L min- 1 ) and stirring 
TABLE 2-1 Bacterial Strains 
Strain Relevant Loci ' Plasmid Source or Reference 
AN589 met B, ndh 401 I - I Young & Wallace, 1976 
AN595 his ., i Zv ., t r p ., r ps L -
, 
This laboratory 
AN596 II " II " ndh 402 - Derived from AN595 by mutagenesis with 
' 
NTGa (Young & Wallace, 1976) 
AN597 II II II II ndh 403 I - I II II II 
' 
AN598 II II II II ndh 404 - II II II 
' 
w 
AN599 II II II " ndh 405 II II II I--' 
' 
-
AN600 II II II II ndh 406 I I l " " " -
' 
AN601 " " II II ndh 407 I - I II II " 
' 
AN602 " II II " ndh 408 I - I " " " 
' 
AN603 " " " " ndh 409 I - I II II " 
' 
AN604 II " II " ndh 410 I I II II " 
' 
AN605 " II II " ndh 411 I I II II II 
' 
AN606 " " II " ndh 412 I I II " " 
' 
AN607 II II II " ndh 413 I I II II " 
' 
aN-methyl-N'-nitro-nitrosoguanidine 
TABLE 2-1 Continued 
Strain Relevant Loci Plasmid 
IYS his ~ i lv ~ t r p ~ pyre, r ps L -
' 
IY12 thi ~ his ~ i lv ~ t r p ~ r p sL, ndh 406 -
IY1 3 " II " II " -
I Y34 II II " " " pSF2124 
I Y3 5 " " " II " pIYl 
IY 3 6 II " II II II ndh 406 pIY2 
' 
I Y85 " II II " II pIY9 I 
) 
) 
) 
Source or Re f erence 
This laboratory 
Isogenic pl transductant pair derived 
from IYS using AN600 as pl donor. 
Young & Wallace (1976). 
Youn g et al . (1978) 
II II 
" 
II 
II II 
" " 
I. G. Young & M.I. Paulis, unpublished 
results 
w 
N 
TABLE 2-2 
Plasmid 
pSF2124 
pGM706 
pIYl 
pIY2 
pIY9 
pLJ3 
r r Ap, Tc 
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Plasmids 
Comments 
pSF2124 with a l.6Mdal fragment, 
carrying the ndh gene inserted at 
the Eco Rl site 
pGM706 with a 4.6Mdal fragment, 
carrying the dld gene , inserted 
at the HindIII site 
Constructed from pIYl and 
carrying an - 0.lMdal Eco Rl 
fragment, containing 2 copies 
of the lac promoter, adjacent to 
the ndh gene 
pMB9 with an - 0.lMdal fragment, 
containing 2 copies of the lac 
promoter, cloned into the Eco Rl 
site 
Source or 
Reference 
So et al. , 
(1975) 
Hamer & 
Thomas (1976) 
Young et al ., 
(1978) 
" 
II II 
I.G. Young & 
M.I. Paulis, 
unpublished 
results 
Johnsrud 
(1978) 
3 4. 
(400 rpm}, to Klett 200 then harvested using a Sharples 
continuous flow centrifuge. The cells were then washed 
(Wallace & Young, 1977), frozen in liquid N2 , and stored 
at -20 ° . Contamination of cultures and possible reversion 
of IY12 were checked by streaking cultures onto brain-heart 
infusion and mannitol-minimal plates. 
Cells were thawed, resuspended in STM buffer (0.25M 
sucrose, O.lM N-tris(hydroxymethyl)methyl-2-aminoethane-
sulphonic acid, 0.02M magnesium acetate, pH 7.5) at a 
concentration of lg wet weight per 3mL buffer, then 
filtered through gauze. The cells were disrupted using a 
. -2 Ribi cell fractionator at 20,000lb in Cell debris was 
removed by centrifugation at 15,000 rpm for lh in a Sorvall 
SS-34 rotor. The ·supernatant was centrifuged for 2h at 
60,000 rpm in a Spinco 60Ti rotor. The pellet, containing 
crude membrane particles, was resuspended in STM buffer to a 
protein concentration of 35 to 45mg rnL-l and then washed ·in 
two volumes of the same buffer. The washed membrane 
particles we~e collected by centrifugation for2h at 
60,000 rpm in a Spinco 60Ti rotor, and resuspended in STM 
-1 buffer to a protein concentration of approximately 35mg rnL . 
Membrane particles were frozen in liquid N2 and stored at 
-15 ° . 
Solubilization of Membranes and Hydroxylapatite Column 
Chromatography 
0 All operations were performed at Oto 4 . 
Membrane particles (12.5mL) were washed and 
resuspended as described above , then l.9mL of 20 % (w/v) 
potassium cholate, and 0.93g of solid KCl were added to 
give the final concentrations of 3% (w/v) cholate and lM KCl. 
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The material was mixed t ho roughly by inversion, and 
insoluble material pelleted by centrifugation for 3h at 
4 8 , 000 rpm in a Spinco SW56 rotor. The clear golden 
supernatant was loaded onto a column of hydroxylapatite 
(1 .6 x 12cm) equilibrated with not less than 200mL of SmM 
potassium phosphate buffer, pH7.5 , containina 0.1 % J (w/v) 
cholate and 20µM FAD . A 400mL linear gradient, 0.005-lM 
potassium phosphate, pH 7.5, containing 0.1 % (w/v) cholate 
and 20µM FAD , was applied immediately at a flow rate of 
approxi mately 30mL h- 1 . 4mL fractions were collected. 
The NADH : ubiquinone oxidoreductase peak , which elutes 
towards the end of the gradient , was pooled, frozen in 
l i quid N2 and stored at - 15 ° . A Phar~acia Kl6/70 column 
was used for these experiments : the fine polyamide filter, 
usually in contact with the bed, was replaced by a wad of 
glass wool , since i ts use was found to be incompatible with 
hydroxylapatite at the high phosphate and cholate 
concentrations used . 
Enzyme Assays 
Procedures for the determination of oxidase rates 
have been described previously (Young et al .~ 1978). 
NADH : ubiquinone oxidoreductase activity was measured 
at 30 ° by following the ubiquinone-1 dependent NADH 
oxi dation at 340nm in a lmL reaction mixture containing 
SOmM TES buffer , pH7 . 5 , 250 µM NADH, 40 µM FAD , enz yme and 
50 µM ubiquinone - 1 . The reaction was started by the addition 
-1 
of ubiquinone - 1 . Rates were calculated using 6s =6,810M 
-1 
cm (Schatz & Racker, 1966) . Ubiquinone-1 was added as a 
lmM solution prepared by diluting - 20mM ethanolic stock 
36 . 
solutions with water, giving a final ethanol concentration 
in the assay of 0.25 % (v/v). Stock ubiquinone-1 solutions 
were standardized spectrophotometrically as described 
(Crane & Barr, 1971). 
0 NADH dehydrogenase rates were measured at 30 , and at 
-1 420nm, with K3Fe(CN) 6 as electron acceptor, using 6E =l,OOOM 
-1 
cm The lmL reaction mixture contained 50mM TES buffer, 
pH 7.5, 250 µM NADH, 40 µM FAD , enzyme and lmM K3Fe(CN) 6 . 
The reaction was started by .the addition of electron 
acceptor. 
When assaying membrane particles for either activity, 
3mM KCN was included in the a~say. For convenience, the 
unit of activity for both reactions is defined as one 
µmole NADH oxidized min-l 
Preparation of Hydroxylapatite 
Hydroxylapatite was made from brushite, essentially 
as described by Tiselius et al. (1956). Special care wa~ 
taken to avoid overheating and excessive shearing during the 
conversion. , The material appeared as large star-shaped 
crystals under the microscope with small plate-like 'fines'. 
The results of calcium and phosphorus analysis of this 
material were in general agreement with the results obtained 
by Tiselius et al . (1956) and showed less calcium on a 
molar basis than predicted from the formula ca 5 (P0 4 ) 30H 
(Ca/P=l.444 instead of 1.667). The chromatographic 
properties of the hydroxylapatite preparations were 
reproducible in over three dozen enzyme purifications, and 
were comparable to those of commercial preparations 
(Bio Rad). Each hydroxylapatite column was used only once. 
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SDS-polyacrylamide Gel El ec t rophoresis 
SDS-polyacrylamide gel electrophoresis was performed 
on vertical slab gels (10 x 14cm) of 10 % or 15 % polyacryl-
amide with a stacking gel of 4.5 % polyacrylamide, using an 
apparatus similar to that described by Studier (1973). The 
discontinuous buffer system of Laemmli (1970) was used. The 
preparation of samples and the staining procedure have been 
described (Young et al . > 1978). 
Gels were scanned using a Schoeffel model SD3000 
spectrodensitometer at ~40nm and using a slit width of 
0.5mm. 
Protein Estimat i on 
Prote in concentrations were determined by the method 
• 
of Lowry et al . (1951) using defatted bovine serum albumin 
(BSA) as standard. -1 BSA stock solutions, nominally 10mg mL , 
1 ~ 
were standardized spectrophotometrically using A 0 lcm,280nm 
6 . 7 . 
RESULTS AND DISCUSSION 
Respiratory Activities in ndh Mutant and Control Strains 
In assaying the ubiquinone reductase activitity of 
the NADH dehydrogenase complex, use was made of the short-
chain isoprenologue ubiquinone-1 as substrate since the 
natural electron acceptor ubiquinone-8 has too low a 
solubility in water to use as a substrate in aqueous enzyme 
assays. This analogue has been shown to interact normally 
at the active site of quinone reduction in both membrane 
and solubilized preparations of the mitochondrial enzyme 
(Hatefi et al .> 1962). Furthermore, the reduction of 
ubiquinone-1 can support proton gradient formation in 
3 8. 
vesicles reconstituted f rom complex 1 and phospholipids 
(Ragan & Hinkle, 1975). 
NADH dehydrogenase activity of membranes and 
solubilized preparations was measured with potassum ferri-
cyanide as electron acceptor since, in general, the traces 
are less curved than with 2,6-dichlorophenolindophenol 
(DCIP) , the other dye commonly used as an electron acceptor. 
Potassium ferricyanide has been extensively used to assay 
the NADH dehydrogenase in mitochondria, and has been 
assumed to accept electrons at a site close to the quinone 
act i ve site (Singer & Gutman , 1971). 
The levels of NADH dehydrogenase activity in membranes 
prepared from the ndh mutant strain, IY12, are normal (Table 
2- 3) . There is however a significant decrease in the level 
of NADH dependent ubiquinone-1 reduction relative to the 
wild-type strain , IY13 : the ubiquinone reductase activity 
i s 2 to 3% , and the NADH oxidase activity less than 2%, that 
of the control s train . It has previously been reported 
(Young & Wallace , 1976) that the DCIP reductase activity in 
ndh mutant strains is 28% that of wild-type strains . The 
reasons for the discrepancy in the rates of NADH oxidase and 
NADH : ub i quinone oxidoreductase on the one hand, and the NADH 
dehydrogenase rate measured with various artificial electron 
acceptors on the other, will become apparent later. 
Cyanide Sensitivity of the Residual NADH oxidase in ndh 
Mutant Membrane Particles 
In order to test whether the low NADH oxidase and 
NADH : ubiquinone oxidoreductase activity seen in ndh mutant 
membrane particles is due to residual activity associated 
39. 
TABLE 2- 3 Respiratory Ac t ivities of Membrane 
Particles Prepared fr om ndh Mutant (IY12) 
and Wild-Type (IY13) Strains 
Activitya IY12 
NADH oxidase <0.01 
Succinate oxidase 0.15 
D-lactate oxidase 0.37 
NADH:ubiquinone oxidoreductase 0.02 
NADH:K 3Fe(CN) 6 oxidoreductase 0.23 
IY13 
0.41 
0.15 
0.21 
0.74 
0.32 
a Oxidase rates are expressed as µg atoms O consumed min-l 
mg-l protein and dehydrogenase rates as µmoles NADH 
oxidized min- 1 mg-1 protein. 
40 . 
with the respiratory NADII de hydrogenase complex, the 
cyanide sensitivity of the NADH oxidase activity was 
examined. 
The wild-type NADH oxidase is almost completely 
inhibited by 3rnM KCN. However, the low NADH oxidase 
activity of ndh mutant membrane particles is not affected 
by KCN even at concentrations as high as 20mM (Figure 2-1), 
suggesting that it is unrelated to the respiratory activity. 
AN602 is a leaky ndh mutant, having 10 to 15% of the wild-
type level of NADH oxidase in the cytoplasmic membrane 
(I.G. Young, unpublished results) . . Interestingly, the NADH 
oxidase in membrane particles prepared from this strain is 
inhibited approximately 37% by 3mM KCN (Figure 2-1), 
suggesting that the respiratory NADH dehydrogenase is 
partially active in this strain. 
From Figure 2-1 it can be seen that the ndh mutant 
strain AN606 is totally deficient in the cyanide sensitive 
-
NADH oxidase and therefore the possibility can be excluded 
that there exists a second NADH dehydrogenase under these 
growth conditions linked to the respiratory chain. 
The nature of the cyanide insensitive NADH oxidase is 
not clear, but it may be related to the cytochrome-
independent NADH oxidase reported by Haddock & Schairer 
(1973). 
Solubilization and Chromatography of NADH : ubiquinone 
Oxidoreductase from Wild-Type Membrane Particles 
Initial attempts at purifying the respiratory NADH 
dehydrogenase complex were carried out with membrane 
particles prepared from IY13 . 
As can be seen in Figure 2-2, there is a high NADH 
41. 
FIGURE 2-1 . Inhibition of ADIi Oxidase Activity in 
Membrane Particles Prepared from JP2140, 
A 602 a11d AN606 . 
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Membrane par icles were prepared from strains JP2140, 
AN602 and A 606 as described in the text, and assayed for 
NADH oxidase activity spectrophotometrically (see Chapter 
4) in the presence of varying concentrations of KCN. 
•----• JP2140 ; •-- -• AN602; • - --eA1'1606 . 
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FIGURE 2-2. Distributio n of NADH Oxidase a nd NADH 
Dehydrogenas e Activities Durin g 
Preparation and Solubilization of 
Membrane Particles from IY13 
Cell Extract · vol - 145mL 
Cytoplasm 
NADH/0 2 
NADH/Ql 
NADH/0 2 
NADH/Ql 
NADH/K 3Fe(CN) 6 
vol - 130mL 
-
260 units (0.13) 
-
2494 units (1.21) 
NADH/K 3Fe(CN) 6 -
6922 units (3.35) 
Wash: vol= 96mL 
NADH/0 2 -
9. 4 units (0.04) 
NADH/Ql -
169 units (0.67) 
NADH/K 3Fe(CN) 6 -
379 units (1.50) 
601 units (0.17) 
- 3500 units (0.98) 
- 7 4 6 8 units ( 2 . 0 9 ) 
Unwashed Membranes 
NADH/0 2 -
591 units 
NADH/Ql -
866 units 
NADH/K 3Fe(CN) 6 -
901 units 
Washed Membranes 
NADH/0 2 -
459 units 
NADH/Ql -
733 units 
NADH/K 3Fe(CN) 6 -
315 units 
vol= 3lmL 
(0.52) 
(0. 76) 
(0.80) 
vol=26.5mL 
(0.46) 
(0. 74) 
(0.32) 
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FIGURE 2-2 Continued. 
washed membranes : vol - 10.6mL 
(see 
1
above) 
Cholate insoluble : vol - lOmL Cholate soluble vol=l0.8 mL 
NADH/0 2 - NADH/0 2 -
2. 3 units (0.03) 14 units (0.09) 
NADH/Ql - NADH/Ql -
9.5 units (0.06) 79 units (0.43) 
NADH/K 3Fe(CN) 6 - NADH/K 3Fe(CN) 6 -
8.9 units (0.06) 44 units (0.24) 
90L of IY13 were grown on mannitol-minimal medium plus 
casamino acids, and membrane particles prepared and 
washed as described in the text: 10.6mL of washed 
membrane particles were solubilized with 3% (w/v) 
potassium cholate, lM KCl. The cholate-insoluble pellet 
was resuspended in STM buffer to a final volume of lOmL. 
Abbreviations: NADH/0 2 , NADH oxidase; NADH/Q1 , NADH: 
ubiquinone oxidoreductase; NADH/K 3Fe(CN) 6 , NADH:ferri-
cyanide oxidoreductase. Figures in parentheses refer to 
specific activities. 
44. 
dehydrogenase activity i n the cytoplasm of E. coli . 
Approximately 88% of the ferricyanide reductase and 74 % of 
the ubiquinone reductase activity is located in the cyto-
plasmic fraction . Furthermore, a large proportion of the 
NADH dehydrogenase activity in crude membranes is removed 
upon washing the particles. This proportion is usually 40 
to 80% depending upon how carefully the cytoplasmic fraction 
is decanted from the membrane pellet initially, and is 
presumably due to cytoplasmic contamination. 
Maximum recovery of ubiquinone reductase activity 
was obtained by solubilizing membrane particles at Oto 4° 
with 3% (w/v) potassium cholate and lM KCl. The apparent 
recovery of activity was 20 to 25% with a slight decrease in 
specific activity (Table 2-4). This drop in specific 
activity is probably due in part to the reversible 
inhibition of NADH :ubiquinone oxidoreductase activity by the 
high concentration of cholate in the sample, as the 
experiments illustrated in Figures 2-3 and 2-4 suggest. 
When the solubilized material is chromatographed on 
hydroxylapatite, several peaks of NADH dehydrogenase activity 
are resolved, but there is only one major peak of NADH: 
ubiquinone oxidoreductase (Figure 2-S(a)). The major peak 
of ubiquinone reductase activity was identified as the 
respiratory NADH dehydrogenase since it is absent from the 
chromatogram of an identical column where solubilized IY12 
membrane particles were chromatographed (Figure 2-S(b)). 
The NADH : ubiquinone oxidoreductase has no measurable 
activity with NADPH as electron donor (as expected for the 
respiratory enzyme) . 
The other NADH dehydrogenase activities are present 
TABLE 2-4 Purification of NADH : ubiquinone Oxidoreductase 
from IY13 Membrane Particlesa 
Volume 
. . b Activity Protein Specific Yield 
(mL) -1 (Units) -1 (mg) Activ
ity ( % ) (Units mL ) (mg mL ) 
-1 (Units mg ) 
' 
Crude Membranes 12.5 25.5 319 36 .5 456 0.70 (100) 
Washed Membranes 10.6 25.2 268 37.2 394 0.68 86 
Cholate-Soluble 10.2 7.06 72.0 17.7 180 0.40 23 
Hydroxylapatite 79 2.09 165 0.111 8. 8 18.8 52 
a For details see Experimental section. 
b l . 1 1 'd' d . -l -l unit = µmo e NADH oxi ize min mg 
Purification 
( fold) 
( 1) 
0.97 
0.57 
27 
.i::,,. 
u, 
4 6 . 
FIGURE 2-3 . Relief of In hib ition of Cholate-Solubilized 
Membrane Par ti les by Preincubation in Assay 
Mix. 
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IY13 membrane particles were solubilized with potassium 
cholate as described in the text: 2 wL of cholate-soluble 
material was preincubated for various lengths of time, at 
30 ° , in lmL of SOmM TES buffer, pH7.S, 40 wM FAD, 2SO wM 
NADH and 3mM KCN . The reaction was started by the addition 
of SO wL ubiquinone - 1 solution (lmM). Preincubation under 
identical conditions did not enhance the activity of either 
membrane particles or pure NADH : ubiquinone oxidoreductase. 
4 7 . 
FIGURE 2 - 4 . NADH : ubiquinon Oxidoreductase Activity of 
Cholate-Solubilized Particles as a Function 
of Added Enzyme . 
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For details of solubilization and assay procedures 
see text . 
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in the IY12 profile. Thi s c an be interpreted in two ways: 
(1) These activities are unrelated to the respiratory 
NADH dehydrogenase. 
(2) They are fragments or different solubilized forms of 
the NADH dehydrogenase complex, containing the primary 
dehydrogenase. 
The latter possibility would be consistent with the 
data if potassium ferricyanide accepts electrons at the 
substrate side of the mutation. 
Pre-empting the results of Chapter 4, it can 
definitely be shown that these activities are unrelated 
to the respiratory enzyme. No increase in the amounts of 
these activities is seen in column profiles from strains 
IY35 or IY85 under conditions where the amount of the 
respiratory NADH dehydrogenase is amplified genetically, in 
the membrane, 50 to 100-fold. Furthermore, it is clear that 
' 
these enzymes do not interact with the endogenous ubiquinone 
in the membrane since the ndh mutants totally lack NADH 
oxidase activity. 
The lack of the membrane-bound NADH oxidase activity 
in ndh mutant strains is seen under a wide variety of 
growth conditions (I.G. Young & B.J. Wallace, unpublished 
results), so it seems likely that there is only one 
respiratory NADH dehydrogenaseproducedaerobically by E. col~ 
and which is defective in ndh mutant strains. Estimations 
of the cytochrome and quinone content of IY12 (see Chapter 3) 
reveal that the lack of the respiratory NADH oxidase in this 
strain is not due to a defect in the biosynthesis of ubi-
quinone or any of the detectable cytochromes, and is 
therefore due specifically to an inactive NADH dehydro-
49 . 
genase complex. 
There are contaminating NADH dehydrogenase activities 
in the membrane as well as in the cytoplasm. The cytoplasmic 
activity could be due to enzymes such as lipoamide 
dehydrogenase (Dancey et al .~ 1976), but the nature of the 
membrane-bound activities is not clear. Owen and Kaback 
(1979) have demonstrated the presence of two or possibly 
three NADH dehydrogenases in the plasma membrane of E. coli 
by crossed irnrnunoelectrophoresis of spheroplasts ·prepared 
by osmotic shock, and Dancey et al. (1976) have concluded 
that there is more than one NADH dehydrogenase, in 
experiments on the inhibition of NADH:DCIP oxidoreductase 
by 2-heptyl-4-hydroxyquinoline-N-oxide (HQNO) in similar 
spheroplast preparations. 
What is now clear is that the NADH dehydrogenase 
activity measured in membrane preparations is due to the 
combined activity of several enzymes, and the levels of 
activity with various electron acceptors in the ndh mutant 
strain, compared to the wild-type strain, reflect the 
relative contribution of the respiratory enzyme to the 
overall activity . It is not valid to relate the contribut-
ions to the membrane-bound activity of any particular enzyme 
to its relative amount seen on the hydroxylapatite column 
chromatogram, since conditions were chosen specifically to 
maximize the recovery of the respiratory enzyme. However 
it is clear from the data presented in Table 2-3 and from 
the previous results (Young & Wallace, 1976) that nearly all 
of the activity with ubiquinone-1 and the majority of the 
activity with DCIP seen in membrane preparations is due to 
the respiratory enzyme, whereas most of the membrane -bound 
so . 
ferricyanide reductase a ctivity is due to the contaminating 
(in the sense of non-respiratory-chain-linked) activities. 
Attempted Purification of NADH :ubiquinone Oxidoreductase 
from Strain IY13 
Conditions for the chromatography of the NADH:ubi-
quinone oxidoreductase on hydroxylapatite were optimized to 
give the conditions described in Figure 2-5. The chromato-
graphic behaviour of the enzyme was found to depend upon 
such parameters as the concentration of cholate and FAD 
present in the column and gradient buffers, the steepness 
of the phosphate gradient and the amount of solubilized 
membranes chromatographed, relative to the column bed 
volume. Under optimum conditions, excellent separation 
of activity from the bulk of the protein is achieved, owing 
to the unusually tight binding of the enzyme complex to 
hydroxylapatite. This may reflect phospholipid binding to 
the phosphate sites in the hydroxylapatite crystal lattice 
rather than protein-hydroxylapatite interactions since such 
tight bindin~ is also a characteristic of phosphoproteins. 
Using this single column step a purification of approxim-
ately 30-fold over the activity in membrane particles can 
be achieved (Table 2-4). 
It was not possible to obtain highly purified 
preparations of the NADH : ubiquinone oxidoreductase from 
IY13. As will become apparent (see Chapter 4), the enzyme 
is present in very small quantities in wild-type membranes. 
The ubiquinone reductase activity proved to be very labile, 
and all attempts at further purification led to large 
losses in activity . Amongst the approaches tested were 
rechromatography on hydroxylapatite under different 
FIGURE 2-5. 
r- 1 
:J • 
Chromatogra p hy of Cholate-Solubiliz e d 
Membrane Pa r ticles on Hydroxylapatite. 
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See Experimen t a l section for details . A 280 was monitored 
continuously with an Isco model UA- 5 absorbance monitor. 
Column flow- rate (30mL h- 1 ) was kept constant by using a 
Pharmacia P- 3 peristaltic pump . 
c ol lected . 
4mL fractions were 
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conditions, gel permeatio a nd affinity chromatography 
(the latter using a variety of ligands). 
The pooled fractions containing NADH:ubiquinone 
oxidoreductase activity from the hydroxylapatite column 
illustrated in Figure 2-S(a) were electrophoresed on 10 % 
polyacrylamide gels in the presence of sodium dodecyl 
sulphate. The respiratory NADH dehydrogenase polypeptide 
was identified by using a purified enzyme preparation from 
strain IY85 as an internal standard (see Chapter 4). It 
was estimated densitometrically that this polypeptide 
represents 3 . 4% of the protein on the gel (Figure 2-6), 
assuming equal binding of the stain for all the species 
present . From this, and the specific activity of the 
preparation (see _Table 2-4) it can be calculated that the 
specific activity of the respiratory NADH dehydrogenase 
. -1 
solubilized from wild-type membranes is 560 units mg . 
This is in good agreement with the specific activity of 
the enzyme purified from strain IY35 or IY85. The 
significance- of this will be discussed in Chapter 4. 
SUMMARY 
E. coli membrane particles were solubilized with 
3% (w/v) potassium cholate and lM KCl. One major NADH: 
ubiquinone oxidoreductase was resolved and partially 
purified by hydroxylapatite chromatography of the solubilized 
material . This enzyme has been identified as the respiratory 
NADH dehydrogenase since it is absent from chromatograms of 
solubilized material from the ndh mutant I Y12. Several 
other NADH dehydrogenases are present in E. coli me mbranes: 
comparative studies with strains IY12 and IY1 3 have shown 
that they are apparently unrelated to the r e s p iratory enz yme. 
FIGURE 2- 6 . 
T 
01 obs 
l 
b 
5 3 . 
SOS Polyacryi mide Gel Electrophoresis of 
NAOH : ubiquinone Oxidoreductase Partially 
Purified from IY13 . 
Front 
l 
Front 
i 
The NAOH : ubiquinone oxidoreductase peak, from hydroxyl-
apatite chromLltography of solubilized IY13 membrane 
particles (fractions 64 to 85, see Figure 2-5 (a)), was 
pooled , electrophoresed on 10 % SOS polyacrylamide gels and 
scanned dens i tometrically (top) . The NAOH dehydrogenase 
flavoprotein (marked with arrow) was identified using pure 
enzyme pr pared from strain IY85 (bottom trace ; see 
Chapter 4) and was calculated to be 3 . 4 % of the protein in 
the sample . From the specific activity of the pooled 
prepar tion , 18.9 units mg - 1 (Table 2-4) , the specific 
activity of t~e pure enzyme from wild - type cells is 
estimated to be 560 units mg-1 assuming one acti.ve site 
per 45 , 000 polypeptide ch~in . 
CHAPTER T. 
Amplification of the Respiratory NADH 
dehydrogenase in Membrane Particles 
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INTRODUCTION 
Preliminary experiments on the purification of the 
respiratory NADH dehydrogenase complex (see Chapter 2) 
indicated that the enzyme would be difficult to purify 
by conventional techniques, and suggested that a new approach 
was necessary. Since it is labile after solubilization and 
refractory to further purification after hydroxylapatite 
chromatography, it was desirable to purify the enzyme as 
much as possible while still in the membrane-bound state. 
Recent advances in genetic engineering suggested approaches 
which might be used to amplify _the levels of the enzyme in 
the membrane in vivo. 
The extrachromosomal factor ColEl is present in 
E. coli under relaxed control, at a level of approximately 
24 copies per cell (Clewell, 1972) . Several plasmid 
vectors have been constructed which are derivatives of 
ColEl , and exist in the cell in multiple copies. These 
are suitable'as cloning vehicles since they possess a single 
site for given restriction endonucleases and carry suitable 
antibiotic resistance markers for ease of selection. 
When a gene is cloned into such plasmids, the amounts 
of enzyme coded by that particular gene can be elevated to a 
level consistent with the increased gene copy-number in the 
cell (Hershfield et al ., 1974; Vapnek et al .~ 1976; Wickner 
et al .~ 1976; Raetz et al .~ 1977; Steffen & Schleif, 1977). 
Cloning a particular gene into multicopy plasmids is 
conveniently carried out if there already exists an enriched 
source of that gene, e . g . if it is carried on a transducing 
phage (Hershfield et al .~ 1974; Steffen & Schleif, 1977) or 
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F factor (Vapnek et al .~ 19 76). Where this is no enriched 
source, the gene must be isolated from total chromosomal 
DNA . Several techniques are available to do this. Clarke 
and Carbon (1976) established a colony bank of over 2,000 
clones by shearing E. coli DNA and ligating the fragments 
to ColEl using the poly (dA.dT) connector method (Jackson 
et al .~ 1972; Lobban & Kaiser, 1973). Collins et al . (1976) 
and Koslov et al . (1977) digested chromosomal DNA with the 
restriction endonuclease Eco RI and ligated the fragments 
with plasmid DNA digested with the same enzyme. The 
resulting hybrid plasmids were then transformed directly 
into relevant mutant strains. A similar approach was used 
by Borek et al . (1976) to prepare specialized lambda 
transducing phages in vitro . 
Up to this time only genes coding for soluble cyto-
plasmic enzymes had been successfully cloned. It remained 
to be seen whether amplification of enzyme levels could be 
achieved through the cloning of genes coding for membrane-
bound enzymes, or whether special requirements, such as for 
insertion into the membrane or assembly into respiratory 
complexes, would circumvent this. 
The gene coding for the respiratory NADH dehydrogenase 
was cloned by a method similar to that used by Collins et al . 
(1976) and Koslov et al . (1977) (Young et al .~ 1978). Total 
chromosomal DNA was digested separately with three different 
restriction endonucleases , Eco RI, BamI and HindIII, to 
increase the chances of cloning the gene intact. A gene 
cannot be successfully cloned with a particular endonuclease 
if it contains a restriction site for that enzyme . There is 
less chance that the gene will contain a restriction site for 
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each of the three enzymes us ed . Cloning vectors which 
possess a single site for a given restriction endonuclease 
were then digested with that enzyme and ligated with the 
corresponding pool of DNA: thus pGM706, which possesses a 
single HindIII site (Hamer & Thomas, 1976), was digested with 
HindIII and ligated with the fragments of DNA obtained from 
HindIII digested chromosomal DNA, to produce a chromosomal 
library . Similar libraries were constructed from BamI and 
EcoRI digested chromosomal DNA and the plasmid pSF2124, 
which possesses a single site for each of these two 
restriction endonucleases (So et al.~ 1975). 
In theory , the hybrid plasmids so produced can be 
transformed directly into ndh point mutants and selection 
made for those cells which have received plasmids (using 
suitable antibiotics) and for complementation of the mutant 
phenotype (in this case using growth on mannitol as one's 
cr i ter i on) . Unfortunately it was found that the ndh mutant 
strains used as recipients are poor transformants. To get 
over this problem , use was made of the fact that the vectors 
used , pSF2124 and pGM706, though non - transmissible in 
themselves , can be mobilized by factors such as F (Young & 
Poulis , 1978) . The hybrid plasmids were therefore 
transformed into an efficient transforming strain, C600, 
then transferred to the ndh mutant recipient strain, IY12, 
by F-mediated conjugation. 
Two hybrid plasmids were obtained , one from the EcoRI 
pool and the other from the HindIII pool, which complement 
the ndh phenotype . These plasmids were designated pIYl and 
pIY2 respectively . 
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once isolated, the pla smids were transformed directly 
into ndh mutant recipients, and were shown to complement all 
the ndh mutants so far isolated (I.G. Young, unpublished 
results). It has been shown (Young et al .~ 1978) that pIYl 
and pIY2 contain a 1.6 and a 4.6Mdalton cloned DNA insert 
respectively. 
since the former hybrid plasmid contains the smaller 
insert, it was selected for further study. In this 
chapter, the use of pIYl in amplifying the level of NADH: 
ubiquinone oxidoreductase in the membrane will be described. 
Furthermore it will be shown that pIY2 does not carry the 
ndh gene , and complements the n.dh mutant phenotype by a 
totally different mechanism to pIYl. Respiratory activities 
of both hybrid plasmid-containing strains are presented, and 
compared to those of ndh mutant and wild-type strains. 
EXPERIMENTAL 
Media and Growth of Bacteria 
For details of the media used, and the growth of 
lOL cultures in glass fermenters, see Experimental section, 
Chapter 2 . 
In growing cultures of strains harbouring plasmids 
carrying drug resistance determinants, the following 
precautions were employed: rubber hoses were attached to 
the air outlets of the fermenter vessels, and the air 
trapped in glass flasks stoppered with cotton wool, and 
containing 1 % (v/v) hibitaneR. The effluent obtained on 
R harvesting the cells was collected in 25L Nalgene bottles, 
and autoclaved prior to disposal, as was all material 
coming in contact with the cultures. 
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Agar plates used t o p r epare inocula of IY35 and 
IY36 contained 2% (w/v) agar and 25 µ g mL-l ampicillin . in 
0 
mannitol-minimal medium, and were stored at 4 and used 
within 4 to 6 weeks of preparation. Cultures of IY35 and 
IY36 were also checked after growth, on the above plates , 
for retention of plasmid: this medium tests for both the 
' presence of the ampicillin resistance gene on the cloning 
vector and complementation of the n d h phenotype by the 
hybrid plasmid. 
Growth Tests 
Growth tests were done, throughout, in 125mL flasks 
fitted with a side-arm which allows the turbidity of the 
culture to be measured directly, using a Klett-Summerson 
colorimeter. 
For the measurement of growth rates, flasks were 
shaken (200 rpm) in a water bath at 37 ° . The flasks were 
cleaned alternately in alcoholic KOH and chromic acid before 
being rinsed thoroughly in distilled water. The medium used 
and the concentrations of the supplements are described in 
Chapter 2. Glucose and mannitol were added at a final 
concentration of 30mM. Succinate was added at a final 
concentration of 4mM and. prepared, for growth tests, from 
succinic acid, rather than the sodium salt, and adjusted 
to pH 7.0 with NaOH. Casamino acids (Difeo, vitamin free) 
were added at a final concentration of 0.1 % (w/v). 
For the determination of growth in limiting 
concentrations of isoleucine plus valine, cultures of IY35 
were grown in lOmL mannitol-minimal medium except that the 
levels of isoleucine plus valine were at the indicated 
final concentrations. 
59. 
Amino Acid Starvation Experiments with IY35 
3 x lOL cultures of IY35 were grown, as described 
above, in mannitol-minimal medium, except that the final 
concentrations of isoleucine and valine were O.lmM each. 
Growth ceased abruptly when the ·culture turbidity reached 
Klett 100. The cultures were incubated with aeration 
(12L min- 1 ) and stirring (400 rpm) for 1, 2 and 4h respect-
ively, after which time growth was restarted by the 
addition of 0.3mM isoleucine and 0.3mM valine to each 
culture. Cells were harvested as described above, when the 
culture turbidity reached Klett 200. 
Recovery of Growth after Chloramphenicol Inhibition 
To determine the recovery of growth after inhibition 
with chloramphenicol, 2 x 50mL cultures of IY35 were grown 
in mannitol-minimal medium to Klett 135. Chloramphenicol 
was added at this point to a final concentration of lSOµg 
-1 
mL , which completely inhibited further growth. At time -
intervals of 0, 1, 2, 4, 6, 8 and 12h, lOmL aliquots were 
transferred to sterile, capped plastic tubes, centrifuged, 
and the cells washed once in lOmL of sterile medium minus 
mannitol and supplements. The washed cells were resuspended 
in lOmL of mannitol-minimal medium and subsequent growth 
recorded . 
Determination of Optimum Inhibitory Concentration of 
Chloramphenicol 
For the determination of the optimum inhibitory 
concentration of chloramphenicol, lOmL cultures of IY35 
were grown in mannitol-minimal medium containing 25, 50, 
-1 75 and lOO µg mL of the antibiotic, in side arm flasks. 
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Amplification of IY35 wit h h loramphenicol 
lOL cultures of IY35 were grown, as described above, 
in mannitol-minimal medium, unless otherwise specified, 
containing 0.1% (w/v) casamino acids. When a Klett value 
of 100 was reached, O.Sg chloramphenicol was added and the 
culture incubated, with aeration (12L min- 1 ) and stirring 
(400 rpm), for 4h, unless otherwise specified. Cells were 
then harvested , washed in 300mL of sterile medium and 
collected by centrifugation for lh at 9,000 rpm in a Sorvall 
GS-3 rotor . The washed cells were then resuspended in an 
equal volume of fresh mannitol-minimal medium containing 
0.1 % (w/v) casamino acids . The initial turbidity of the 
culture on reinoculation was generally Klett 8 0, and growth 
was continued until the turbidity doubled. The cells were 
then harvested and membrane particles prepared (see below). 
Preparation of Membrane Particles and Assay Procedures 
Membrane particles were prepared as described in the 
Experimental section, Chapter 2, except that the final wash 
was omitted since it was found that the specific activities 
of NADH oxidase and NADH : ubiquinone oxidoreductase were not 
significantly altered by this step. 
D-lactate dehydrogenase was assayed by measuring the 
phenazine methosulphate-coupled reduction of 3-(4,5-dimethyl-
thiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) (Futai, 
1973) . Duroquinol oxidase was measured polarographically 
using a Clark-type oxygen electrode . The reaction mixture 
contained O. OSmL of membrane particles, 0 . 5mg sodium 
dithionite and 0.6mg duroquinone (added as an ethanolic 
solution, concentration 30mg mL-l) in 2.SmL STM buffer (see 
Chapter 2) . The concentration of dissolved oxygen was 
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taken to be 450ng atoms mL - l (Chappell, 1964). 
Details of other assays are presented in Chapter 2. 
Quinone Estimations on Whole Cells 
Bacteria were grown in lOL batch cultures and 
harvested at Klett 200 . The cells were then washed in 300mL 
of STM buffer (see Chapter 2) and pelleted by centrifugation 
for lh at 8,000 rpm in a Sorvall GS-3 rotor. 
10g of cell paste was transferred to an extraction 
thimble (Whatman , cellulose) and extracted with lSOmL 
boiling acetone for 4h in a Soxhlet apparatus (Young et al., 
1973). The acetone was evaporated over steam, and the 
residue extracted with 3 x 50mL petroleum spirit (b.p. 
60-80°) . The combined extract was rotary evaporated to a 
small volume and applied to a silica gel, GF 254 , thin 
layer plate (0 . 5mm thick, 18 x 20cm) as a band approximately 
2 x 8cm . The chromatograms were developed in chloroform: 
0 petroleum spirit (b.p . 60-80), 7:3 (v/v). The dark yellow 
ubiqui none band, Rf= 0.3, and the faint yellow naphtho-
quinone band, (containing both menaquinone and demethylmena-
quinone), Rf= 0 . 7, were each eluted with 6 x 2mL absolute 
ethanol . 
Ubiquinone was determined spectrophotometrically by 
measuring the difference in absorbance at 275nm after 
-1 -1 
reduction with solid NaBH 4 , and using 6 c = 12,700cm M 
(Crane & Barr , 1971). 
D methylmenaquinone was determined by measuring the 
visible absorbance due to the violet chromophore formed 
between 2- B-alkenyl-1,4-naphthoquinones and ethanolic KOH 
(Baum & Dolin, 1965) : to 0.8mL of the naphthoquinone 
extract , in a lmL quartz cuvette, was added 0.2mL of freshly 
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made lM KOH, and the absorbance at 560nm followed. Values 
were calculated from the maximum absorbance change using 
-1 -1 LE= 8,300cm M (Alexander & Young, 1978b). 
The total naphthoquinone content was determined 
by measuring the difference in optical density at 245nm 
following the addition of solid NaBH 4 to lmL of the naphtho-
quinone solution containing lOµL of lM sodium acetate buffer, 
pHS . O. The contribution to the absorbance change due to 
demethylmenaquinone was calculated from its content, 
estimated as described above, and using LE= 19,BOOcm-l M-l 
(Dunphy & Brodie , 1971) ~ The menaquinone content was 
bt · d f th d'ff A - 25,800c--.1 M-l o aine rom e i erence, assuming uE rn 
(Dunphy & Brodie , 1971). 
Determination of Cytochrome Levels in Membrane Particles 
'' Dithionite-reduced minus oxidize~'difference spectra 
were recorded at room temperature using an Aminco Chance DW2 
dual wavelength spectrophotometer: 0 . 9mL of membrane 
particles (protein concentration= 35 to 45mg mL- 1 ) were 
diluted with, 2.lmL STM buffer (see Chapter 2), and lmL 
transferred to sample and reference cuvettes. To the 
reference cuvette was added 2 . Sµmoles H2o2 and 4 units 
catalase (beef liver, Sigma) and to the sample cuvette 
was added a few grains of sodium dithionite. The spectrum 
was recorded at the following instrument settings: full 
scale deflection, 0.2 A ; spectral bandpass, 1nm; scan-rate, 
-1 . 1nm sec ; instrument response , medium . The contents of 
the reference cuvette were then reduced with excess 
dithionite and the baseline spectrum recorded. The 
concentrations of cytochromes b 1 and d were measured as 
described previously (Wallace & Young , 1977(b) using the 
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following molar absorption coefficients and wavelength 
-1 -1 pairs : cytochrome b 1 17 500cm M at 560 minus 575nm 
-1 -1 (Jones & Redfearn, 1966) and cytochrome d ~ 8,500cm M 
at 615 minus 630nm (ibid.). For determination of cytochrome 
o , the particles in the sample cuvette were bubbled 
vigorously with CO for 2min and the 'CO-reduced minus 
reduced ' difference spectrum was recorded using the same 
instrument settings as above . Cytochrome o content was 
estimated at the wavelength pair 415 minus 430nm using the 
molar absorption coefficient 80,000cm-l M-l (Chance, 1961). 
Low Temperature Cytochrome Spectra 
' Dithionite-reduced minus oxidized' difference spectra 
of membrane particles were obtained at liquid N2 temperature 
(77K) using the Aminco Chance DW2 dual wavelength spectro-
photometer with the low temperature attachment. Other 
details are given in the figure legends. 
RESULTS AND DISCUSSION 
Respiratory 'Activities in Membrane Particles Prepared 
from Strain IY35 
Membrane particles were prepared from strains IY35 
(which carries the hybrid plasmid pIYl), IY34 (which carries 
the plasmid vector pSF2124) and IY13, and respiratory 
activities determined for both the membrane and cytoplasmic 
fractions (Table 3-1) . 
The results show that there is an approximately 
seven-fold elevation in the level of NADH:ubiquinone oxido-
reductase in the membrane of IY35 compared to the wild-type 
strain IY13, without appreciable amplification of the 
activity in the cytoplasm. Comparing the results for 
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TABLE 3-1 Respiratory Acti· ities of Membrane and 
Cytoplasmic Fractions from IY35 and 
Control Strains 
IY13 IY34 IY35 
Activitya Mb cc Mb cc Mb 
cc 
NADH oxidase 0.679 0.041 0.684 0.053 2.54 0.170 
Succinate 
oxidase 0.362 ND 0.198 ND 0.498 ND 
D-lactate 
oxidase 0.240 ND 0.289 ND 0.574 ND 
NADH:ubiquinone 
oxidoreductase 0.576 0.718 0.577 0.423 3.86 0.776 
NADH:ferricyanide 
~ 
oxidoreductase 1.60 0.950 1.01 1.04 0.790 1.55 
I 
a . -1 -1 Oxidase rates expressed as µg atoms O consumed min mg 
protein and dehydrogenase rates as µmoles NADH oxidized 
. -1 -1 
min mg protein. 
b Membrane fraction. 
c Cytoplasmic fraction. 
Other details given in text. 
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IY34 and IY35, it is app a ren t that this is not a n effect of 
the plasmid vector itself but, rather, due to the cloned DNA 
insert . The results for five membrane preparations (two 
each of IY35 and IY13, and one of IY34) showed that IY35 has 
a 7 to 10-fold amplification of NADH:ubiquinone oxido-
reductase levels relative to the control strains (average 
8 . 8-fold) . 
The amount of NADH:ubiquinone oxidoreductase in IY35 
membranes is consistent with that expected if the level is 
proportion~l to the gene copy-number in the cell, and is of 
the same magnitude as the amplification of the various soluble 
enzymes whose genes have been cloned into multicopy plasmids 
to date (Hershfield et al ., 1974; Vapnek et al ., 1976; 
Wickner et al ., 1976; Raetz et al ., 1977; Steffen & Schleif, 
1977). Although the number of pIYl molecul~s per cell has 
not been determined, an idea of the expected levels · can be 
gained from the copy-number of pSF2124 itself, which has been 
estimated to be approximately 20 copies per cell (So et al ., 
1975) . The degree of amplification expected is correctly 
related to the gene copy-number per chromosome-equivalent. 
The exact number of chromosome molecules per cell depends 
upon the stage of growth of the culture as well as the growth 
conditions used, but can vary between 2 (Cooper & Helmstetter, 
1968) and 4 (Clewell, 1972). On this basis we would expect 
an amplification of between 5 and 10-fold over the wild-type 
levels of a particular protein if the gene coding for that 
protein were cloned into p SF2124, and there were no other 
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* controls on gene expressior 
Amplification of Plasmid Copy-Number 
An important property of ColEl, as well as its 
derivative plasmids such as pSF2124, is that it can continue 
to replicate when cellular protein synthesis is inhibited. 
Replication of chromosomal DNA and cell division cease 
under such conditions, resulting in a very high plasmid 
copy-number (Clewell, 1972). Experiments were undertaken 
to try to improve enzyme levels by making use of this 
property to further increase the gene copy-number in the 
cell . 
The logic behind the amplification experiments can be 
summarised as follows: cultures of IY35 were grown to one 
half the cell density desired for harvesting, then protein 
synthesis was inhibited either by amino acid starvation or 
by the use of specific inhibitors . The cultures were 
incubated under such conditions for varying lengths of time 
to allow the gene copy-number to increase, then the 
inhibition was relieved and the cells grown for one 
generation to allow expression of the amplified genes. 
Amplification of Enzyme Levels by the Use of Amino Acid 
Starvation 
* 
An effective way to inhibit protein synthesis in an 
In actual fact, this approximation seems to fit the data 
quite well. However, to be more exact, consideration may 
have to be taken of the relative sizes of pIYl and pSF2124, 
which are 9.0 and 7.4Mdaltons respectively. It has been 
claimed that the plasmid copy-number, for a given ColEl 
derivative or chimera, is inversely proportional to its size 
(e . g . see Gelfand et al ., 1978). This contention does not 
seem to have been proven and it may be that the t y pe of 
regulation fixes the plasmid copy-number independent of 
its size. 
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auxotrophic strain of E. co~ is to limit the concentration 
of a requisite amino acid . 
IY35 has an absolute requirement for isoleucine plus 
valine . 
As can be seen in Figure 3-1, ·a concentration of 
O. lmM each of isoleucine plus valine limits the growth of 
IY35 to a Klett of 100. Consequently, IY35 was grown in lOL 
batch cultures under the same conditions as for IY13 (for 
details see Experimental section , Chapter 2) except that the 
f i nal concentrations of isoleucine and valine were O.lmM, 
and casamino acids were omitted. Growth ceased when a Klett 
of 100 was reached . The cultures wer~ incubated under such 
conditions for 1 , 2 and 4 hours before growth was restarted 
by the addition of 0 . 3mM each of isoleucine plus valine . 
Cells were harvested at Klett 200 (Figure 3-2). 
Membrane particles were then prepared from each batch 
of cells , and respiratory activities determined for both -
membrane and cytoplasmic fractions. 
By usiBg amino acid starvation to amplify the copy-
number of the hybrid plasmid pIYl in strain IY35, the levels 
of NADH : ubiquinone oxidoreductase in the membrane were found 
to be amplified up to 15-fold relative to the wild-type 
level , without appreciable amplification of the activity in 
the cytoplasm (Table 3-2) . 
Amplification of Enzyme Levels with Chloramphenicol 
A potentially more e ffective way of increasing plasmid 
copy-number is to use the protein synthesis inhibitor, 
chloramphenicol . This antibiotic is routine l y us e d to 
amplify plasmid levels when large amounts of DNA are 
required , e . g . to prepare plasmid DNA for cloning experime n ts. 
FIGURE 3-1 . 
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Growth of IY35 Under Limiting Concentrations 
of Isoleucine and Valine. 
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f o r l h , 2 h ( i n t he a b o v e i n s tan c c ) a n d 4 h , an d o r o \,' t h 
restart d by he addition of 3mmoles (per lOL culture) each 
of isoleuc1r.e one! v line . Cells were harvested c1t a Klett 
alue of 200 in ach case and membrane particles prepared 
and assayed (see text) . 
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TABLE 3-2 Respiratory Act ivities of Membrane 
and Cytoplasmic Fractions of IY35 Amplified by 
Amino Acid Starvation 
1 hour 2 hours 
Activitya Mb Cb Mb Cb 
NADH oxidase 2 . 81 0.063 2.93 0.046 
Succinate oxidase 0.330 NDc 0.240 NDc 
D-lactate oxidase 0 . 160 NDc 0.150 ND c 
NADH : ubiquinone 
oxidoreductase 7.14 0.405 8. 4 6 0.405 
NADH : ferricyanide 
oxidoreductase 0 . 550 0.590 ,-0 . 560 0.765 
4 hours 
Mb Cb 
3.11 0.076 
0.430 ND c 
0.170 NDc 
8.68 0.574 
0.815 0.830 
lOL cultures of IY35 were amplified by the amino acid 
starvation procedure for 1, 2 and 4h as described in the 
Experimental section . Membrane particles were prepared and 
assayed , together with the cytoplasmic fraction for various 
respiratory activities : see text for further details. 
a . d d . -1 Oxi ase rates are expresse as wg atoms O consumed min 
-1 
mg protein; dehydrogenase activity as wmoles NADH 
oxidized min-l mg-l protein. 
bM, membrane particles; C, cytoplasmic fraction. 
c Not determined. 
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For it to be usefu l in amplifying enzyme levels 
however, conditions have to be found which allow subsequent 
recovery of protein synthesis after inhibition by chlor-
amphenicol. 
The experiments illustrated in Figure 3-3 show that 
even after 12h incubation with 150 µg mL-l chloramphenicol, 
growth of IY35 cultures could be restarted, without 
excessive lag, after removal of the inhibitor, suggesting 
that protein synthesis is being recovered in the majority 
of cells. It is also apparent that the longer the cultures 
are incubated in the presence of chloramphenicol, the longer 
is the lag period before growth restarts, and the longer the 
subsequent generation time. 
To minimize the possible side-effects of incubation 
with chloramphenicol, the minimum concentration which 
produces bacteriostasis was determined (Figure 3-4). Slow 
growth was seen in the presence of 25µg mL-l antibiotic, 
and from the results of Figure 3-4 a concentration of . SOµg 
mL-l was considered optimal and chosen for all subsequent 
experiments. 
IY35 was grown in lOL batch cultures to Klett 100, 
then solid chloramphenicol added to a final concentration of 
-1 SOµg mL . Growth ceased almost immediately (Figure 3-5). 
Cultures were incubated for 4 and 9h with aeration and 
stirring then the cells harvested, washed in a small volume 
of sterile medium and used to reinoculate lOL of fresh 
medium . After one generation's growth the cells were 
harvested, then membrane particles prepared and assayed for 
various respiratory activities . This procedure results in 
an approximately SO-fold amplification of the levels of 
FIGURE 3- 3 . 
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Effect of IncLb tion with Chloramphenicol 
on the Viability of IY35 Cultures 
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Cultures of IY35 were grown on mannito!1minimal medium 
to a Klett value of 135 , then lSO wg mL chloramphenicol 
was added . At various time intervals lOmL aliquots were 
removed , the cells washed free of antibiotic and used to 
re i noculate fresh med i um . Shown above is the recovery 
of growth after O • • 4 • • · 8 • • and 
12h • • incubat i on with chloramphenicol . 
For deta i ls see Experimental section . 
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FIGURE 3-4. Optimum I n hib i tory Concentration of 
Chlorampheni co l. 
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4 x lOmL cultures of IY35 were grown on mannitol-minimal 
medium at 37 ° . When a Klett value of - 80 was reached, 
10.0, 7 . 5 5.0 and 2.5mL of sterile medium containing 
200µg mL-i chloramphenicol was added (at arrow) and the 
cultures adjusted to a final volume of 20mL with sterile 
medium. Subsequent growth was monito~Id for 15h: _1 o o 2 5 µ g mL - 1 i o D 5 0 µ g mL , • • 7 5 µ g mL , 
• alOOµg mL- . 
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FIGURE 3-5. Amplification of NADH : ubiquinone Oxido -
reductase Levels by Chloramphenicol Treatment . 
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2xl0L cultures of IY35 were grown on mannitol - minimal 
medium+ 0 . l ~ (w/v) casamino acids . When culture turbidity 
reached Klett 100 , chloraTphen i col was added to a final 
concentration o SO iJ g mL - , and the cultures incubated for 
4h ( s above) and 9h after whi ch time the cells were 
harvested , w shed in a small volume of sterile medium and 
used to reinocul te lOL of fresh medium . Growth restarted 
after a lag of 3 to 4h in both cases , and after allowing 
the cul ure to grow for about one generation the cells were 
harvcs cd t1nd mcmbrc1ne particles prepared and assayed . 
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NADH : ubiquinone oxidoreducla se in the membrane (Table 3-3), 
without any appreciable increase in the specific activity 
in the cytoplasm . 
There appeared to be no advantage in incubating for 
longer periods of time with chloramphenicol, under these 
conditions . Presumably this means that either the plasmid 
copy- number is already saturated after 4h treatment with 
chloramphenicol or that some factor other than gene-dosage 
is limiting enzyme production . The former explanation is 
not consistent with the data of Clewell (1972) , who showed 
that i n the case of ColEl the copy number does not level 
off until after about 12h treatment with chloramphenicol. 
It may be however that pSF2124 is affected in its ability to 
replicate under these conditions since the final copy-number 
reached , after amplification with chloramphenicol, is 
substant i ally lower for pSF2124 than for ColEl (So e t a l.~ 
1975) . 
There was no difference seen in the levels of the 
various respiratory activities assayed when the amplific-
act i on was carried out in glucose-minimal medium as opposed 
to mannitol-minimal medium (data not shown). 
In Table 3- 4 the data are summarised from five 
separate chloramphenicol amplification experiments, and 
compared to those from three control membrane preparations. 
These results show that this procedure increases the NADH: 
ubiquinone oxidoreductase activity in the membrane over 
fifty - fold, and that furthermore there is a five-fold 
increase in the level of NADH oxidase. Data will be 
presented (see below) that this is not accounted for by an 
increase in the levels of the other measurable respiratory 
7 6. 
TABLE 3-3 Respiratory Activities of Membrane and 
Cytoplasmic Fractions of IY35 Amplified 
with Chloramphenicol 
. . a Activity 
NADH oxidase 4.33 0.077 3.01 
Succinate oxidase 0.399 NDc 0.317 
D-lactate oxidase 0.112 NDc 0.064 
NADH:ubiquinone 
oxidoreductase 27.9 0.635 28.4 
NADH:ferricyanide 
oxidoreductase 1.87 0.550 2.87 
0.060 
NDc 
NDc 
1.000 
0.615 
lOL cultures of IY35 were amplified by the chloramphenicol 
amplification procedure for 4 and 9h as described in the 
Experimental section. Membrane particles were prepared ~nd 
assayed, together with the cytoplasmic fraction, for various 
respiratory activities: see text for further details. 
a . -1 Oxidase activity expressed as µg atoms O consumed min 
-1 
mg protein, dehydrogenase activity as µmoles NADH 
oxidized min-l mg-l protein. 
b M, membrane particles; C, cytoplasmic fraction. 
c Not determined. 
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TABLE 3-4 Comparison of the Res p i rat o r y Ra tes of 
IY13 and Chloramphe ni c ol-Amplified I Y3 5 
Membrane Particles 
IY13 IY35 
- -Activity X s X 
NADH oxidase 0 . 631 0.087 3.39 
Succinate oxidase 0 . 280 0 . 116 0.304 
D- lactate oxidase 0 . 253 0.031 0.130 
NADH : ubiquinone 
oxidoreductase 0.508 0 . 119 26 . 1 
-
s 
0 . 739 
0.105 
0.067 
3.371 
Respiratory activities were determined on membrane 
particles prepared from 3 separate lOL cultures of IY13 
and 5 separate chloramphenicol-amplified lOL cultures of 
IY35 . The respective mean values and standard errors are 
tabulated . See text for further details. 
7 8 . 
components . This shows that the NADH:ubiquinone oxido-
reductase is probably rate-limiting in the overall NADH 
oxidase pathway in wild-type cells, a situation opposite 
to that seen in the mitochondrion (Singer & Gutman, 1971), 
and that in chloramphenicol-amplified cells the activity 
of some other component becomes rate-limiting . This is 
supported by the fact that the levels of succinate and D-
lactate oxidases are not enhanced. 
Complementation of Ndh in IY36 
The hybrid plasmid pIY2 carries a 4.6Mdalton DNA 
fragment inserted into the HindIII site of pGM706 (Young 
et al . ., 1978) . Strain IY36, which carries pIY2, is able 
to grow on medium with mannitol as sole C source (Table 3-6). 
If pIY2 carries the gene coding for the respiratory 
NADH dehydrogenase, since it possesses the larger piece of 
DNA , either the l . 6Mdalton Eco Rl fragment in pIYl is a 
subset of the 4 . 6Mdalton HindIII fragment, or they 
represent overlapping pieces of the chromosome. Restriction 
analysis of pIYl and pIY2, however, has demonstrated that 
the two cloned DNA fragments do not have a region of common 
sequence (I . G. Young, unpublished results). 
It was not clear how pIY2 complements ndh mutant s, 
and, when the levels of various respiratory activities in 
membrane particles prepared from IY36 were examined, it was 
found that there is negligible NADH oxidase activity (Table 
3-5), which agrees with the results of restriction analysis 
that the 4.6Mdalton HindIII fragment does not carry the 
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TABLE 3-5 Respiratory A tivities in Membrane 
Particles Prepared from Strains IY36 and IY13 
Activitya 
NADH oxidase 
Succinate oxidase 
D-lactate oxidase 
D-lactate dehydrogenase 
IY13 
0.78 
0.09 
0.10 
0.09 
IY36 
<0.02 
0.06 
1.03 
2.33 
lOL cultures of IY13 and IY36 were grown on mannitol 
minimal medium+ 0.1 % (w/v) casamino acids, and membrane 
particles were prepared and assayed for various respiratory 
activities as described in the text. 
a Oxidase activities are expressed as wg atoms O consumed 
. -1 -1 . 
min mg protein. D-lactate dehydrogenase activity 
is expressed as µmo les MTT reduced min-l mg-l protein. 
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* 
ndh gene . The D-lactate oxidase activity is increased 
however 10-fold , and this is paralleled by a 25-fold 
i ncrease in the D-lactate dehydrogenase activity. There 
is no change in succinate oxidase levels. 
It seems likely that pIY2 contains the gene coding 
for the respiratory chain-linked D- lactate dehydrogenase 
flavoprotein . The amplification of this activity in IY36 
membrane particles correlates with the augmentation of a 
protein band , seen in SDS polyacrylamide gel electrophoresis 
of IY36 membrane preparations , of apparent molecular weight 
64 , 00 0 (Young, Jaworowski & Poulis, unpublished results). 
To understand how the amp±ification of D-lactate 
dehydrogenase and D-lactate oxidase levels can overcome a 
mutational block in the membrane-bound NADH oxidase, let us 
consider the scheme shown in Figure 3-6. The soluble 
pyridine nucleot i de - linked lactate dehydrogenase in E. coli 
i s specif i c for the D( - ) isomer of lactic acid (Tarmy & 
Kaplan , 1968) . The equilibrium position for this reaction 
' 
favours the formation of lactate . When coupled to the 
D-lactate oxidase react i on , thi s results in a 'futile 
cycle ' whose net effect is that of NADH oxidation linked to 
the reduction of molecular o2 . Apparently the extent of 
th i s bypass pathway for NADH oxidation is not significant 
in wild - type cells (see below) , but when the level of the 
D-lactate dehydrogenase flavoprotein is amplified by gene 
cloning , it becomes a major route for the regeneration of 
NAD+ . 
* This statement presupposes the results of Chapter 4, where 
it is shown that the NADH : ubiquinone oxidoreductase 
amplifed in IY35 membranes is the respiratory NADH 
dehydrogenase . 
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FIGURE 3- 6 . A Bypass Route for NADH Oxidation i n £ . coli . 
Glucose-6-P NVDH ! 
Mannitol -1-P _____ _.. Fructose-6-P 
Glyceraldehyde-3-P ••--••Dihyclroxy acetone P 
C
AD 
- ADH 
1,3 -Di phosphoglycerote 
NADH NAO 
~ 
Pyruvate ------•• D- Lactate 
t 
N:::) ~ .... ...................... ..  ········ ,/ 
Acetyl CoA 
V Citrate NAO 
Mo/ate 
+ Succinate 
' d... -Oxoglutarote 
Succinyl Co~ r~AD . 
NADH 
··--···-Amplified D- lactate oxidase (see text for details) 
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Growth Characteristics o f I Y12, IY13, IY35 and IY36 
IY12 is unable to grow on media containing mannitol 
as sole carbon source unless the medium is supplemented 
with either succina te or casamino acids (Figure 3-7) . As 
suggested previously (Young & Wallace, 1976) this is 
probably indicative of a defective tricarboxylic acid 
cycle in ndh mutant strains, with the result that the 
biosynthesis of amino acids and other compounds, from the 
intermediates of this cycle, is impaired. 
IY12 grows very slowly on media containing glucose as 
sole carbon source (Figure 3-7, inset). Presumably, under 
these conditions , the NADH pool is reoxidized following 
the complete conversion of glucose to D-lactate, and slow 
growth occurs by virtue of the subsequent utilization of 
D-lactate by the respiratory D-lactate oxidase. Growth on 
glucose is markedly stimulated by the addition of succinate 
or casamino acids to the medium, and mean generation times 
approaching those of the wild-type strain, IY13, are 
obtained (Table 3-6). Evidently, this pathway is not 
sufficient to support any growth on mannitol; presumably 
+ due to the extra molecule of NAD reduced per molecule of 
glucose catabolized . 
IY36 can grow on media with either mannitol or glucose 
as sole carbon source (Table 3-6). Thus the pathway out-
lined above for the utilization of D-lactate is apparently 
sufficient to support relatively high rates of growth when 
the levels of the respiratory D-lactate dehydrogenase are 
amplified by gene cloning. The efficiency of this by-pass 
route for the reoxidation of NADH is less than that with 
the respiratory NADH oxidase itself however, since IY36 
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FIGURE 3 - 7 . Gr o wth of IY12 wi th Glucose or Mannitol as 
C Source . 
200 
100 
7 
-
(lJ 
.i 
> 100 
f-
0 
co 
Cl'.'. 
:J 
f-
UJ 
Cl'.'. 
:J 
f-
...J 
:J 
u 
-· 
.-----
.-
,0 ...... -----------------------------' 
./ 
2:i :i O • _.-/ _.-/ • 
TIME (lir) ,.,,--- ~ 
.~ ~-/ -~· 
/ . .. / ----· 
----· ./. 
• • 
10 ..... ----..... ----..-----.-----.-----..-----....----..-------f 
2 4 6 8 10 12 14 16 /' 
TIME (hr ) 
For dctoils sPc Cxpcr i mcnt0l section . From the _initiol 
phase of qrowth a minimum doublinq time of 2 . lh was 
estima ed for growth on mannitol + succinatc and mannitol + 
Zlsamino 3cids . ormal exponential qrowth was seen wi h 
ol u ose + sue i nate and glucose + casamino acids ( f o r 11e.1n 
qencro.t i on times s ee Tabl 3- 6) . 
• ---- • :T'c1.nn i tol + asamino acids ,----• manni tol + 
su i nate ,A . mannitol . Inset , 8luc0se . 
TABLE 3-6 . 
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Growth Rates of IY12, IY13, IY35 and 
IY36 on Mannitol and Glucose 
Carbon Source Mean Generation Time 
IY12 IY13 IY35 
Glucose slowa 1.9 1.5 
Mannitol b 2.1 1.5 co 
Glucose + gasamino acids 1.8 
Glucose + succinate 2.4 
( h) 
IY36 
2. 8 
3.1 
For measurement of growth rates, lOmL cultures were grown 
at 37° in 125mL side-arm flaks which allowed turbidity to 
be measured directly with a Klett -Summerson colorimeter. 
For details of growth media see Experimental section. 
a See inset Figure 3-7. 
b No growth was seen after 30h. 
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grows more slowly on mannito l or glucose compared to IY13 
(Table 3-6). 
As can be seen in Table 3-6, . the high level of NADH: 
ubiquinone oxidoreductase and NADH oxidase does not impair 
the growth of IY35 on either mannitol or glucose. 
Quinone and Cytochrome Content of Ndh Mutant, Wild-Type and 
Plasmid Strains 
Estimation of the cytochrome and quinone content of 
IY12 revealed that the lack of the respiratory NADH oxidase 
in this strain is not due to a defect in the biosynthesis of 
ubiquinone or any of the detectable cytochromes, and is 
therefore probably due specifically to an inactive NADH 
dehydrogenase complex (Tables 3-7 & 3-8). 
The levels of ubiquinone, menaquinone, demethylmena-
quinone and cytochromes b 1 , c and dare within normal values 
for strains IY35 (with or without chloramphenicol 
amplification) and IY36 (but see below). Thus the rise in 
the NADH and D-lactate oxidase levels seen in strains IY35 
and IY36 respectively is not due to an increased synthesis 
of the other measurable respiratory components. This 
demonstrates that the NADH and D-lactate dehydrogenases are 
rate-limiting for their respective oxidases in wild-type 
cells. Upon amplification of either dehydrogenase in the 
membrane by the genetic techniques described above, an 
amplification of the relevant oxidase rate occurs until, 
presumably, the activity of some other component becomes 
rate-limiting. Alternatively a level may be reached where 
the excess dehydrogenase molecules cannot interact with 
the respiratory chain . In support of this, it has been 
found that the duroquinol oxidase activity in IY35 is not 
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TABLE 3-7. Cytochrome Content of Membrane Particles 
from Strains IY12, IY13, IY35 and IY36 
Strain Klett Cytochrome a 
bl 0 d 
IY12 200 0.203 0.088 0.085 
IY13 40 0.222 0.081 0.035 
11 200 0.159 0.087 0.053 
IY35 200 0.163 0.057 0.030 
cap.amp. IY35b 200 0.181 0.065 0.021 
IY36 40 0.244 0.065 0.064 
11 200 0.137 0.085 0.087 
-
lOL cultures were grown on mannitol-minimal medium+ 
0.1 % (w/v) casamino acids to the indicated Klett value. 
Where indicated, cultures of IY35 were amplified with 
chloramphenicol for 4h as described in the text. For 
details of membrane preparation and cytochrome 
estimations see Experimental section. 
a -1 Cytochrome content expressed as nmoles mg membrane 
protein. 
b Amplified with chloramphenicol as described in 
Exper imental section. 
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TABLE 3-8 . Quinone Estimations on Whol e Ce lls f r om 
Strains IY12, IY13, IY35 and IY36 
Strain . a Quinone 
UQ MK DMK 
IY12 247 0.5 37.8 
IY13 250 5.4 42.2 
IY35 250 NDb 45.9 
cap.amp. IY35 c 218 12.5 28.9 
IY36 180 26 42.9 
lOL cultures were grown on mann±tol-minimal medium+ 
0.1 % (w/v) casamino acids. For details of quinone 
extraction and estimation see Experimental section . 
-1 Quinone content expressed as nmoles g cells wet weight. 
a UQ, ubiquinone; MK , menaquinone; DMK, demethylmenaquinone. 
b ND , non detected . 
C Amplified with chloramphenicol as described in 
Experimental section. 
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amplified relative to tha t o f IY13 (data not shown). 
Closer examination of the results in Table 3-7 
reveals an interesting observation: the cytochrome d levels 
in strains IY12 and IY36 are generally higher than those 
found in the control strain IY13 , whereas the level in 
IY35, chloramphenicol amplified IY35, or cells grown to 
early exponential phase, is lower. High levels of cytochrome 
dare found in cells as cultures approach stationary phase 
(Castor &· chance, 1959; Shipp, 1972), and it has been 
speculated whether this may represent an adaptation by 
E. coli to conditions of low o2 tension (Haddock & Jones, 
1977). It has also been suggested that, under such 
conditions, E. coli synthesizes an alternative terminal 
respiratory complex consisting of cytochromes b 558 and d, 
and that the synthesis of these two cytochromes is co-
ordinately controlled (ibid.). 
In the context of the above observation it is 
interesting to note that the response of cytochrome d 
synthesis to' conditions of low oxygen tension is probably 
linked to the level of respiratory activity or some 
parameter associated with it, rather than o2 tension per se, 
since a similar response is seen when cultures of E. coli 
are grown , aerobically, in the presence of sub-lethal 
concentrations of KCN (Ashcroft & Haddock, 1975) or under 
conditions of sulphate limitation (Poole & Haddock, 1975). 
Low temperature 'dithionite-reduced minus oxidized' 
difference spectra of membrane particles revealed 
discernable quantities of cytochrome ·b 558 in IY12 (Figure 
3-B(a)). This is not clearly seen in particles prepared 
from IY36, however (Figure 3-S(d)), suggesting that 
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FIGURE 3-8. Low Temperature 'Dithionite-Reduced Minus 
Oxidized' Diffe rence Spectra of IY12, IY13, 
IY35 and I Y36 embrane Particles 
I 556 I 
I 1i5sa I T I I I 
SCALE0 ·2 ~CALE 0·04 
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D 
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' Dithionite-reduced minus oxidized' difference spectra of 
membrane particles were obtained at 77K as described in 
the Experimental section. Spectra were scanned between 
400 and 700nm with the following instrument settings: 
full scale deflection, 0.S A (400 to 500nm) and 0.2 A (SOQ 1 to 700nm); spectral bandpass, 1nm; scan-rate, 1.0nm sec 
Indicated in spectrum (a) are the spectral positions of 
cytochrome d (peak 625nm, trough 645nm), cytochromes b 556 , bsss and b562 · and the Soret peaks of cytochromes b (428nm) and a (439nm). (a) IY12 membrane particles _1 (14 . 7mg mL- 1 ) . (b) IY13 membrane particles (17. 3mg mL ) . 
(c) IY35 membrane particles (15.0mg mL-1) . (d) IY36 
membrane particles (13 . 4mg mL-1) . 
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synthesis of cytochromes b 55 8 and d are not strictly linked 
under all conditions. 
The high levels of cytochrome din IY36 are 
reconcilable with the slower growth of this strain, on 
media with mannitol as sole carbon source, as compared with 
IY13 or IY35. 
During transition to stationary phase, and after 
aerobic growth in the presence of KCN, the membrane content 
of menaquinone is seen to increase (Ashcroft & Haddock, 1975). 
One might expect that higher levels of menaquinone would be 
present in IY12 and IY36 cells. This however is not the 
case (Table 3-8). The situation in these strains is 
similar to the growth of E. coli under conditions of 
sulphate limitation, in that the biosynthesis of menaquinone 
on the one hand and cytochromes b 558 and don the other are 
independently controlled (Poole & Haddock, 1975). 
A General Method for the Amplification of Membrane-
Bound Proteins in V &V o 
The results presented in this chapter demonstrate the 
feasibility of amplifying the levels of membrane-bound 
enzymes in viv o using various cloning techniques. The 
enhancement of two separate enzymes, i . e . the NADH and 
D-lactate dehydrogenases, illustrates the general nature 
of the approach used. This is the first reported instance 
of the successful cloning of a gene coding for an intrinsic 
membrane-bound enzyme. 
A technique has been developed to amplify the levels 
of NADH:ubiquinone oxidoreductase in the membrane over 
fifty-fold. No appreciable increase occurs in the activity 
seen in the cytoplasm, under the conditions used to prepare 
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the membrane particles, whic h suggests that the over-
production does not lead to a saturation of binding sites 
for this enzyme in the membrane (however see below). The 
observed increase in NADH oxidase activity suggests that 
at least a proportion of the amplified enzyme interacts 
normally with the respiratory chain. 
Since this work was published (Young et al .~ 1978), 
a report has appeared detailing the overproduction of the 
membrane-bound enzyme, phosphatidylserine decarboxylase, in 
a strain of E. coli carrying a hybrid plasmid which has the 
psd gene inserted into ColEl (Tyhach et al .~ 1979). This 
strain was obtained by screening the Clarke and Carbon colony 
bank (Clarke & Carbon, 1976) for plasmids whtch complemented 
a psd point mutant following F-mediated conjugal transfer. 
Attempts were made to further increase the levels of 
phosphatidylserine decarboxylase by amplifying the plasmid 
copy-number with chloramphenicol. These attempts failed, · 
presumably because there was no allowance made for the 
recovery of protein synthesis after the addition of the 
antibiotic. A similar degree of amplification, to the 
maximal levels reported above for NADH:ubiquinone oxido-
reductase, was obtained by growing cultures of strains 
carrying the hybrid plasmid in medium containing a high 
concentration of valine. This has the effect of repressing 
the isoleucine and valine biosynthetic pathway, thereby 
starving the cells for isoleucine, and is a useful method 
of inducing amino acid starvation in strains which do not 
have a particular amino acid requirement. The amplified 
phosphatidylserine decarboxylase was reportedly inserted 
into the membrane at two distinct classes of binding site: 
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when membranes were prepared by osmotic lysis of sphero-
plasts, essentially all of the activity was membrane-bound, 
whereas when membrane particles were prepared by sonication, 
approximately 50 % of the activity appeared in the cytoplasm . 
This was taken to mean that the normal membrane binding site 
is saturated by the overproduced enzyme, resulting in the 
binding of the remainder of the enzyme to a second, weaker 
site. If a similar situation exists upon amplification of 
NADH:ubiquinone oxidoreductase in IY35 , it is not seen: it 
may be that disruption of cells in the French press does not 
dislodge enzyme from the membrane. No evidence to support 
the concept of specific binding ~ites for membrane-bound 
enzymes in general, was obtained by the amplification of 
either the NADH or D-lactate dehydrogenase. 
It will be shown in the following chapter that the 
NADH:ubiquinone oxidoreductase amplified in IY35 cells is 
indeed the respiratory NADH dehydrogenase, i. e . the same · 
enzyme whose activity is abolished in ndh mutant strains. 
SUMMARY 
During attempts to clone the gene coding for the 
respiratory NADH dehydrogenase, two hybrid plasmids were 
constructed, designated pIYl and pIY2, both of which, when 
present in ndh mutant strains, confer the ability to grow 
on media with mannitol as sole carbon source (Young et al . 3 
1978). 
Strains carrying pIYl have 7 to 10-fold the wild-type 
level of NADH : ubiquinone oxidoreductase in their cell 
membranes , without any increase in the activity present in 
the cytoplasm . 
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A method has been deve loped which allows further 
amplification of the NADH:ubiquinone oxidoreductase level 
in the membrane to 50 times that found in wild-type cells. 
Under the conditions used, no amplification is seen in the 
activity present in the cytoplasmic fraction. NADH oxidase 
activity increases 4 to 6-fold without any increase in the 
levels of succinate or D-lactate oxidases. 
Ndh mutant strains carrying pIY2 still lack membrane-
bound NADH oxidase activity but have amplified D-lactate 
oxidase levels, presumably because pIY2 .contains the gene 
coding for the respiratory D- lactate dehydrogenase flavo-
protein . It is postulated that ~uch strains have a novel 
pathway for NADH oxidation involving D-lactate oxidase and 
the soluble pyridine nucleotide-linked D-lactate dehydro-
genase . 
Examination of the quinone and cytochrome content of 
hybrid plasmid- containing strains suggests that the 
amplif i ed levels of NADH and D-lactate oxidases in membrane 
particles prepared from IY35 and IY36 respectively are 
probably due solely to the modulation of the activity of 
the relevant dehydrogenase in these strains. 
CHAPTER 4-;-
Purification and Properties of the Respiratory 
NADH dehydrogenase from Genetically-Amplified 
Strains 
9 4. 
INTRODUCTION 
In Chapter 2 it was shown that the ndh mutant strain, 
IY12, has less than 2% of the membrane-bound NADH oxidase 
activity compared to the control strain IY13, and that this 
can be correlated with the disappearance of a peak of NADH: 
ubiquinone oxidoreductase activity seen in chromatograms 
of cholate-solubilized IY13 membranes separated by hydroxyl-
apatite column chromatography . 
Following the construction of hybrid plasmids which 
complement ndh point mutants, a method has been described in 
Chapter 3 to amplify the levels of NADH : ubiquinone oxido-
reductase up to SO-fold in the membrane of a strain (IY35) 
carrying one such plasmid, pIYl. In this chapter it is 
shown that the enzyme whose levels have been amplified in 
IY35 is in fact the respiratory NADH dehydrogenase. The 
purification and characterization of this enzyme complex 
is presented. 
Most of the work has been carried out with_ enzyme 
preparations purified from strain IY35, and using the 
chloramphenicol amplification procedure, described in 
Chapter 3, to prepare membrane particles with a very high 
specific activity. During the course of this work another 
approach was developed to achieve even higher levels of 
NADH:ubiquinone oxidoreductase in the membrane. This 
involved the insertion of a piece of DNA containing two 
copies of the highly efficient lac promoter region into 
pIYl , presumably at the 5' end of the ndh gene, in an 
attempt to amplify enzyme levels by a combination of the 
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effects of both increased ge ne copy-number and an increased 
efficiency of transcription. To do this, plasmids pIYl and 
pLJ3 (which was the source of the double l ac promoter, 
Johnsrud (1978)) were separately digest~d with the 
restriction endonuclease Ec oRl, and then ligated together 
(M.I. Paulis & I.G. Young, unpublished results). The 
ligation-mix was then transformed into IY12, and selection 
made for complementation of the ndh mutant phenotype on 
mannitol-minimal plates. The viable colonies were replated 
onto selective plates containing 5-bromo-4-chloro-3-indolyl-
S-D-galactoside ('x-gal'). Strains carrying hybrid plasmids 
which contain the double la c promoter fragment produce blue 
colonies since they are constitutive for the l a c operon and 
therefore hydrolyze the non-inducing, chromogenic substrate 
(Johnsrud, 1978). Such an isolate, found to possess the 
highest NADH:ubiquinone oxidoreductase levels, was selected 
for further study, and designated IY85 and the plasmid it 
contains, pIY9. 
' 
Ongoing studies in the laboratory required large 
amounts of pure enzyme; consequently, in collaboration with 
Dr H.D. Campbell, the use of strain IY85 for the large-scale 
purification of NADH :ubiquinone oxidoreductase, was 
investigated . 
EXPERIMENTAL 
Media and Growth of Bacteria 
For details of the medium used and the growth of lOL 
cultures in glass fermenters, see Experimental section, 
Chapter 2. lOL cultures of IY35 and I Y85 we re a mplified 
with chloramphenicol as described in Chapte r 3. 
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Purification of NADH:ubiquinone Oxidoreductase 
For the preparation of highly purified NADH:ubiquinone 
oxidoreductase from chloramphenicol amplified IY35 or IY85, 
identical procedures to those used for the preparation of 
partially purified enzyme from IY13 were used (see 
Experimental section, Chapter 2) . Peak fractions of NADH: 
ubiquinone oxidoreductase were pooled , frozen in liquid N2 
and stored at -15 ° . 
Large Scale Growth of Bacteria 
A 40L batch culture of strain IY85 was grown in the 
stainless steel vessel of a New Brunswick Fermacell 
fermenter (model CF-50), with aeration (30L min-1 ) and 
stirring (200 rpm). When the culture reached a Klett of 
200 , 2g of chloramphenicol was added and the culture 
incubated , typically for 8h, under the same conditions as 
above . The cells were then harvested , resuspended in a 
small volume of sterile medium, and used to inoculate 
9 x lOL lots of fresh medium in 14L New Brunswick glass 
' fermenters (to a starting ~lett of approximately 100). The 
cultures were grown for one generation, exactly as for the 
small-scale work and the cells harvested (y ield approximately 
150g wet weight) . The Fermacell was also used in the 
continuous culture mode to grow 240L quantities of IY85 at 
Klett 200 . 
Large-Scale Enzyme Purification 
The preparation of membrane particles from the large-
scale chloramphenicol-amplified IY85 culture s was 
essentially a scaled-up version of the small-scale procedure. 
Washed, resuspended membrane particles from one large-scale 
growth of cells were placed in a beaker, on ice, and 20 % 
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(w/v) cholate and solid KCl were slowly added to the 
stirred solution to give final concentrations of 3% (w/v) 
cholate and lM KCl. The mixture was centrifuged for 2h at 
60 , 000 rpm in a Beckman 60Ti rotor. The resulting super-
natant was loaded onto a column of hydroxylapatite 
(5 x 25-30cm) equilibrated with 4L of 20mM potassium 
phosphate buffer, pH 7.5, containing 0.1% (w/v) cholate and 
20µM FAD. A 4L linear gradient; 0.02-lM potassium phosphate 
buffer, pH7.5, containing 0 . 1% (w/v) cholate and 20µM FAD, 
was applied immediately at a flow-rate of 150-200mL h-l and 
25mL fractions were collected. The pooled enzyme fractions 
were frozen in liquid N2 in 50mL screwcap polypropylene 
centrifuge tubes and stored at -60°. 
SDS Polyacrylamide Gel Electrophoresis 
SDS polyacrylamide gel electrophoresis on 10% and 
15% polyacrylamide slab gels was carried out as described in 
Chapter 2. Gels were also used in which the separation gel 
contained a linear 10-25% concentration gradient of 
acrylamide. 
For the determination of apparent subunit molecular 
weight, the following protein standards were used: y-
globulin (human), catalase (bovine liver), ovalbumin 
(chicken), L-lactate dehydrogenase (rabbit muscle), hexo-
kinase (yeast), pyruvate kinase (rabbit muscle), serum 
albumin (bovine), phosphoglyceromutase (rabbit muscle), 
myoglobin (horse muscle), lysozyme (chicken), ferritin 
(horse spleen) and cytochrome c (horse heart). All were of 
the highest grades commercially available. Subunit molecular 
weight values were obtained from Weber and Osborn (1969) and 
Darnall and Klotz (1975). The logarithm of the subunit 
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molecular weight was plot ted against Rf-l' and estimates 
of the subunit molecular weight of NADH:ubiquinone oxido-
reductase were obtained from the standard curve of the 
above data fitted by the least squares method. 
Determination of FAD 
-1 A 20mL solution of pure enzyme (0.316mg mL , specific 
activity 532 units mg- 1 ) was dialyzed against 90 volumes 
. 
(nominal) of 5mM potassium phosphate buffer, pH 7.5, 0.1 % 
(w/v) cholate (twice recrystallized, as described in Chapter 
2), for 24h with one change of dialysis buffer. The volume 
of the solution after dialysis was determined gravimetric-
ally, and the protein concentration by the procedure of 
Lowry et al . ( 19 51) ( see Chapter 2) and corrected according 
to the factor determined in Chapter 5 to give a true protein 
-1 
concentration of 0.168mg mL . The molarity of the solution, 
with respect to the enzyme subunit, was determined from the 
molecular weight predicted from the protein sequence (see 
Chapter 5). 
Total flavin was estimaied fluorometrically according 
to the procedure of Bessey et al . (1949) with FAD (Sigma 
Chemical Co., St. Louis,Mo) as standard. The FAD stock 
solution (72.5 µM) was standardized spectrophotometrically 
-1 -1 
at 450nm using E = 11,300cm M . Fluorescence measure-
ments were made with a Perkin Elmer spectrofluorometer 
(model 6000) with the excitation wavelength set, nominally, 
at 450nm and the emission wavelength set, nominally, at 
535nm. Measurement of the concentration of flavin in the 
dialyzed enzyme sample was made in triplicate using 0.3mL 
aliquots and corrected for the determined flavin 
concentration of the final dialyzate (approximately 2% of 
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the sample value). 
Visible and ultraviolet spectra of the dialyzed 
enzyme preparation were obtained using a Cary llBC spectra-
photometer, in 3mL matched quartz cuvettes. The reference 
cuvette contained a sample of the final dialyzate as blank, 
and the baseline, obtained with aliquots of dialyzate in 
sample and reference cuvettes, was manually subtracted to 
give the resulting spectra, depicted in Figure 4-B(a). The 
appropriate extinction coefficients at each wavelength were 
calculated from the molarity of the protein solution 
determined as described above. 
A 2mL aliquot of dialyzed enzyme, sampled with an 
'A- grade' bulb pipette, was extracted with 3 x 2mL of 
chloroform/methanol, 2:1 (v/v). The lipid extract was rotary 
evaporated then resuspended in 2mL of absolute ethanol. 
The final volume (1.98mL) was determined gravimetrically 
assuming a density of 0 . 79g cm- 3 The ultraviolet spectrum 
of the extract was obtained, using a Cary llBC spectro-
photometer, against absolute ethanol . Apparent extinction 
coefficients for the lipid extract were calculated relative 
to the molarity of the protein making a correction for the 
minor volume change. 
Extraction and Estimation of Lipid 
For each determination, the pooled hydroxylapatite 
column fractions from one small-scale preparation were 
dialyzed for at least 24h at 4° against 3 changes of glass-
distilled water (40 volumes), then freeze dried. The freeze 
dried material was resuspended in SmL of distilled water and 
extracted 4 to 6 times with an equal volume of chloroform/ 
methanol, 2:1 (v/v). The lipid extract was then extracted 
100. 
once with 2mL distilled wate r and analyzed. 
Phospholipid P was estimated by measuring enhancement 
of the natural fluorescence of rhodamine 6G according to 
the method of Schiefer & Neuhoff (1971) and using E. coli 
phosphatidylethanolamine (Sigma Chemical Co., St. Louis, Mo.) 
as standard. The lipid extract was also analyzed for total 
phosphorus and estimated by dry weight determination after 
evaporation of the solvent and drying in vacuo to constant 
weight. The latter two analyses were kindly performed by 
Dr J. Fildes of the A.N.U. Analytical Services Department. 
Chromatography of extracted lipids was carried out on 
silica gel thin layer plates (Merck, F 254 , 0.5mm thick) 
using chloroform/methanol/H2o, 65:31:4 (v/v) and chloroform/ 
methanol/NH 3 , 65:30:5 (v/v) as solvents. Lipids, in 
general, were visualized with iodine vapour, and lipids 
containing a free amino group (such as phosphatidyl-
ethanolamine) by spraying plates with ninhydrin (0.2 % (w/v) 
in acetone). 
Reconstitution of Ndh Mutant Membrane Particles 
Two methods were used to reconstitute NADH oxidase 
from ndh mutant me1nbrane particles and purified NADH:ubi-
quinone oxidoreductase. 
In the first method, 0.05mL aliquots of membrane 
particles were placed in glass vials at 0-4 ° , and varying 
amounts of pure enzyme (0 to lOO wL of pooled hydroxylapatite 
column fractions, - 30 units mL- 1 ) were added, and mixed 
thoroughly. 5 wL of the mixture was assayed for NADH 
oxidase in an assay mixture containing lmL 50mM TES buffer, 
pH 7.5, 40 wM FAD and 250 wM NADH , preincubated at 30 ° . The 
reaction was started by the addition of reconstituted 
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membrane particles and f ollowed at 340nm . 
NADH oxidation was calculated assuming€ 
The rate of 
-1 -1 
- 6,200cm M 
In the second method, lmL of assay buffer (SOmM TES 
buffer, pH7 .5, 40µM FAD), 250µM NADH and SµL of ndh mutant 
membrane particles were placed in a lmL quartz cuvette and 
preincubated at 30° . Various volumes of pure enzyme (0 to 
lOOµL of pooled hydroxylapatite column fractions, - 30 units 
mL-l) were added, and NADH oxidation followed as above . 
The rates of NADH oxidation obtained in both cases 
were corrected for the NADH oxidase activities of the mutant 
membrane particles and the pure enzyme, measured individ-
ually in the above assay system. 
The cyanide sensitivity of the various NADH oxidase 
activities was measured after the addition of 3µL of a lM 
KCN solution. 
Method 2 was used routinely to test reconstitution of 
ndh mutant particles under different conditions. To 
determine the location of the reconstituted NADH oxi dase, 
. -1 
O.S mL of IY}2 membrane particles (44mg mL ) was 
reconstituted, using method 1, with 250 µL o f pure enzyme 
(28 . 5 units mL- 1 ), then diluted with 3 . 45mL of STM buffer, 
and centrifuged for 3h at 48,000 rpm in a Spinco SW56 
rotor. The pellet was resuspended in SmL of the same buffer 
then assayed , together with the soluble fraction, for NADH 
oxidase , as above , and NADH : ubiquinone oxidoreductase. 
Metal Analyses and Other Assays 
Analysis of the metal content of NADH : ubiquinone 
oxidoreductase was done, following the development of 
large-scale preparation of enzyme , in conjunction with 
Dr H.D. Campbell who performed the analyses. 
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The Mo and W content o f the pure enzyme preparation 
was measured after digesting the pooled hydroxylapatite 
column fractions with H2so4 and H2o2 as described by 
Cardenas and Mortenson (1974). Digestions were performed 
i n 3mL stoppered quickfit tubes as suggested by Beinert 
(1978) . Cu was assayed, after wet ashing of pooled column 
fractions , according to Beinert (1978). Total Fe and 
non-haem iron were assayed essentially by the method of 
Doeg and Ziegler (1962) on 400µL and lOO wL aliquots 
respectively of individual hydroxylapatite column fractions, 
and acid-labile sulphur assayed on the same material 
(Rabinowitz , 1978) . 
Procedures for the determination of protein by the 
method of Lowry et al . (1951) , and for enzyme assays, 
have been described in Chapter 2 . 
RESULTS AND DISCUSSION 
Purif i cation of NADH : ubiquinone Oxidoreductase from 
Chloramphenicol-Amplified IY35 Cultures 
Membrane particles were prepared, washed and 
solubilized as described in Chapter 2 from chloramphenicol-
amplified IY35 cultures. The apparent recovery of NADH: 
ubiquinone oxidoreductase activity during solubilization 
was generally higher than obtained, under identical 
conditions, with IY13 membrane particles (Table 4-1). This 
appears to be due to a partial inhibition of activity, by 
potassium cholate, which is less apparent with the 
procedures used in assaying IY35 solubilized preparations: 
even though identical conditions are used to assay both 
wild-type and the highly amplified preparations, the very 
TABLE 4-1. Purification of NADH :ubiquinone Oxidoreductase from Chloramphenicol-amplified IY35 
Membrane Particlesa 
Volume . . b Protein 
Specific Yield Purification Activity Activity 
mL 
(Units mL-1 ) (Units) - 1 -1 (mg mL ) (mg) (Units mg ) ( % ) 
, 
Membrane Particles 12.5 1027 12844 36.6 457 28.1 ( 10 0) 
Cholate-soluble 10.5 1152 12093 12.1 127 95.2 94 
Hydro xy l a p a tite 75.0 41.1 3083 I 0.077 5.8 531 24 
a IY35 cultures were amplified with chloramphenicol as described in Chapter 3. Details of 
I 
purification are given in Chapter 2 and are identical to those used for the preparation of 
p a rtially purified enzyme from IY13 membrane particles. 
b 1 . 1 1 . d. d . -l unit = µmo e NADH o x i ize min For details of assay see text. 
(fold) 
( 1) 
3.4 
19 
f-' 
0 
w 
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high levels of enzyme in the latter necessitate diluting 
the sample assayed at least 100-fold for accurate 
determination of activity, and this probably has the 
effect of relieving the slowly-reversible inhibition by 
cholate (Figure 2-3). 
The cholate-soluble material was chromatographed on 
hydroxylapatite under conditions identical to those 
described in Chapter 2, and column fractions were assayed 
for protein (A280 ), NADH:ferricyanide oxidoreductase and 
NADH:ubiquinone oxidoreductase (Figure 4-1). The 
chromatograms reveal a very large increase in the size of 
the NADH:ubiquinone oxidoreductase peak. Remembering that 
equivalent amounts of membrane particles were solubilized 
in all cases, this indicates that the enzyme whose levels 
are amplified in IY35 membranes, and the gene for which 
has been cloned into pIYl, is the respiratory NADH 
* dehydrogenase , identified as the enzyme inactivated by the 
mutation in IY12. Furthermore, the overproduced enzyme 
behaves chromatographically in an identical manner to the 
enzyme obtained from wild-type cells. No detectable 
activity with NADPH as electron donor was seen across the 
amplified peak; an upper limit can be set such that under 
identical assay conditions the activity with NADPH as 
electron donor is less than 0.02 % that with NADH as 
electron donor. 
* This statement anticipates later results which show that 
the enzyme complex actually consists of a sing le type 
of polypeptide chain (see below and also Chapter 5). 
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In other respects, t he chromatograms depicted in 
Figures 2-S(a) and 4-1 are similar, in particular with 
regards to the amount of the other NADH:ferricyanide oxido-
reductases resolved during chromatography. Although there 
were variations seen in the sizes of the peaks corresponding 
to these enzymes between different experiments, their 
amounts are clearly not increased to anywhere near the 
same extent as that of the respiratory NADH dehydrogenase 
complex, in IY35. This fact is hard to reconcile with any 
assumption that they are either subunits or different 
solubilized forms of the respiratory complex, and, taken 
together with the observation that they are also present 
in column profiles of the ndh mutant IY12 (Figure 2-S(b)), 
suggests that they are unrelated to the respiratory enzyme 
complex. It would be speculative to comment further on the 
possible origin of these species or the metabolic 
significance of the enzymes they are derived from, but it 
may be noted that the presence of several NADH dehydro-
genases in ~- coli membrane preparations has been reported 
elsewhere (Dancey e t al .~ 1976; Bragg & Hou, 1967; Hendler 
& Burgess, 1974). 
SDS polyacrylamide gel electrophoresis of membrane 
preparations revealed that a single polypeptide of 
apparent molecular weight 45 ,000 (see below) is present in 
significantly increased amounts in chloramphenicol-
amplified IY35 membranes as compared to membranes from IY13 
(Figure 4-2). When the peak fractions, after hydroxyl-
apatite chromatography, of the respiratory NADH:ubiquinone 
oxidoreductase, were pooled and electrophoresed, it was 
found that this enzyme consists of a s~ngle polypeptide 
107 . 
FIGURE 4-2. SDS-polyacrylamide Gel Electrophoresis of 
Membranes Prepared from Wild-Type and 
Plasmid-Containing Cells and Pure NADH: 
ub1qu1none Oxidoreductase. 
a b C d e 
• 
Samples: (a) and (e), pure NADH:ubiquinone oxidoreductase 
(see text); (b), IY13 membrane particles; (c), IY34 
membrane particles; (d), chloramphenicol-amplified IY35 
membrane particles. 
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species with an apparent mol ecular weight coinciding with 
that of the polypeptide whose level is increased in IY35 
membranes . It appears, therefore, that the respiratory 
NADH dehydrogenase complex is an enzyme consisting of a 
* 
single polypeptide type , in marked contrast to the 
corresponding enzyme complex from mitochondria. 
As can be seen in Table 4-1, the NADH:ubiquinone 
oxidoreductase has been purified 19-fold over the activity 
found in chloramphenicol-amplified IY35 membrane particles, 
which corresponds to a purification of 800 to 1000-fold 
relative to wild-type membrane particles. 
The mitochondrial NADH:ubiquinone oxidoreductase has 
been isolated as a large lipoprotein complex (complex 1) 
with an estimated molecular weight of approximately 
850 , 000 (Hatefi & Stigall, 1976). Reports vary on the 
actual polypeptide composition of this complex, but it has 
been reported to contain at least 10 (Capaldi, 1974; 
Hatefi & Stempel, 1969) and as many as 16 (Ragan, 1976(b)) 
or even 26 0Heron et al . ~ 1979) different polypeptides. 
Taken at face value, the evidence points to the 
E. coli NADH:ubiquinone oxidoreductase as being much 
simpler in construction compared to the corresponding 
mitochondrial enzyme. There are three possible explanations 
for this apparent difference: 
(1) The two enzymes are fundamentally different 
in structure, which underlies a basic difference in their 
metabolic roles or mechanism of catalysis. 
* Evidence will be presented in Chapter 5 that the enzyme 
does not consist of two dissimilar polypeptides of the 
same molecular weight. 
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(2) The enzyme puri f ie d from IY35 is the primary 
NADH dehydrogenase of E. coli > but can reduce ubiquinone 
in vitro; however, electron transport between NADH and 
ubiquinone in the membrane involves other, additional 
polypeptides. 
(3) The structure of the mitochondrial NADH:ubi-
quinone oxidoreductase is very much simpler than that of 
complex 1, and many of the polypeptides present in complex 1 
are not involved in electron transport between NADH and 
ubiquinone. 
Alternatives (2) and (3) imply that the differences 
between the mitochondrial and E. coli NADH:ubiquinone 
oxidoreductases are only apparent. The second alternative 
is not considered a valid proposition, and this point will 
be taken up again in Chapter 6. 
The specific activity of the E . coli NADH:ubiquinone 
oxidoreductase, approximately 530 µmoles NADH oxidized mi~-l 
-1 0 
mg , at 30 (Table 4-1), is the highest reported so far 
with ubiquinone as electron acceptor, and it is therefore 
unlikely that the activity measured is artifactual. The 
turnover number assuming one active site per polypeptide 
4 -1 
chain, under the assay conditions used, 2.51 x 10 min 
(30 ° , pH7.5) is similar to that of complex 1, admittedly 
d d 'ff t d't' f 2 12 x 10 4 mi·n-l un er i eren assay con i ions, o . 
(38 ° , pH8.0) assuming one active site for complex 1 for a 
molecular weight of 850,000. The specific activity of 
complex 1 used for the calculation was taken as 25µmoles 
NADH oxidized min-l mg-l (Hatefi & Stempel, 1969) . 
Complex 1 is possibly the only solubilized preparation 
from the mitochondrion , to-date, which catalyzes a 
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physiologically meaningful ADH :ubiquinone oxidoreductase 
activity (see Chapter 1), but it is still not clear, despite 
intense investigation in many laboratories, how many poly-
peptides are involved in the electron transfer between NADH 
and -ubiquinone on the mitochondrion. Without this knowledge, 
a meaningful comparison between the enzymes from E. coli and 
mitochondria is not possible. 
The specific activity of the pure NADH:ubiquinone 
oxidoreductase from chloramphenicol-amplified IY35 is in 
close agreement with that estimated for the enzyme in the 
partially purified preparation from IY13, which is based on 
the assumption that there is one active site per polypeptide 
of apparent molecular weight 45,000 (Chapter 2). This 
supports the assumption that the catalytic centre activity 
of the enzyme has not been altered by the techniques 
employed to amplify its levels in the membrane. Taken in 
conjunction with the evidence from SOS polyacrylamide gel· 
electrophoresis (Figure 4-2) this shows that the increase 
in the specific activity of IY35 or chloramphenicol-
amplified IY35 membranes, compared to IY13 membranes, is 
due to a parallel increase in the number of enzyme molecules, 
and not due to activation. The argument can be advanced that 
the NADH : ubiquinone oxidoreductase is a multisubunit enzyme, 
but that only the content of the primary dehydrogenase has 
been increased and that this has been subsequently 
purified (e . g . see case 2 above) . It is unlikely that such 
an enzyme preparation would have the same specific activity 
as the stoichiometric complex , and this is not considered 
a tenable proposition. 
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The cloned DNA insert is of sufficient size (1.6M 
daltons or approximately 2,600 base pairs) to code for a 
maximum of approximately 800 amino acids, or the equivalent 
of a protein with a molecular weight about 90,000. It does 
not seem likely, therefore, that the DNA fragment contains 
the structural genes coding for two separate polypeptides 
of identical molecular weight, and indeed that this is not 
so will be shown in Chapter 5. 
Estimation of the Subunit Molecular Weight of NADH:ubi-
quinone Oxidoreductase 
The subunit molecular weight of the pure enzyme was 
estimated by SDS polyacrylamide gel electrophoresis using 
the same gel system employed for analytical separation. It 
was found that plots of the logarithm of apparent molecular 
weight versus Rf, for various standard proteins, are not 
linear with this system, using either 10 % or 15% acrylamide 
gels. Plots of the logarithm of apparent molecular weight 
-1 
versus Rf are linear, however, within the molecular 
weight rang~ 30,000 to >70,000, and such plots, fitted by 
the least squares method, were routinely employed for 
molecular weight estimation (Figure 4-3). The subunit 
molecular weight, calculated from the results of four 
separate experiments, was estimated to be 44,600 (S.E. -
1,200). 
Experiments with 10 % and 15 % polyacrylamide gels 
showed that the apparent molecular weight estimated by this 
technique is not significantly altered by increasing the 
degree of cross-linking in the gel, as is the case for 
some membrane-bound proteins (Tanner, 1979). 
There are traces of impurities of lower molecular 
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FIGURE 4- 3 . Molecular ~ . ight Estimations by SDS -
polyacrylamide Gel Electrophoresis . 
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Details are given in the Exp~rimental section. Linear 
estimation of the subunit molecular weight of NADH : 
ubiquinone oxidoreductase on such plots in four separate 
experiments (3 on 10 % and l on 15 % polyacrylamide gels) 
gave values of 45 , 600 , 45 , 500 , 43 , 000 and 44 , 400 (mean= 
44 , 600 , S . E . = 1200) . 
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weight, as well as mater ial migrating at the dye front, 
visible on 10 % acrylamide gels (Figure 4-2). The latter 
material is not present on 15% acrylamide gels, and may be 
an artifact: the major band accounts for 90 to 95 % of 
the material included in 10 % or 15 % polyacrylamide gels. 
It was found that the purity of the preparation diminished 
when enzyme was purified from membrane particles which had 
b t d f k t -20 0 . een sore or many wees a The two major 
impurities, of apparent molecular weights 41,000 and 33,000, 
correspond to the major polypeptides present in the 
partially purified preparation from IY13 (Figure 2-6). 
A comparison between chloramphenicol-amplified IY35 
membranes and the pure enzyme by SDS polyacrylamide gel 
electrophoresis indicates that proteolysis has not occurred 
either during solubilization of the membrane particles or 
subsequent column chromatography. This is supported by 
protein chemical studies (see Chapter 5), which indicate 
that the amino and carboxy-termini of the pure enzyme are 
as predicted from the DNA sequence of the structural gene. 
Lipid Content of the NADH:ubiquinone Oxidoreductase 
Preparation 
The amount of lipid present was estimated following 
extraction of enzyme preparations with chloroform/methanol, 
2:1 (v/v) (see Experimental section for details). 
Total lipid was determined gravimetrically by drying 
the chloroform extract to constant weight. Determinations 
on thre~ separate enzyme preparations gave an average lipid 
content of 2 .2 g lipid per g protein (S.E. = 0.34) or 
approximately 70 % by weight. 
Thin layer chromatography of the chloroform/methanol 
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extracts on silica gel (solvent: chloroform/methanol/water, 
65:31:4 (v/v)), resolved one maJor (Rf,0.48) and several 
minor (Rf' 0.38, 0.58, 0.80, 0.90) lipid species (Figure 
4-4). Comparison with pure standards, as well as the 
positive reaction with ninhydrin, indicated that the major 
lipid present is phosphatidylethanolamine. From their Rf 
values in this solvent system, relative to phosphatidylethan-
olamine , the other species correspond to phosphatidylglycerol 
(Rf' 0.38 & 0.58), cardiolipin (Rf, 0.80) and neutral lipid 
(Rf, 0.90) (Ames , 1968) but were not further identified. 
The lipid extract was also assayed for phospholipid 
phosphorus , by the fluorometric grocedure of Schiefer and 
Neuhoff (1971), using phosphatidylethanolamine as standard, 
and total phosphorus. The results of the former assay are 
in reasonable agreement with the dry weight determinations, 
and gave an estimate of 2 .08 g phospholipid per g protein, : 
or 67 % by weight. Total phosphorus analysis gave an 
estimate of 0.0852g P per g protein. 
From the high lipid content of the preparation, it is 
likely that the enzyme has been purified as a lipoprotein 
complex, similar in nature to comple x 1. This is expected 
from the known properties of the detergent used for 
solubilization, potassium cholate, which forms mixed 
micelles with lipids rather than homogeneous protein-
detergent complexes . 
The lipid content of complex 1 , 0.22g lipid per g 
protein (Hatefi et al ., 1962) is much lower than that of 
the preparation described above, and this may be the result 
of the repeated treatment with bile salts and a mmonium 
salts during the preparation of the former complex. There 
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FIGURE 4-4. Thin Layer Chromatography of Lipids 
Extracted from Pure Enzyme Preparations . 
..... -----NL 
... 
... 
PG 
PE 
PG 
Solvent: chloroform/methanol/H2o, 65:31:4 (v/v). Lipids 
visualized with Iodine vapour. Tentative assignments: 
PE, phosphatidylethanolamine; PG, phosphatidylglycerol; 
CL, cardiolipin; NL, neutral lipid. For further details 
see text. 
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is sufficient lipid present in complex 1 to retain the 
rotenone-sensitive activity with ubiquinone as electron 
acceptor; however, that there has been a change at the 
active site of the complex during its isolation is shown by 
the. 5 to 6-fold increase in the apparent K for ubiquinone-1 
m 
compared to the membrane-bound enzyme (44 wM compared with 
8µM (Hatefi & Stempel, 1969; Schatz & Racker, 1966)). 
Preliminary experiments with the pure E. coli NADH:ubi-
quinone oxidoreductase suggest that the apparent K for 
m 
ubiquinone-1 (under the assay conditions described above) 
is approximately lµM (data not shown). 
A complete characterizatiQn of the detergent-lipo-
protein complex has not been attempted, and a detailed 
hydrodynamic study, such as that by Dooijewaard et a l. (1978) 
of complex 1 would need to be attempted. The type of data 
that one could derive from such a study would serve to 
characterize the preparation but could not be used to infer 
the structure of the enzyme complex in the membrane . How 
much lipid in the preparation is tightly associated with the 
enzyme is not known, and it may be that much of the lipid 
simply co-chromatographs with the complex. 
Identification and Quantification of the Flavin Prosthetic 
Group of NADH:ubiquinone Oxidoreductase 
During chromatography of the solubilized NADH:ubi-
quinone oxidoreductase on hydroxylapatite, 20µM FAD was 
included in the equilibration and gradient buffers. It was 
found that if flavin is omitted from the column buffers, the 
resulting preparation is inactive unless FAD is present in 
the assay. The reactivation of the apoenzyme by flavin was 
found to be rapid, and the activity obtainable could not be 
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increased by preincubation with FAD for periods as long as 
5 min. Maximum reactivation was obtained at approximately 
SO µM FAD, with higher concentrations being slightly 
inhibitory; the requirement for flavin was not satisfied 
by FMN at comparable concentrations (Figure 4-5). 
The above experiments suggest that the prosthetic 
group on the enzyme is non-covalently-bound FAD. No . 
covalently-bound flavin was detected when preparations ·of 
pure enzyme were electrophoresed on SDS polyacrylamide gels 
and analyzed fluorometrically and at acid pH by the method 
of Sato et al . (1977): 9µg of pure enzyme was electro-
phoresed in each analysis. 
The stoichiometry of the flavin prosthetic group was 
estimated following dialysis of the enzyme preparation 
against SmM potassium phosphate, pH7.5, 0.1% (w/v) 
potassium cholate , to remove flavin present in the elution 
buffer. Total flavin was estimated fluorometrically by the 
procedure of Bessey et al. (1949) and the values obtained 
from the co~centration of flavin in the preparation were 
corrected for the determined concentration of flavin in the 
dialyzate. The true protein concentration of the solution 
was obtained by using the correction factor for Lowry 
protein estimation as determined in Chapter 5. A value of 
1.02 ± 0.11 moles flavin per mole subunit was obtained 
(Figure 4-6) . Assuming that no flavin has been lost from 
the enzyme during dialysis, this data indicates that there 
is one molecule of non-covalently-bound FAD per subunit. 
Dialysis under these conditions can sometimes lead 
to a gradual loss of activity , for reasons which are not 
fully understood (Figure 4-7) . The rate of NADH oxidation , 
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FIGURE 4- S . Reactivation o ' De - flavo ' Apoenzyme by 
----=------ -------FAD and FMN . 
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ADH : ubiquinone oxidoreductase was purified from 
chloramphenicol~amplified IY35 cultures exactly as 
described (see Chapter 2) except that FAD was omitted from 
the hydroxylapatite column equilibrat i on and gradient 
buffers. The pooled enzyme peak was assayed for NADH: 
ubiquinone ox i doreductase act ivit y under the stan~ard 
assay conditions (see Chapter 2) except that 40 \i M FAD was 
replaced by either fAD or FMN at the indicated 
concentrations . The activity assayed in the absence of 
fl vin was 0 . 027 units mL - 1 , or 0.]4 % of the maximal 
-1 
activi y obtained (at S0 ;1 M FAD) ; the latter, 7 . 82 units rrL , 
corresponded to a specific activity of 130 units mg - 1 . 
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NADH:ubiquinone oxidoreductase was dialyzed against SrnM 
potassium phosphate, pH7.5, 0.1% (w/v) cholate, as 
described in the Experimental section. Acid-extractable 
flavin was determined on O. 3rnL aliquots of the dialyzed 
enzyme preparation (concentration= 3.56 µM) in triplicate, 
and the final d i alyzate . Values were determined of 4.09, 
3 . 50 and 3 . 52 µM (average= 3 .70 µM) and 0.08 µM respectively. 
From this data a Flavin/Enzyme stoichiometry of 1.02 (per 
subunit of molecular weight 47 , 300) was determined. 
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f I GU RE ~ - 7 . Lo S S o f AC ti Vi t y O f N A,D H : U bi q U in One OX id O -
reductase During Dialysis . 
30 
• 'J 
20 
10 
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TIME OF DIALYSIS (hr) 
0 
• 
30 
4 x l.OOmL alituots of NADH :ubiquinone oxidoreductase 
( ~31 units mL-) were dialyzed against O.SL of SmM potassium 
phosphate, pH7.S, 0.1% (w/v) cholate, at 4 ° . Dialysis 
buffer was changed after 4, 8 and 12h. Samples were 
assayed at 0, 4, 12 and 24h for NADH:ubiquinone oxido-
reductase activity both under the standard assay conditions 
(see Chapter 2) and with the omission of FAD from the assay 
buffer. Activities ar~ corrected for the volume changes 
after dialysis (estimated gravimetrically) and are 
normalized to the Oh figure. 
• • + FAD; o o - FAD. 
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however, is not affected b y t he omission of FAD from the 
assay buffer, and since it has already been shown that FAD 
can rapidly reconstitute the holoenzyme from the 'de-flavo' 
enzyme (Figure 4-5), this suggests that very little flavin 
is lost from the enzyme under these conditions. 
Visible and Ultraviolet Spectra of NADH:ubiquinone 
Oxidoreductase 
The visible and ultraviolet spectra of the dialyzed 
enzyme preparation, used in estimating the flavin content 
of the enzyme (see above), were obtained (Figure 4-8(a)). 
The major features of the visible spectrum are the peaks at 
370nm and -440nm, characteristic of FAD in the oxidized form. 
The ultraviolet spectrum is unusual in that there is a peak 
of absorption at 268nm which cannot be attributed to the 
absorption by the protein . This may be accounted for by the 
absorption in the ultraviolet region of the spectrum by both 
-1 -1 FAD (A 263nm , E = 38,000cm M ) and the lipid (Figure 
max 
4- 8(b)) present in the preparation. The apparent extinction 
-1 
coefficient of the enzyme preparation at 450nm, 14,800cm 
- 1 -1 -1 M , is considerably greater than that of FAD, 11,300cm M , 
but is consistent with there being 1 mole of FAD per mole 
subunit . 
An attempt was made to estimate the flavin content of 
the preparation by making a correction for the light 
scattering of the sample in the following manner: a plot 
of the logarithm of absorbance versus wavelength was found 
to be linear in the region 530 to 700nm, where there is no 
contribution by either flavin or lipid to absorbance. The 
contribution of light scattering to the absorbance at 450nm 
was then estimated by extrapolation, and subtracted to obtain 
E 
1 2 2 . 
FIGURE 4- B(a) . Visible and Ultraviolet Spectra of 
NADH : ubiquinone Oxidoreductase . 
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FIGURE 4-8 (b) . Ultraviolet Spectrum of Lipid Extracted 
from NADH : ubiquinone Oxidoreductase . 
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the corrected extinction coe ff icient. From this value, 
-1 -1 11,050cm M , the flavin content of the preparation was 
estimated to be 0.98 moles per mole subunit. If we assume 
that the empirical method used in correcting the extinction 
coefficient is valid, then this indicates that there is one 
molecule of flavin per subunit, in agreement with the 
fluorometric assay, and that all of the bound flavin is 
in the oxidized state. 
An attempt was made to estimate the contributions to 
the peak of absorbance at 268nm by the flavin, using the 
known extinction coefficient at this wavelength and 
assuming 1 mole flavin per mole subunit; by the protein, 
from the amino acid composition derived from the sequence 
(see Chapter 5) and the extinction coefficients of tyrosine 
and tryptophan at this wavelength; by the lipid, from the 
ultraviolet spectrum of the extracted lipid in ethanol 
(Figure 4-B(b)); and correcting for light scattering using 
the empirical method described above. The contributions 
-1 1 -1 -1 -1 -1 were 38,000cm M- , 24,000cm M , 23,500cm M , and 
-1 -1 12,000cm M , respectively. The extinction coefficient 
-1 -1 for the preparation derived this way, 97,500cm M , agrees 
with the experimentally determined value of 98,000cm-l M-l 
(Figure 4-B(a)). 
Reconstitution of NADH Oxidase in Membrane Particles 
Prepared from Ndh Mutants 
Experiments were undertaken to see whether an active 
NADH oxidase could be reconstituted from the pure NADH: 
ubiquinone oxidoreductase and membrane particles prepared 
from ndh mutant strains. 
IY12 membrane particles were titrated with the enzyme 
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preparation and assayed, spe ctrophotometrically, for NADH 
oxidase activity . This was done two ways (see Experimental 
section for details): 
(1) Varying amounts of pure enzyme (0 to lOOµL 
aliquots) were added to a fixed volume (O.OSmL) of membrane 
0 particles at 4 . THe resulting mixture was assayed for 
NADH oxidase. 
(2) A fixed volume of membrane particles (usually 
SµL) was added to a cuvette containing lmL assay buffer and 
250µM NADH, then various amounts of pure enzyme were added 
and the resulting NADH oxidase rate measured. 
The NADH oxidase rates obtained in both cases were 
corrected , not only for the residual NADH oxidase activity 
present in the mutant membrane particles, but also for the 
activity of the added enzyme: it was found that the 
purified NADH:ubiquinone oxidoreductase possesses a cyanide-
insensitive oxidase activity (Figure 4-9) characteristic of 
flavoprotein dehydrogenases. The NADH dehydrogenase rate 
with o2 as electron acceptor is low, being less than 1% that 
with ubiquinone-1 as electron acceptor under the assay 
conditions used, but this rate is significant when compared 
to that of the residual, and the reconstituted, NADH 
oxidase activity of the ndh mutant membrane particles. 
As can be seen in Figures 4-10 and 4-11, addition of 
pure NADH:ubiquinone oxidoreductase to IY12 membrane 
particles reconstituted a functional NADH oxidase. This 
activity , in contrast to those present prior to 
reconstitution, is sensitive to potassium c y anide (see 
--(/) 
-C 
:::) 
--
>-
~ 
-
> 
~ 
u 
~ 
12 6 . 
fIGURL 4 - 9 . ADH Oxidas e Ac tivity of ADH~~biguin ~ nc 
6xio.oreductase: . 
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NADH : ubiquinone oxidoreductase (40 . 3 units mL- 1 ) was 
assayed spectrophotometrically for NADH oxidase activity 
before and after dialysis against Sm.M potassium phosphate, 
pH7 . 5 , 0 . 1 % (w/v) cholate (100 vol . ) at 4 ° for 3h . The_ 1 
ADH oxidase activity of the pure enzyme, 0 . 44 units mL , 
was not affected by dialysis and was 1 . 1 % of the ubiquinone 
reductase activity of the enzyme under these assay 
conditions . 
4 • dialyzed ; • • undialyzed . 
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below). The specific activity of the NADH oxidase in 
reconstituted IY12 membrane particles approaches that 
of wild-type membrane particles. 
The purified NADH:ubiquinone oxidoreductase could 
reconstitute a cyanide sensitive NADH oxidase in membrane 
particles derived from each of the dozen ndh mutant strains 
isolated so far (data not shown) and this, taken in 
conjunction with the fact that pIYl complements all the ndh 
mutant strains (I.G. Young, unpublished results), suggests 
that they are all defective in the same component of the 
respiratory chain. 
When the pure enzyme was added directly to the IY12 
membrane particles prior to assay (method 1), a linear 
relationship between the amount of added enzyme and the 
reconstituted NADH oxidase rate, was observed (Figure 4-10), 
whereas there was a more complicated relationship between 
the two when membrane particles and enzyme were mixed 
during the assay (Figure 4-11). The appearance of 
cyanide-sensitive NADH oxidase was rapid in both cases, 
being within the time taken for mixing and assay, and 
preincubation for periods as long as 90 min did not 
increase the rate obtained: this did not hold, however, 
in method 1 where more than 20D µL of enzyme was added to 
O.OSmL of particles. 
Reconstituted particles were washed in STM buffer, 
and the membranes collected by centrifugation (Figure 4-12). 
100 % of the cyanide-sensitive, and over 93 % of the total, 
NADH oxidase activity appeared in the particulate fraction. 
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Reconsti ul 10 n of 1 ADH Oxidase in IY12 
Membr ne ror ticles : 
Method l . 
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Various volumes of NADH : ubiquinone oxidoreductase (0 to 
100 11 L , 24 . 6 units mL- 1 ) were added to O. SmL of IY12 membrane 
particles , at Oto 4 ° . The reconstituted particles were 
assayed spectrophotometrically for NADH oxidase and the 
rate obtained corrected for the activity of the pure enzyme 
(0 . 163 units mL-1) and IY12 membrane particles (0.524 units 
mL- 1) . The highest activity corresponds to a specific 
activity of 0 . 14 units mg - 1 for the reconstituted NADH 
oxidase . 
FIGURE 4-11 . 
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Reconstitution of NADH oxidase in IY12 
Membrane Particles : 
Method 2 
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SµL of IY12 membrane particle s plus various aliquots of _1 NADH : ubiqu i none oxidoreductase (0 to 60µL , 40.2 units JTtL ) 
were mi xed together in lmL assay buffer and assayed 
spectrophotometrically for NADH oxidase . The resulting 
ac t iv i ty was correcled for the NADH oxidase activity of the 
membran~ pa r t i cles (0 . 40 units mL- 1) and the pure enzyme 
(0 .44 unit s mL- 1). The highes t net activity measured above , 
corre s ponds to a specific activ i ty of 0 . 42 units mg-1 
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This suggests that a proport ion of added enzyme molecules 
has become attached to the membrane and can pass electrons 
from NADH to the respiratory chain, presumably at the level 
of the endogenous ubiquinone since no exogenous ubiquinone 
was added: this, in turn, implies that the pure enzyme can 
reduce the natural electron acceptor ubiquinone-8 as well as 
the short-chain isoprenologue, ubiquinone-1, although this 
has yet to be demonstrated directly. The exact nature of 
the reconstitution is still not understood, and whether the 
enzyme can insert into the membrane in a topologically 
similar attitude to the enzyme &n vivo, is still an open 
question. 
From the results presented in Figure 4-12, the 
efficiency of reconstitution can be estimated: this can be 
defined as the units of reconstituted NADH oxidase per unit 
of added NADH:ubiquinone oxidoreductase. For this to be a 
direct measure of the proportion of added enzyme interacting 
with the respiratory chain, it is necessary to assume that 
' 
the catalytic centre activity of the pure enzyme and the 
* membrane-bound enzyme are identical . The efficiency, based 
on the cyanide-sensitive NADH oxidase present in the 
* For the membrane-bound enzyme, the rate of the reaction 
with saturating concentrations of ubiquinone-1 as electron 
acceptor is not substantially different to that with the 
endogenous ubiquinone. This can be inferred from the 
fact that in wild-type membrane particles, where the 
respiratory NADH dehydrogenase is rate-limiting to the 
overall NADH oxidase rate, the rate of NADH dependent 
ubiquinone-1 reduction closely parallels that of the 
NADH oxidase. 
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particulate fraction after c entrifugation (Figure 4-12), is 
20% , and slightly higher (22 %) if based on the net NADH 
oxidase in the pellet after correction for the activity 
present prior to reconstitution. Even making allowance for 
the assumption made, it is evident that the reconstitution 
is remarkably efficient . 
. From the NADH:ubiquinone oxidoreductase activity of the 
particulate and soluble fractions, and the inherent activity 
of the ndh membrane particles, the proportion of the added 
enzyme which becomes attached to , or inserted into, the 
membrane can be calculated . This figure, 3.16 units or 54.5% 
(allowing for the incomplete recovery of activity after 
washing and centrifugation) can be used to estimate the 
efficiency of reconstitution of the enzyme in the membrane, 
which can be defined as the number of units of NADH oxidase 
reconstituted per unit of NADH : ubiquinone oxidoreductase . 
inserted into , or attached to, the membrane particles. 
turns out to be 44 %, based on the cyanide-sensitive NADH 
' 
This 
oxidase present in the washed particles, and 49 % when based 
on the net NADH oxidase in the pellet after correction for 
the activity prior to reconstitution. 
It was observed that the purified enzyme preparation 
is reconstitutively inactive after dialysis against low 
ionic strength buffer (Figure 4-13). This phenomenon is of 
interest since it is possible that some component of the 
enzyme , necessary for electron transfer to endogenous 
ubiquinone but not for ubiquinone-1 reduction, is being lost 
during dialysis . The significance of this is heightened by 
reports that short-chain analogues of ubiquinone can inter-
act with mitochondrial membrane particles and solubilized 
FIGURE 4-12. Distribution of Activities Following Washing of Reconstituted IY12 Membrane Particles 
Before Reconstitution 
NADH oxidase 
CN sensitive NADH oxidase 
NADH:ubiquinone oxidoreductase 
NADH oxidase 
IY12 membranes 
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0 .,,91 
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CN-sensitive NADH oxidase 
NADH:ubiquinone oxidoreductase 
Membrane Particles 
NADH oxidas~ 1.63 units 
CN sensitive NADH oxidase 1.40 II 
NADH:ubiquinone oxidoreductase 4.07 11 
pure enzyme 
0.04 units 
total 
0.20 units 
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7.12 
II 
II 
After Reconstitution 
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1.20 
6.38 
II 
II 
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8.03 
Supernatant 
NADH oxidase 
CN s~nsitive NADH oxidase 
II 
II 
0.11 units 
0.00 II 
NADH:ubiquinone oxidoreductase 2.64 II 
0.5mL of IY12 membrane particles was mixed with a 0.25rnL aliquot of pure NADH:ubiquinone oxido-
reductase (28.5 units rnL- 1 , specific activity= 450 units mg-l) at 4 ° . The reconstituted particles 
were immediately diluted with 3.45mL ice-cold STM buffer and centrifuged at 47,000 rpm for 3h in a 
Spinco SW56 rotor. The supernatant (vol= 4.0SmL) was decanted, and the pellet resuspended in 
5.0mL STM buffer. For details of assay procedures, see text. CN-insensitive NADH oxidase was 
measured following the addition of 3mM KCN to the assay. 1 unit= lµmole NADH oxidised min- 1 . 
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FIGURE 4-13. Reversibl e Los s of Reconstitution Activity 
of ADH : ubiq u i none Oxidoredu~_!_a s e Activity 
by Dialysi s . 
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2xlmL aliguots of NADH:ubiquinone oxidoreductase (19.4 
units mL-I) were dialyzed at 4 c1 for 3h against 0.lL of 
SmM potassium phosphate, pH7 . 5, 0.1 % (w/v) cholate. After 
3h , one aliquot was transferred to O.lL of lM potassium 
phosphate , pH7 . 5, 0 . 1% (w/v) cholate and dialyzed for a 
further 3h at 4 ° . 
SwL of IY12 membrane particles were reconstituted with 0 
to SO wL aliquots, each, of the 2 dialyzed preparations, and 
the undialyzed control preparation, of NADH:ubiquinone 
oxidoreductase by method 2 (see text) . No correction was 
made for the small volume changes accompanying dialysis. 
• -• undialyzed control; o - o dialyzed, SmM buffer; 
•-• redialyzed, lM buffer . 
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preparations at a site d istinct to that of endogenous 
ubiquinone (e .g. de Otamendi & Stoppani, 1974; Ragan & 
Hinkle , 1975) . 
The pure NADH:ubiquinone oxidoreductase can reduce 
long-chain isoprenologues of ubiquinone such as ubiquinone-3, 
although the traces obtained are curved owing to the low 
solubility of these compou·nds in aqueous buffers. The 
initial rate of reduction of ubiquinone-3 is about 30% that 
with ubiquinone - 1 as el~ctron acceptor. As can be seen in 
Figure 4-14, dialysis , under conditions which lead to a 
reconstitutively inactive preparation, does not affect the 
ub iquinone - 3 reductase activity, nor does it affect the 
NADH oxidase activity of the pure enzyme (Figure 4-9). 
It was felt that the inability of such preparations to 
reconstitute an active NADH oxidase in ndh mutant membrane 
particles may be due to a loss of divalent cations, 
especially Ca++ , which may be present in the preparation, · 
since it is known that divalent cations promote the fusion 
of phospholipid vesicles (Portis et al . ~ 1979). However, 
attempts to restore a reconstitutively active preparation 
by the addition of Ca++ or Fe++ salts, crude phospholipids 
or a boiled extract from undialyzed enzyme preparations, 
to the dialyzed enzyme , were unsuccessful. Also, EDTA, at 
-1 
a final concentration in the assay of 0 . 1mg mL , was found 
not to inhibit the reconstitution by undialyzed enzyme 
preparations . 
The loss of the ability to reconstitute ndh mutant 
membrane particles, after dialysis of enzyme preparations 
against low ionic strength buffer, is reversible, since it 
was found that a reconstitutively active preparation can be 
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FIGURE 4- 14 . Ubiquinone- J Reductase Activity of NADH : 
ubiquinone Oxidoreductase Before and 
After Dialysis . 
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NADH:ubiquinone oxidoreductase (40 . 2 units ~L- 1 ) was 
dialyzed against 100 volumes of SrnM potassium phosphate, 
pH7 . 5 , 0.1 % (w/v) cholate for 3h (see also Figure 4 - 9) . 
Ubiquinone - 3 reductase activ ity was assayed exactly as 
ubiquinone-1 reductase activity (see Chapter 2) except 
that ubiquinone - 3 was added as electron acceptor ( 12 . 5 1J L 
of a 4mM ethanolic stock solution) . 
upper tracing , undialyzed enzyme; 
lower tracing , dialyzed enzyme . 
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obtained by redialysis aga inst lM phosphate buffer (Figure 
4-13). It is therefore unlikely that there is a loss of 
any component of the enzyme during dialysis. Rather, a 
change in the state of aggregation or a slow conformational 
change is probably responsible for the loss of reconstitutive 
ability after dialysis. 
Large-Scale Purification of NADH:ubiquinone Oxidoreductase 
Using Strain IY85 
In an attempt to further increase the yield of NADH: 
ubiquinone oxidoreductase, a hybrid plasmid (pIY9) was 
constructed which contains two copies of the highly 
efficient lac promoter adjacent- to the ndh gene (see 
Introduction). 
lOL cultures of strain IY85 (which carries pIY9) 
were grown with and without being subjected to chlor-
amphenicol amplification, and membrane particles prepared. 
As can be seen in _Table 4-2, the specific activity of IY85 
membrane particles is as high as for particles prepared 
from chloramphenicol-amplified IY35. It is also possible 
to combine the effect of amplifying the gene copy-number 
with chloramphenicol and the efficient transcription due 
to the double lac promoter on pIY9. Thus when cultures 
of IY85 were amplified with chloramphenicol, a further 
doubling of the specific activity occurred, giving an 
amplification of 80 to 100-fold relative to the level in 
wild-type membranes, with a small but variable amount of 
activi~y appearing in the cytoplasm. 
It was hoped that the high specific activity of IY85 
membrane particles might obviate the need for chlor-
1 37 . 
TABLE 4-2. NADH Oxidase and NADH:ubiquinone Oxido-
reductase Activities of Membrane and Cytoplasmic 
Fractions of IY85 and Chloramphenicol-amplified IY85 a 
IY85 Cap.amp. b I Y85 
Small scale Large scale 
Membrane fraction 
NADH oxidase 4.39 5.01 3.76 
NADH:ubiquinone 
oxidoreductase 24.5 47.9 31.8 
Cytoplasmic fraction 
NADH oxidase 0.097 0.276 0.347 
-NADH:ubiquinone 
oxidoreductase 1.96 2.47 5.49 
a Details of membrane preparations and assay conditions 
are given in the text. 
b Chloramphenicol~amplified: details of chloramphenicol 
amplification on both small scale and large scale 
cultures are given in the text. 
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amphenicol amplification on a large-scale. Consequently, 
240L of IY85 were grown in continuous culture. Unfortunat-
ely, the specific activity of membrane particles prepared 
-1 from such cultures was only - 10 units mg (Dr H.D. 
Campbell , unpublished results). Apparently this is a 
function of the continuous culture mode since 40L batch 
growth of IY85 in the continuous culture vessel resulted 
in membrane particles being prepared with specific 
activities >20 units mg-l (ibid.). For large-scale growth 
of bacteria and high membrane specific activity, IY85 was 
grown in 40L batch culture in a stainless steel fermenter 
and amplified with chloramphenicol, with the second stage 
of growth being carried out in 9 x 14L glass fermenters 
(see Experimental section). The preparation of membranes 
and hydroxylapatite column chromatography are essentially 
scaled-up versions of the procedures already described 
(see Experimental section and Chapter 2). 
Typically - lOOmL of membrane particles were obtained 
from - 150g (wet weight) of bacteria, yielding 50 to 100mg 
of purified enzyme protein with a specific activity of 
-1 550 units mg . The purity of such preparations, gauged 
by SDS polyacrylamide gel electrophoresis, was not 
noticeably different to the small-scale - preparations 
(Figure 4-15). 
Analysis of Metal Content of NADH:ubiquinone Ox idoreductase 
Preparations 
NADH:ubiquinone o x idoreductase was purified from 
chloramphenicol-amplified IY85 on a large-scal e : 130mL of 
-1 
membrane particles (specific activity 34.8 units mg ) 
were washed, solubilize d and chromatographed on an hydroxyl-
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FIGURE 4-15 . SOS Polyacrylamide Gel Electrophoresis of 
NADH : ubiquinone Oxidoreductase Purified 
from Chloramphenicol-amplified IYBS on a 
Large Scale. 
I SCALE T FRONT 
• 
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apatite column (5 x 32cm). Peak fractions were then assayed 
directly for activity, protein, non-haem iron, total iron, 
and acid-labile sulphur. Aliquots were also taken for 
analysis by SDS polyacrylamide gel electrophoresis. The 
results presented in Table 4-3 indicate that no stoichio-
metric amount of iron or acid-labile sulphur was detected 
in column fractions possessing full activity with 
ubiquinone-1 as electron acceptor. Analyses for Mo, W, Fe 
and Cu on pooled column fractions also proved negative. 
The involvement of iron, especially in the form of 
iron-sulphur clusters, in electron transport between NADH 
and ubiquinone in the purified enzyme preparation can 
therefore be ruled out, although extension of this 
conclusion to the membrane-bound respiratory chain rests 
on the assumption that no loss of iron and acid-labile 
sulphur has occurred during solubilization or subsequent 
column chromatography and ultimately on the assumption 
that the mechanism of catalysis of ubiquinone reduction is 
identical in,the purified and membrane-bound enzyme. 
SUMMARY 
Following hydroxylapatite column chromatography of 
cholate-solubilized membrane particles from genetically-
amplified strains, an NADH:ubiquinone oxidoreductase has 
been purified 800 to 1000-fold relative to the activity 
present in wild-type membranes. The specific activity with 
-1 
ubiquinone-1 as electron acceptor, - 530 units mg measured 
at 30 ° , is the highest reported for any preparation. The 
enzyme is specific for NADH as electron donor. 
Comparison with analogous column profiles of cholate-
TABLE 4-3. Activity and Iron Content of Peak Fractions during Large-scale Hydroxylapatite Column 
Chromatography 
Fraction Activity 
Protein Specific Activity [Protein] [Total Fe] Fe/Protein 
- 1 -1 - .1 (Units mL ) (mg mL ) (Units mg ) (µM) ( 1-1M) 
132 10.8 0.190 57 3.45 0.322 0.09 
' 
136 42 . 8 0.192 222 3 .49 0.645 0.18 
140 92 .6 0 . 203 ' 456 3.69 0.902 0.24 
144 111.5 0 . 181 617 3.29 0.452 0.14 
148 91.2 0.147 621 2.67 - -
152 45 . 2 0.106 425 1.93 0.257 0.13 
90L of chloramphenicol amplified IY85 were grown, and enzyme purified on a large scale. 130mL 
of membrane particles (specific activity 34.8 units mg- 1 ) were solubilized and chromatographed 
on a column of hydroxylapatite (5 x 32cm) as described in the text. 25mL fractions were 
collected: the peak tubes of activity were assayed for NADH:ubiquinone oxidoreductase, protein, 
total iron, and non-haem iron (see Experimental section). 
Protein concentration was determined from the Lowry estimate using MW 47304 and as described in 
Chapter 5. 
I--' 
J::. 
I--' 
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solubilized membrane particles prepared from strains IY12 
and IY13, indicate that the pure enzyme is the respiratory 
NADH dehydrogenase and may represent the r esp iratory NADH: 
ubiquinone oxidoreductase in a highly purified form. 
The enzyme consists of a single subunit type of 
apparent molecular weight 44,600, estimated by SDS poly-
acrylamide gel electrophoresis, and one molecule of non-
covalently bound flavin per subunit. Reconstitution studies 
with 'de-flavo' apoenzyme strongly suggest that the flavin 
prosthetic group is FAD. The preparation contains 2.2glipid 
per g protein but no Fe, acid-labile S, Mo, W or Cu. There 
is no evidence for other prosth@tic groups from the visible 
or ultraviolet spectra of the pure enzyme. 
The preparation is reconstitutively active : a 
cyanide-sensitive NADH oxidase can be reconstituted by 
mixing pure enzyme and ndh mutant membrane particles. This 
process is very efficient, and nearly 50 % of the pure 
enzyme which becomes attached to the membrane particles can 
participate in electron transport via the endogenous 
ubiquinone. 
CHAPTER 5. 
Protein Chemical Studies on the Respiratory 
NADH dehydrogenase 
14 3. 
INTRODUCTION 
In previous chapters the identification and 
purification of the respiratory NADH:ubiquinone oxido-
reductase from E. coli membrane particles has been 
presented . As well as defining the role of this enzyme in 
respiration, our interest is in developing the preparation 
as a model system to study the basic properties .of membrane 
proteins and, ultimately, membrane-bound enzymes. 
One of the basic pieces of information, which was 
accessible following the cloning of the structural gene 
and the subsequent purification of the enzyme, is the 
complete primary structure of the polypeptide chain. This 
i nformation is not only necessary in any future mechanistic 
study on the enzyme , but is also intrinsically important in 
v i ew of the fact that very little sequence data is available 
for enzymes which are intrinsic membrane proteins. 
Of the two approaches possible (vi z. protein and DNA 
sequencing) , , it was felt that DNA seque ncing is the more 
powerful technique , and was chosen to obtain the requisite 
data . The protein chemical studies which are described in 
this chapter , were initiated with the following objectives 
i n mind : 
1 . To confirm the single subunit nature of the enzyme. 
2 . To obtain su f ficient data to check the accuracy 
of the nucleic acid s equence and to confirm the identific-
ation of the structural gene within the cloned DNA fra gment. 
3 . To lay the groundwork for future struc t ural 
studies . 
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The first two objec t i ves are self-explanatory. With 
respect to the third, experiments are being planned to map 
the active site of the enzyme with photoaffinity substrate 
analogues, and the topology of the membrane-bound enzyme 
with surface labelling reagents. Identification of the 
reactive residues can be accomplished following isolation 
of the relevant tryptic peptides containing such a residue, 
and assignment of that peptide in the primary sequence. 
The DNA sequence of the structural gene has resulted 
in an unexpected discovery related to the initiation of 
protein synthesis, in that the structural gene possesses a 
unique and novel initiation codon (B.L. Rogers, H.D. 
Campbell, & I.G. Young, unpubli~hed results. See below). 
The importance of this finding has led to further protein 
chemical studies aimed at positively identifying the amino 
terminal sequence of the plasmid-coded gene product. 
The work presented in this chapter was done in clos~ 
co-operation with Pr D.C. Shaw, who also operated the 
protein sequencer. I also thank Dr I.G. Young for his 
permission in reproducing the nucleic acid and derived 
amino acid sequences. 
EXPERIMENTAL 
Amino Acid Composition of NADH :ubiquinone Oxidoreductase 
NADH:ubiquinone oxidoreductase was purified on a 
large scale from chloramphenicol-amplified IY85 cultures 
as described in Chapter 4. Active fractions were pooled and 
dialyzed at 4° against 3 x 40 volumes of SmM potassium 
phosphate buffer, pH7.5, and 2 x 40 volumes of glass 
distilled water, with 10 to 12h between each buffer change. 
After dialysis, lmL aliquots were accurately transferred to 
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glass hydrolysis tubes a nd a n equal volume of cone. HCl 
was added. The tubes were evacuated, sealed, and heated at 
110° for 22, 48 and 96h, then the hydrolyzate was analyzed 
on a modified Beckman 120C amino acid analyzer, fitted 
with a single 6mm column of W2 resin (Beckman Instruments 
Inc., Palo Alto, Calif.). Peaks were integrated with a 
Beckman 126 Data System. 
lmL aliquots of the dialyzed enzyme preparation were 
taken for simultaneous protein estimation using the 
procedure of Lowry et al . (1951) (see Chapter 2), and the 
remainder freeze dried. 
Delipidation of the freeze-dried material was carried 
0 
out at 4 : 53mg of solid was transferred to a 15mL glass 
centrifuge tube and lmL of chloroform/methanol, 2:1 (v/v) 
(chilled to -15 °) was added, and the mixture vortexed for 
1 min. A second lmL of solvent was added and the mixture 
again vortexed for 1 min. A further 2mL of solvent was 
added and, after a short mix, the protein pelleted by 
cen tri fuga tipn ( 10 min. , 2,000 rpm) . The extraction was 
repeated 5 times. After the last extraction, the protein 
pellet was dried under N2 , washed twice in ice-cold 
distilled water and desiccated under vacuum. 
This material, with and without performic acid 
oxidation (Hirs, 1956), was analyzed following hydrolysis at 
110° in 6N HCl for 22h. 
The tryptophan content was estimated as described by 
Penke et al. (1974) following mercaptoethane sulphonic acid 
hydrolysis of delipidated enzyme. 
Dual Column Amino Acid Analysis 
NADH:ubiquinone oxidoreductase was purified on a small 
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scale from chloramphenicol-amplified IY35 cultures as 
described in Chapter 4. Samples were hydrolyzed as 
described above then analyzed on a dual column Beckman 
120C analyzer. The peaks were quantified manually. 
Peptide Mapping of NADH:ubiquinone Oxidoreductase 
Dialyzed and delipidated NADH:ubiquinone oxido-
reductase (- 6.6mg) was oxidized with performic acid (Hirs, 
1956). The oxidized protein was resuspended in 4mL of 1% 
(w/v) ammonium bicarbonate, pH - 8, then digested with 1% 
(w/w) (relative to the weight of oxidized protein) of TPCK 
treated trypsin (Worthington) 0 for 2h at 37 . A further 
70µg trypsin was added and the-- digestion continued for 
another 2h. The digested protein was then centrifuged to 
remove any precipitated material (pH8 core peptides). The 
soluble peptides were lyophilized, dissolved in lmL H2 0, 
then acidified to pH4 with acetic acid. The insoluble 
material which precipitated on standing (pH4 core peptides) 
was removed by centrifugation. The amino acid composition 
of both the pHB and pH4 core peptides was analyzed after 
hydrolysis with 6N HCl at 110 ° for 22h as described above. 
The soluble peptides- were lyophilized and redissolved 
in lOO µL H2 0, then a ppl ied to a sheet of Whatman 3MM paper 
(46 x 57cm) as a band - 2cm wide). Peptides were resolved in 
the first dimension by electrophoresis at pH4 .7 (1.5h, 
-1 40Vcm ) using the buffer system pyridine/glacial acetic 
acid/H 20, 25 : 25 :950 (v/v) in an apparatus similar to that 
described by -~ichl (1959) using mineral turpentine ("Varsol") 
as heat exchanger. After electrophoresis, the peptides were 
cut out as a strip 3.5 x 57cm and sewn onto a fresh sheet 
of Whatman 3MM paper. Separation in the second dimension 
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was by ascending paper c hromatography in n-butanol/glacial 
acetic acid/H 2 0/pyridine, 15:3:12:10 (v/v) for 16h (Waley & 
Watson , 1953). 
Peptides were visualized by dipping the maps in a 
solution of ninhydrin (0.2 % (w/v) in acetone). 
Alternatively, maps were sprayed with a solution of 
fluorescamine ('Fluram', Hoffman-La -1 Roche); 2mg L in 
acetone and containing 6mL pyridine per litre, and the 
peptides viewed under UV light (Chromato Vue, Ultraviolet 
Products Inc., St. Gabriel, Calif.). The spots were circled 
with pencil and cut out. The peptides were extracted by 
macerating the cut-out spots in 6N HCl, filtered, then 
hydrolyzed and analyzed by amino acid analysis as described 
above . 
When further purification was required, peptides were 
cut out as strips 2 x 12cm, sewn onto fresh sheets of 
Whatman 3MM paper, and electrophoresed in a third dimension 
at pHl . 9 -1 (1 . 5h, 40Vcm ) in the buffer system acetic acid/ 
formic acid/H 2 0, 87:22 . 5;890 . 5 (v/v), and extracted as 
above . 
Two-dimensional peptide maps were stained specific-
ally for tyrosine (Easley, 1965), arginine (Yamada & Itano, 
1966) and histidine (Easley, 1965). 
CNBr Cleavage 
NADH : ubiquinone oxidoreductase was dialyzed and 
delipidated as described above; 5mg was then reduced and 
carboxymethylated by the procedure of Crestfield et .., a i . 
(1963) . CNBr cleavage was carried out as described by 
Gross (1967) and the more soluble of the resulting 
peptides separated by two-dimensional paper chromatography 
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(see above). Peptides were visualized with Fluram, cut 
out, and analyzed by amino ac id analysis as described above. 
Detection of Formyl-homoserine 
Reduced and carboxymethylated NADH:ubiquinone oxido-
reductase ( - 2mg) was cleaved with CNBr. The CNBr peptides 
were dissolved in O.SmL of 50 % (v/v) acetic acid and 80 % 
of this material was chromatographed on a Sephadex G25 
column (1.5 x 18cm), pre-equilibrated in 50 % (v/v) acetic 
acid. The peptides were eluted with the same buffer. 
O.SmL fractions were collected, and those fractions, 
corresponding to the elution position of free amino acids, 
were collected (vol. 7.SmL). The pooled fractions were 
rotary evaporated, resuspended- in O.SmL of 50% (v/v) acetic 
acid, and loaded onto a column of Dowex 50 x 2, H+ form, 
(0.8 x 8cm), and eluted with - lSmL H2o. The water eluate 
was hydrolyzed with 3N HCl at 110 ° for 22h, and then 
analyzed on a single column Beckman 120C amino acid analy~er. 
The homoserine content was estimated from the sum 
total of the homoserine and homoserine lactone peaks: the 
' 
former eluting before glutamic acid, and the latter between 
histidine and _lysine on the above analysis. The 
concentrations of homoserine and homoserine lactone were 
estimated using the colour factor for aspartate and are 
therefore only approximations. 
Determination of Amino Terminal Sequence 
Reduced and carboxymethylated NADH:ubiquinone oxido-
reductase (see above) was sequenced directly in a Beckman 
890C spinning-cup liquid-phase sequencer, using Beckman 
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quadrol program 122974 for p roteins. Identifica t ion of the 
residues at each cycle was made after hydrol y sis of the 
-1 
corresponding PTH derivatives with 6N HCl + SnC1 2 (1mg mL ) 
0 for 4h at 150 (Mendez & Lai, 1975). This procedure does 
not allow the positive identification of tryptophan or 
serine, whose PTH derivatives are hydrolyzed to glycine 
plus alanine and alanine respectively. Similarly, 
distinction between aspartic acid and glutamic acid from 
their respective amides is not possible. 
RESULTS AND DISCUSSION 
Amino Acid Composition of NADH:ubiquinone Oxidoreductase 
The amino acid composition of NADH:ubiquinone oxido-
reductase was determined for enzyme prepared on a large 
scale from chloramphenicol-amplified IY85 cultures. The 
pure enzyme was exhaustively dialyzed, and duplicate lmL 
aliquots were hydrolyzed in 6N HCl for 22, 48 and 96h. A 
portion of the dialyzed enzyme preparation was also freeze 
dried and extracted with chloroform/methanol, 2:1 (v/v) to 
remove lipid, and this material was analyzed after hydrolysis 
in 6N HCl for 22h with and without prior performic acid 
oxidation. The results of these analyses, shown in Table 
5-1, are presented as the value for each a mino acid 
normalized to the alanine content, and assuming 39 alanine 
residues per polypeptide chain (deduced from the amino acid 
sequence, see Table 5-1). 
In general, the analyses are comparable, suggesting 
that the high phospholipid content does not inter f ere with 
the amino acid analy sis. Ox idation, dur ing hyd r o lysis of 
the non-performic acid-o x idized material, c a n be inferred 
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TABLE 5-1 . Amino Acid Comp o sition of NADH:ubiquinone 
Oxidoreductase : Large-scale Preparation 
Amino acid 1 2 3 4 
Lys 84.3 25.4 24 . 4 25 
His 12.2 12.0 11.7 17 
Arg 21.1 21.3 21.3 22 
Asx 40.0 39.9 39.4 41 
Thr 22.3a 20 .9 21.0 26 
Ser 21.4a 20 .6 20.9 20 
' 
Glx 41.1 41.1 42.0 37 
Pro 16.6 17.4 18.0 17 
Gly 39.4 37 .7 38.5 42 
Ala 39 39 39 39 
Cys - - 3.9d 4 
Val 28.6b 26.3 25.4 27 
--
Met - - 12.3 15 
Ile 22.9b 21.4 20.9 26 
Leu 46.4 46.4 46.2 51 
Tyr 8. 8 6. 4 3. 9 12 
Phe 11.5 11.0 11.1 11 
Trp 2.5c - - 2 
NADH:ubiquinone oxidoreductase was purified on a large-scale 
and delipidated as described in the Experimental section. 
column 1: Data averaged for duplicate 22, 48 and 96h 
hydrolyses on non-delipidated enzyme. 
column 2: Delipidated enzyme , 22h hydrolysis. 
column 3: Delipidated enzyme oxidized with performic acid, 
22h hydrolysis. 
column 4: Amino acid composition predicted from DNA 
sequence (see Chapter 5). 
a Estimated by extrapolation to zero time. 
b Estimated from the 96h hydrolysis values. 
C Estimated separately by mercaptoethane sulphonic acid 
hydrolysis. 
d Corrected assuming 94 % recovery (Moore, 1963). 
Ami~o acid values were normalized to the alanine content 
and are expressed as residues per polypeptide assuming 
ala= 39 (see column 4). For further details see text. 
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from the presence of meth ion ine sulphoxides as well as 
some cysteic acid in the relevant chromatograms. This 
suggests that the value for tyrosine may be low and that the 
value for methionine should be obtained as methionine 
sulphone from the performic acid oxidized sample. 
One major discrepancy between the analyses is in the 
lysine content of the preparation. The very high value 
obtained with the non-delipidated preparation suggests that 
some lipid component is interfering with the quantification 
of this particular amino acid. Amino acid analyses of 
enzyme prepared on a small scale from chloramphenicol-
amplified IY35 cultures, and p~rformed on a dual-column 
amino acid analyzer, suggest that an hydrolysis product 
of phosphatidylethanolamine co-chromatographs with lysine 
on the single column analyzer (Figure 5-1): during analysis 
of such preparations several unknown peaks were resolved on 
the short column of the Beckman 120C analyzer, which 
correspond in their elution positions to peaks obtained 
when pure phDsphatidylethanolamine was hydrolyzed and 
analyzed under identical conditions (Figure 5-1). 
In general, the results of the analyses of the small-
scale preparations agree with those obtained on material 
prepared on a large scale (c.f. Tables 5-1 and 5-2) with 
the exception of serine, which is unaccountably higher in 
the former. In neither case, however, is there any marked 
difference in the serine content of preparations subject to 
delipidation, which suggests that, as expected (see Ames, 
1968), phosphatidylserine is not present in the 
preparation in large amounts . 
The tryptophan content of the protein was estimated 
FIGURE 5-1. 
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Samples of NADH : ubiquinone oxidoreductase ( 200 ug) and 
E. oZi phosphatidylethanolamine (lOO ug) were hydrolyzed 
in 6N HCl for 22h at 110 ° . Aliquots of the hydrolyzates 
(~ and 1/ 5 respectivel y) were analyzed on a dual colu~n 
Beckman 120C analyzer. Only the short-column profiles 
are shown ; no extra peaks are visible on the long-column 
profiles . Positions of the unknown peaks in the enzyme 
analysis are shown with arrows . 
Top , ADH : ubiquinone oxidoreductase; bottom, phosphatidyl -
ethanolamine . 
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TABLE 5-2 . Amino Acid Compo sition of NADH:ubiquinone 
Oxidoreductase : Two-column Analysis 
Amino Acid Residues 
Lys 25.4 
His 11.3 
Arg 21. 6 ' 
Asx 39.7 
Thr 22.4 
Ser 26.0 
Glx 43.9 
Pro 19.8 
Gly 47.4 
Ala 39 
Cys a 4. 8 
Val 24.5 
Met 10.l 
Ile 21.6 
Leu 43.7 
Tyr 12.l 
Phe 13.l 
NADH : ubiquinone oxidoreductase, purified on a small-scale, 
was hydrolyzed for 22h at 110 ° in 6N HCl as described. 
' 
Amino acid values were normalized to the alanine content 
and are expressed as residues per polypeptide assuming 
ala= 39 (see Table 5-1, column 4). 
a Estimated separately as cysteic acid and corrected 
assuming 94 % recovery (Moore, 1963). 
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separately following mercaptoethane sulphonic acid 
hydrolysis of pure enzyme prepared from chloramphenicol-
amplified IY35 cultures. The tryptophan content, 
calculated from the amino acid values normalized to alanine 
(and assuming 39 alanine residues per polypeptide chain) 
was estimated to be 2.49 residues per polypeptide chain 
(data not shown). 
From the data used in obtaining column 1 of Table 5-1, 
the weight of protein in the sample analyzed was calculated 
from the recovery of individual amino acids. Corrections 
were applied for the loss or incomplete recovery of serine, 
threonine, valine and isoleuc~De, and an estimate included 
for the weight contribution of tryptophan (from the 
normalized value to the alanine content as determined above) 
and methionine (estimated as methionine sulphone). A 
-1 
concentration of 35.14µg rnL protein was determined in 
this manner. From estimates of the protein concentration 
by the procedure of Lowry et al . (1951) on the same 
-1 
material, a ~alue of 40.94 µg mL was obtained. This gives 
the following relationship: 
[Protein] = ' Lowry estimate' x 0.86. 
The analytical data agrees with the amino acid 
composition obtained from the sequence of the polypeptide 
chain (Table 5-1), for all the stable amino acids with the 
exception of histidine and, to a lesser extent, leucine. 
The reason for the discrepancy with histidine is not under-
stood, although hydrolytic losses of about 20 % have been 
observed in control experiments under identical conditions 
(D . C. Shaw, personal communication). 
Using the amino acid sequence data, the partial 
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specific volume was calculated by the method of Cohn & 
-3 Edsall (1943) to be 0.747g cm . Using the same data, 
several parameters were calculated which reflect the hydro-
phobicity of the polypeptide chain. The polarity index 
(Capaldi & Vanderkooi , 1972) was calculated to be 43.3 %, 
whilst the average hydrophobicity, H~ , is 1,061 calories 
'+' a V 
residue-l (Bigelow, 1967). These figures show that the 
polypeptide chain is not significantly hydrophobic overall, 
relative to the polypeptide chains of soluble proteins (see 
above references), and that therefore the membrane-bound 
nature of this enzyme is a function of the specific folding 
of the polypeptide chain which must generate hydrophobic 
regions capable of interacting with phospholipid. 
Peptide Mapping of the NADH :ubiquinone Oxidoreductase 
NADH:ubiquinone oxidoreductase was delipidated 
following exhaustive dialysis, then oxidized with performic 
acid and digested with TPCK treated trypsin. A portion of 
the soluble peptides (2mg) was then resolved by two-
dimensional paper . chromatography on Whatman 3MM paper, and 
visualized by dipping the resulting tryptic map in ninhydrin. 
The insoluble 'pH8 core' peptides, present after the tryptic 
digestion, as well as the 'pH4 core' peptides, which 
precipitated on lowering the pH prior to electrophoresis, 
were collected by centrifugation and analyzed separately, 
after hydrolysis in 6N HCl , by amino acid analysis (Table 
5-3) . 
A total of 39 spots were visible on the tryptic map 
(Figure 5-2) , but there is also the possibility of there 
being several polypeptides present in the core material . · 
From the arginine plus lysine content of the enzyme (22 and 
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TABLE 5-3. Amino Acid Analysis of Tryptic Core Peptides 
oH4 core pH8 core J.. 
nmoles ng nmoles ng 
Lys 10.463 1341 31.377 4023 
His 8.622 1183 15.287 2097 
Arg 9.430 1473 24.386 3809 
Asx a 30.320 3490 45.620 5251 
Thr 8.339 843 27.738 2804 
Ser 15.215 1325 37.799 3292 
Glx 21.939 2832 44.517 5747 
Pro 5.866 570 17.884 1737 
Gly 25.528 1458 65.640 3748 
Ala 20.003 1422 60.935 4332 
Cya 2.380 246 - 4.600 475 
Val 17.610 1745 48.097 4766 
Meta 
- - 28.763 3774 
Ile 16.222 1836 42.741 4838 
Leu 28.698 3249 78.922 8934 
Tyr 6.976 1138 21.158 3453 
Phe 12.855 1892 31.218 4595 
-
26043 67675 
' 6.6mg (or ~150nmoles) of NADH:ubiquinone oxidoreductase was 
digested with trypsin as described in the text. The pH4 
and pH8 core peptides were collected by centrifugation, 
hydrolyzed in 6N HCl at 110 ° for 22h, then 1/10 of this 
material analyzed. From the above analysis, the yield 
pH4 core - 0.26mg; pH8 core - 0.68mg. From the arginine 
and lysine content there is a possibility of 2 and 5 tryptic 
peptides (at the lOOnmole level) in the pH4 and pH8 core 
respectively. 
aAsx + Met : aspartic acid and methionine sulphone were 
insufficiently resolved to permit separate quantification. 
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FIGURE 5-2. Two Dimensional Paper Chromatography of 
NADH:ubiquinone Oxidoreductase Soluble 
Tryptic Peptides 
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2mg of soluble tryptic peptides were resolved by 
two dimensional paper chromatography as described in 
the text. The above peptide map was stained with 
ninhydrin. 
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25 residues per polypeptide respectively) a total of 48 
tryptic peptides would be predicted. Consideration of the · 
amino acid sequence however (Figure 5-3) indicates that, due 
to the presence of various arg-arg, lys-pro et c. sequences, 
only 39 tryptic peptides plus free arginine and lysine 
would be produced . This is in agreement with the number 
of tryptic peptides visible, which in turn suggests that 
the enzyme is not composed of two dissimilar polypeptides of 
identical molecular weight, since if this were the case, 
double the number of tryptic peptides would be expected. 
(Note : this does not preclude there being two non-identical 
though related polypeptides 0£ approximately the same 
molecular weight). 
Nine tyrosine containing peptides were detected when 
the aforementioned peptide map was specifically stained, 
following ninhydrin staining, with a -nitroso- B-naphthol 
(Easley , 1965). This is exactly the number one would 
predict from the expected tryptic peptides produced as a 
' 
consequence of the amino acid sequence. 
A separate tryptic map was produced with 0.5mg of 
the soluble tryptic peptides and stained consecutively with 
Fluram, and then specifically for histidine (Easley, 1965) 
and arginine (Yamada & Itano, 1966) containing peptides. 
A total of 8 histidine and 13 arginine-containing peptides 
were visualized, which compares with 13 and 19 respectively, 
expected from a consideration of the amino acid sequence. 
It is possible that a ma x imum of 2 histidine and 3 arginine-
containing peptides are present in the core peptides 
(Table 5-3). 
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FIGURE 5-3. Amino Acid Sequence of NADH:ubiquinone 
Oxidoreductase Showing Location of 
Isolated Tryptic and CNBr Peptides 
Met-Thr-Thr-Pro-Leu-Lys-Lys-Ile-Val-Ile-Val-Gly-Gly-Gly-Ala-
1 T-1-----
..,__ ___________________ C- I 
Gly-Gly-Leu-Glu-Met-Ala-Thr-Gln-Leu-Gly-His-Lys-Leu-Gly-Arg-
Lys-Lys-Lys-Ala-Lys-Ile-Thr-Leu-Val-Asp-Arg-Asn-His-Ser-His-
T-2 
Leu-Trp-Lys-Pro-Leu-Leu-His-Glu-Val-Ala-Thr-Gly-Ser-Leu-Asp-
Glu-Gly-Val-Asp-Ala-Leu-Ser-Tyr-Leu-Ala-His-Ala-Arg-Asn-His-
Gly-Phe-Gln-Phe-Gln-Leu-Gly-Ser-Val-Ile-Asp-Ile-Asp-Arg-Glu-
Ala-Lys-Thr-Ile-Thr-Ile-Ala-Glu-Leu-Arg-Asp-Glu-Lys-Gly-Glu-
-T-3 -i~--- T-4 
Leu-Leu-Val-Pro-Glu-Arg-Lys-I1e-Ala-Tyr-Asp-Thr-Leu-Val-Met-
T-5a & T-5b 11 
Ala-Leu-Gly-Ser-Thr-Ser-Asn-Asp-Phe-Asn-Thr-Pro-Gly-Val-Lys-
T-6 
.___~~~~~~~~~~-c-2 
Glu-Asn-Cys-Ile-Phe-Leu-Asp-Asn-Pro-His-Gln-Ala-Arg-Arg-Phe-
T-7 
His-Gln-Glu-Met-Leu-Asn-Leu-Phe-Leu-Lys-Tyr-Ser-Ala-Asn-Leu-
Gly-Ala-Asn-Gly-Lys-Val-Asn-Ile-Ala-Ile-Val-Gly-Gly-Gly-Ala-
- T-8 
Thr-Gly-Val-Glu-Leu-Ser-Ala-Glu-Leu-His-Asn-Ala-Val-Lys-Gln-
Leu-His-Ser-Tyr-Gly-Tyr-Lys-Gly-Leu-Thr-Asn-Glu-Ala-Leu-Asn-
160. 
FIGURE 5-3 Continued. 
Val-Thr-Leu-Val-Glu-Ala-Gly-Glu-Arg-I1e-Leu-Pro-Ala-Leu-Pro-
-----T-9a & T-9b-
Pro-Arg-Ile-Ser-Ala-Ala-Ala-His-Asn-Glu-Leu-Thr-Lys-Leu-Gly-
--/ T-10 ~T-11 -
Val-Arg-Val-Leu-Thr-Gln-Thr-Met-Val-Thr-Ser-Ala-Asp-Glu-Gly-
~-----111 T-12~~~~~~ 
Gly-Leu-His-Thr-Lys-Asp-Gly-Glu-Tyr-Ile-Glu-Ala-Asp-Leu-Met-
Val-Trp-Ala-Ala-Gly-Ile-Lys-Ala-Pro-Asp-Phe-Leu-Lys-Asp-Ile-
1-----------~T-13------~----4 
Gly-Gly-Leu-Glu-Thr-Asn-Arg-Ile-Asn-Gln-Leu-Val-Val-Glu-Pro-
t-------T-14 
Thr-Leu-Gln-Thr-Thr-Arg-Asp-Pro-Asp-Ile-Tyr-Ala-Ile-Gly-Asp-
Cys-Ala-Ser-Cys-Pro-Arg-Pro-Glu-Gly-Gly-Phe-Val -Pro-Pro-Arg-
-------- ,--15 
Ala-Gln-Ala-Ala-His-Gln-Met-Ala-Thr-Cys-Ala-Met-Asn-Asn-Ile-
Leu-Ala-Gln-Met-Asn-Gly-Lys-Pro-Leu-Lys-Asn-Tyr-Gln-Tyr-Lys-
- C-3 '"------i 
Asp-His-Gly-Ser-Leu-Val-Ser-Leu-Ser-Asn-Phe-Ser -Thr-Val-Gly-
Ser-Leu-Met-Gly-Asn-Leu-Thr-Arg-Gly-Ser-Met-Met-Ile -Glu-Gly-
Arg-Ile-Ala-Arg-Phe-Val-Tyr-Ile-Ser-Leu-Tyr-Arg-Met - His -Gln-
Ile-Ala-Leu-His-Gly-Tyr-Phe-Lys-Thr-Gly-Leu-Met-Met-Leu-Val-
1 T-16 ---
1 
Gly-Ser-Ile-Asn-Arg-Val-Ile-Arg-Pro-Arg-Leu-Lys -Leu-His 
-------11 T-17 /~T-18 -i 
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Amino Acid Analysis of CNBr a nd Tryptic Peptides 
It was decided to use the techniques of two and three 
dimensional paper chromatography to isolate individual 
tryptic peptides and determine their composition. This 
would serve as an independent check on the nucleic acid 
sequence of the structural gene since all such peptides 
should be locatable within the derived amino acid sequence. 
In practice, this approach is limited by the resolution of 
the trypic peptides achieved. In an attempt to further 
purify the poorly resolved peptides, they were cut out as 
strips from the two-dimensional peptide map and electro-
phoresed in a third dimension at pH 1.9. 
A total of 9 well-separated tryptic peptides were 
obtained from the two-dimensional peptide map. Six of these· 
were recognised in the amino acid sequence following their 
elution from the chromatogram and determination of their 
amino acid composition (Figure 5-3). Of the remainder, two 
were probably mixtures of unresolved peptides, and the third 
could only be tentatively identified. A total of 15 tryptic 
peptides were sufficiently resolved following further 
purification in the third dimension, and located in the amino 
acid sequence (Figure 5-3). The amino acid compositions of 
the purified tryptic peptides are given in Table 5-4. 
A dialyzed and delipidated sample of NADH:ubiquinone 
. 
oxidoreductase was reduced and carboxymethylated, then 
cleaved with CNBr. Four CNBr peptides were sufficiently 
resolved by two and three-dimensional paper chromatography, 
and their compositions are given in Table 5-5. One of these 
peptides, C-4, can be identified as the carboxy (C)-terminal 
peptide since it contains no homoserine; this assignment was 
Amino acid 
T-1 
Cys a 
As x (0.56) 
Thr 1.06 (1) 
Ser 1.03 (1) 
Gl x 2.40 ( 2) 
Pro 
Gly 5.49(6) 
Ala 1.95(2) 
Val 1.35(1) 
Meth 1.12(1) 
I le 1.1 0 (2) 
Le u 2.19(1) 
Ty r 
P h e 
Hi s 1.22(1) 
Ly s 1.00(1) 
Ar g , 
nmol e s 3.230 
TABLE 5-4. Amino Acid Composition of Tryptic Peptides 
Peptide 
T-2 T-3 T-4 T-5 (a) T-5 (b) 
1.01(1) 
' 
0.97(1) 0.78(1) 1.77(2) 
1.37(1) 1.57 (2) 2.84(2) 
0.72(1) 0.80(1) 
0.69(1) 1.15 (1) 
0.95(1) 1.12 (1) I 
1.01(1) 0.82 (1) 0.84(1) 
0.81(1) 1.84(2) 
1.15 (1) 1.25(1) 1.72(2) 1.82(2) 
1.00(1) 1.00(1) 1.00(1) 
1.00(1) 1.00(1) 0.73(1) 0.88 (1) 
' ·-
7.588 10.230 2.035 2.172 2.219 
T-6 
4.94 c 
1.64(3) 
1.84(2) 
1.19 (1) 
1.23(1) 
2.70(2) 
2.52 (2) 
2.14 (2) 
C 
-
0.87 (1) 
2.76(2) 
0.97(1) 
1.00(1) 
(0. 29) 
3. 42 7 
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TABLE 5-4 Continued. 
Amino acid 
T-7 T-8 T-9(a) 
Cys a 1.00(1) ' 
Asx 3.12(3) 2.23(2) 
Thr 
' 
Ser 1.22 (1) 
Glx 2.12 (2) (0.57) (0.33) 
Pro 0.99(1) 2.38 (3) 
Gly (0.35) 2.36(2) (0.33) 
Ala 1.27(2) 2.24(2) 1.02(1) 
Val 
Meth 
Ile 0.90(1) 0.90(1) 
Leu 1.12(1) 1.18 (1) 2.84(2) 
Ty r 0.53(1) 
Phe 0.89(1) 
His 0.91(1) 
Lys 1.00(1) 
Arg 1.00(1) 1.00(1) 
nmoles 6.561 2.831 6.018 
' .. 
Peptide 
T-9 ( b) T-10 
1.07(1) 
0.90(1) 
1.21(1) 
1.66(1) 
I 2.70(3) (0.35) (0.67) 
1.12 (1) 2.47 (3) 
I 
0.88 (1) (0.50) 
2.24 (2) 1.26 (1) 
0.88(1) 
1.00(1) 
1.00(1) 
5.537 1.421 
T-11 
1.13 (1) 
0.87 (1) 
1.04(1) 
(0.28) 
1.00(1) 
8.878 
T-12 
1 . 06(1) 
2.55(4) 
0.97(1) 
2.04(2) 
1.95(2) 
1.20(1) 
1.41(2) 
0.81(1) 
1.73(2) 
0.50(1) 
1.00(1) 
6.999 
Continued. 
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TABLE 5 - 4 Continued . 
Amino acid 
T- 13 T- 14 
Cys a 
As x 0 . 94(1) 1 . 36(1) 
Thr 3.07(3) 
Ser 
Gl x 3 . 22(3) 
Pro 1.01(1) 1 . 05(1) 
Gl y (0 . 40) 
Ala 0 . 87(1) (0 . 25) 
Val 1 . 34(2) 
Meth 
Ile 0.84(1) 
Leu 1.16(1) 2.26(1) 
Ty r 
P h e 0.93(1) 
His 
Ly s 1.00(1) 
Ar g 1.00(1) 
nmo les 8.617 7.736 
Peptide 
T- 15 T - 16 
2 . 15(2) . 
3 . 24(3) 1.15 (1) 
0 . 92(1) 
1.18 (1) 1.30(1) 
1 . 51(1) (0.69) 
4 . 81(5) 
3 . 23 (3) 2 . 92(2) 
2 . 18(2) (0.58) 
1 . 01(1) 1 . 23(1) I 
2.28(2) 
1.83(2) 1.07(1) 
2.39(2) 
0.51(1) 
0.94(1) 
2.00(2) 1.00(1) 
11.062 2.977 
' • · 
T - 17 T- 18 
I 
0 . 95(1) 
0 . 44(1) 
0.49(1) 
0.73(1) 
1.00(1) 
2.00(2) 
10.524 10.343 
T-19 
I 
1.00 
30.60 4 
Continued . 
f--' 
m 
~ 
TABLE 5- 4 Continued . 
Tryptic peptides were purified by two and three dimensional paper chromatography (see text for 
details) . Values for each amino acid are normalized to either the lysine or arginine content : 
residues present at a level less th~n 0.25moles/mole peptide are not listed . Levels of the 
peptides (based on either the lysine or arginine content) are given in the last row . 
contaminants are given in parentheses . 
a Estimated as cysteic acid . 
b . d h' . Estimate as met ionine 
Major 
C Asx + Met: aspartic acid and methionine sulphone insufficiently resolved for separate 
quantification. 
1--' 
O'\ 
u, 
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TABLE 5-5. Amino Acid Compo sition of Purified 
CNBr Peptides 
Amino Peptide 
Acid 
I 
C-1 C-2 C-3 C-4 
Lys 16.3(2) 25.0(1) 8.3(1) 
His 12.5(1) 8.7(1) 
Arg 36.2 (2) 25.9(3) 
Asx 50.1(4) 12.5(1) 10.5 (1) 
Thr 18.7(2) 54.6(2) 
Ser 33.4(2) 10.0(1) 
Glx 12.4(1) 84.9(4) 11.8(1) 
Pro 8.5(1) 64.6(3) 8.1(1) 
-
Gly 49.5(5) 70.6 (3) 7.9(1) 12.2 (1) 
Ala 10.8 (1) 84.7(4) 9.8(1) 
Cys a 8.0(1) 
Val 16.9(2) 34.1(2) 14.9(2) 
Met 
Ile 15.0(2) 42.3(2) 9.1(1) 14.2(2) 
Leu 21.3(2) 48.3(2) 11.0(1) 26.2(3) 
Tyr 13.5 (1) 
Phe 19.6(1) 
' 
Trp 
Hse b 5.6(1) 11.0(1) 6.9(1) 
CNBr peptides were analyzed following hydrolysis in 6N 
0 HCl at 110 for 22h. The amount (nmoles) of each amino 
acid is listed, with the probable number per peptide in 
parentheses. Residues present at less than the 3nmole 
level are not listed. For further details see text. 
aEstimated as carboxymethyl cysteic acid. 
b · 1 h . 1 Homo serine p us. omoserine actone. 
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subsequently borne out by the sequence data (Figure 5-3). 
All four CNBr peptides were located in the amino acid 
sequence (Figure 5-3), and one of these, C-1, was positioned 
at the amino (N) terminus. 
The fact that both the N and C-terminal peptides have 
been isolated is good evidence that significant proteolysis 
has not occurred during enzyme purification, which supports 
the evidence obtained by SDS polyacrylamide gel electro-
phoresis (see Chapter 4). 
The tryptic and CNBr peptides together constitute 
49.8% of the polypeptide chain, sufficient to verify that 
there are no major flaws in the _.nucleic acid sequence. It 
is interesting that most of the peptides isolated and 
purified seem to fall within four or five major regions in 
the primary sequence. 
N-terminal Amino Acid Sequence of NADH:ubiquinone 
Oxidoreductase 
The primary structure of the N-terminus was obtained 
by direct sequence determination on reduced and carboxy~ 
methylated NADH:ubiquinone oxidoreductase in a Beckman 890C 
sequencer. The residues released after each cycle were 
determined by amino acid analysis after hydrolysis of the 
corresponding PTH derivatives. 
The results of the first 21 cycles of one such 
experiment are shown in Figure 5-4 . Interpretation of the 
data was rendered difficult by the fact that the background 
concentration of amino acids was high and by the fact that 
the yield of the true sequence was low. One reason for this 
appears to be the incomplete solubility of the carboxymethyl -
ated enzyme in quadrol buffer, but the possibility was also 
(1) 
0 
E 
C: 
0 
u 
~ 
0 
z 
:E 
~ 
1 6 8 . 
FIGURE 5-4. Amino Acid Sequencer Data for the First 20 
Residues of NADH:ubiquinone Oxidoreductase 
,-------------r:~=----------,....----,,------------,...5 
~==---;;;;i;;:;;.------~5 
-1-.1...,1....1........-r....1...1 ...... i....i...~ ....................... ~1--1-.i....i.. ...... ..i...i. ................ .....,._.1...1........_..i...i.......,....p ...................... ..i...i.. ..................... 1...1... ...... ~....,...o 
5 
4-J..L.L..LLLLJLI..l..L.Ll..LLU..J..J.4.L!..JLI..l..L.Ll..LLLI..J..J...LL.LI...J~~.c:l:l;:;;l::I:I::J;;;;;C:c:I::t:::J::J::I:I::I::J::l-0 
5 
-,_ ....... .i....i....i...i.......i. ............... i....i....._..i...1,,_......,ti,..i...i....i... ........ .._. ..................... 1.,,6.., ........................ -t-l ......................................................................... .....+-o 
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SEQUENCER CYCLE 
Amino acid analysis of the first 21 cycles of a single 
sequencer experiment on NADH:ubiquinone oxidoreductase. 
Deduced sequence: ·thr.pro.leu.lys.lys.ile.val.ile.val. 
ala trp. gly. gly. . gly. gly. leu. glx. met ... 
ser 
Threonine was determined as y -amino isobutyric acid and the 
isoleucine values were obtained from the sum of the iso-
leucine and allo -isoleucine peaks. See tex t for details. 
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considered that a considera b le proportion of the enzyme in 
the preparation has a blocked N-terminus (see below). The 
high background may result from a partial degradation of 
the polypeptide during delipidation. 
All in all, the sequence of the first 19 amino acids 
was determined in 2 separate experiments and that of the first 
8 amino acids in 3 separate experiments. From these 
preliminary experiments the following sequence was deduced: 
met thr, leu, lys, lys, ile, val, ile, val, trp, thr ' pro, 
gly, gly, ala gly, gly, leu, glx, met. 
ser ' 
The residue at position 11 was designated as trypto-
phan on the basis that both glycine and alanine were found 
to increase in this cycle, and the PTH derivative of 
tryptophan breaks down to these two amino acids on hydrol-
ysis . It is not possible to distinguish between alanine or 
serine at position 14 with the technique used since the PTH 
derivatives of both alanine and serine yield alanine on 
hydrolysis. 'The amino acid at position 1 could not be 
unequivocally assigned since glycine, alanine, threonine 
(as y-amino isobutyric acid) and methionine were all 
detected in this cycle. Free glycine and alanine (from 
serine) are likely contaminants in the preparation, so their 
presence is not unexpected. Threonine is less likely to be 
a contaminanl, although like serine it can arise by partial 
acid cleavage involving N ~---o acyl migration. A tentative 
assignment of methionine at position 1 was made. 
The prediction of the N-terminal sequence in these 
early experiments was found to be remarkably accurate, 
considering the quality of the data, when the corresponding 
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nucleic acid sequence data wa s finally obtained (c .f. above 
and Figure 5-3). The nucleic acid sequence corrected the 
interpretation of the residue at position 11, and decided 
between the alternatives at position 14. By far the most 
important finding predicted by the nucleic acid sequence, is 
that the first residue in the protein is threonine, and not 
* 
methionine as assigned above. Presumably, therefore, the 
N-terminal formyl-methionine is wholly or partially 
processed (i. e. cleaved) in the preparation t . A related 
explanation considered was that the enzyme has a short 
signal peptide (for a review see Davis & Tai, 1980) which 
is not cleaved in a proportion of enzyme molecules. Such 
signal peptides, or leader sequences, are usually 16 to 20 
amino acids long and serve as a mechanism for the trans-
membrane insertion of both excreted proteins and membrane-
bound proteins (ibid.). If such a signal peptide were still 
present on a proportion of enzyme molecules, then this could 
help explain how the pure preparation can reconstitute NADH 
oxidase in mutant membrane particles (see Chapter 4). This 
explanation was not considered the most likely since the 
processed and unprocessed enzyme, unlike the case where 
processing involves the cleavage of only an N-terminal 
formyl-methionine, should be resolved on SDS polyacrylamide 
* 
t 
rhis, as well as the other corrections, has been confirmed 
following the sequencing of the first 36 residues of NADH: 
ubiquinone oxidoreductase (D.C. Shaw & H.D . Campbell, 
unpublished results). The quality of the data was 
considerably improved when the enzyme was delipidated by 
chromatography on a Sephacryl S300 column in the presence 
of 1% (w/v) SDS. 
Any enzyme molecules which have formyl-methionine as their 
N-terminus would not react with phenylisothiocyanate, and 
the presence of such unprocessed enzyme would manifest 
itself in a low sequence yield , as was observed. 
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gel electrophoresis. 
The codon immediately preceding the first threonine 
codon in the nucleic acid sequence, is not the initiation 
codon, AUG, but is instead a leucine codon, UUG (Figure 5-5) 
The designation of this UUG as the initiation codon in the 
ndh gene is strengthened by the presence of a very strong 
ribosome binding site ( "Shine-Dalgarno sequence") starting 
13 bases towards the 5' end of the UUG and which has 9 
bases complementary to the 3' end of the l 6S rRNA of E. coli. 
There is no other candidate for an initiation codon 
* in the sequence . 
The question which must be asked is whether the UUG 
specifies a formyl-methionine as the first amino acid, and 
whether translation is initiated by the normal tRNAf-met. 
The existence of both methionine and threonine in the first 
sequencer cycle can be interpreted as there being enzyme 
molecules in the preparation in which either the formyl 
group or the formyl-methionyl residue has been cleaved, 
yielding sequences beginning with methionine and threonine 
respectively. A small yield of the sequence beginning with 
methionine would not be detected, except at cycle 1, against 
a larger yield of the sequence beginning with the first 
threonine, since the former is only one amino acid out -of 
phase with the latter and would be obscured by the 'ghosting' 
normally observed after each cycle. It is likely that if 
partial processing of the enzyme is the case, this is a 
* There is an AUG 51 bases 'upstream' from the UUG codon,· . 
which would fit the model that NADH:ubiquinone oxido-
reductase has a signal polypeptide, but it is separated 
from the coding sequence by termination codons in all 
three reading frames. 
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FIGURE 5-5. Nucleic Aci d Sequence at the 5' of the 
Ndh Gene 
. . . . T A A G G G T C A C G T T G A C T A C G C C A 
(met) thr thr pro 
T T G 
leu 
A A A A A G A T T G T G A T T G T C G G C G G C G G T 
lys lys ile val ile val gly gly gly 
G C T G G T G G G C T G G A A A T G G C A A C A . . . . . . 
ala gly gly leu glu met ala thr 
The sequence homologous to the 16S rRNA of E . coli , 
the possible ribosome binding site, is underlined. 
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result of the very high a mpl ification of the enzyme levels 
achieved in vivo exceeding the capacity of the processing 
machinery in the cell. Such a phenomenon has recently been 
reported for the tryptophan synthetase a -subunit purified 
from genetically amplified strains of E. coli (Sugino et al .~ 
1980). 
Demonstration of the Amino-Terminal Formyl-Methionine 
Experiments were undertaken, aimed at identifying the 
formyl-methionine at the N-terminus of the unprocessed 
enzyme. Approximately 2mg of carboxymethylated NADH: 
ubiquinone oxidoreductase was cleaved with CNBr, and the 
reaction products chromatograph~d on a column of Sephadex G25 
(Figure 5-6). The low molecular weight material was pooled 
and chromatographed on a column of Dowex-50x2 + ( H form) , 
eluted with H2o , then analyzed. The rationale behind this 
procedure is that CNBr should cleave the enzyme, producing 
formyl-homoserine, derived from the N-terminal formyl-
methionyl residue, and various CNBr peptides. After 
collection of the low molecular weight fraction, the formyl-
homoserine is further purified by making use of its lack of 
a free amino group, This step is necessary because, as was 
shown later, the protein may contain met.met sequences 
which produce free homoserine on cleavage with CNBr: such 
material is retained on the Dowex column. The presence of 
formyl-homoserine in the H2o eluate was established by amino 
acid analysis following acid hydrolysis to remove the formyl 
group. The results of the analysis are shown in Table 5-6. 
A total of - ll.5nmoles of homoserine plus homoserine lactone 
was recovered from - 45nmoles of carboxymethylated enzyme 
(these results should only be seen as an approximation, see 
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r I GC RE 5 - 6 . Sephadex G2 5 Lh r oma t og raph y of ~ADH : 
~biq u ino n e Oxido r ed uc t a s C Br Pep ti de s 
OVALBUMIN PHENYLALANINE 
t 
SCALE ... , 
20 40 60 80 
FRACTION NUMBER 
A 280 trace of CNBr peptides separated on Sephadex G25 was 
obta ined with an Isco Model UA-5 absorbance monitor. The 
column was pre - calibrated with ovalbumin and phenylalanine . 
Fract ions 56 to 70 were p o oled (vol . 7.SmL). For further 
details 1 ee Experimental section . 
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TABLE 5-6. Amino Acid Analy sis of Dowex 50x2 H2o Eluate 
Amino Acid nmoles 
Asx 1.277 
Thr 0.793 
Ser 2.350 
Hse 2.074 
Glx 38 .809 
Pro NDa 
Gly 5.396 
Ala 3.585 
Val NDa 
Met ND a 
Ile 2.665 
Leu 0.986 
Tyr NDa 
Phe 0.603 
His 4.473 
Hse lactone 9.329 
Lys ND a 
Arg NDa 
Hse + Hse lactone = 11.403 nmoles 
For details see text. 
a 
non detected. 
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Experimental section). Thi s indicates that about 25 % of 
the enzyme in the sample hydrolyzed may have a blocked 
N-terminus. 
The amino acid analysis also showed a high yield of 
glutamic acid and lesser amounts of glycine, alanine and 
histidine, but no methionine. The presence of glutamic 
acid is expected since glutamine can cyclize to form 
pyrrolidone carboxylic acid, which has no free amino group. 
It is stressed that this is only an indirect 
demonstration of formyl-methionine in the preparation 
and that, even when taken into consideration with the 
sequence data, this has not proven that the UUG initiation 
codon is specific for formyl-methionine (although this 
remains the most likely model at present). To this end 
experiments have been in progress to try to isolate the 
unprocessed N-terminal tryptic peptide and sequence it 
by mass-spectrometry and to identify the N-terminal di- or 
tri-peptide by GC-mass-spectrometry. 
SUMMARY 
The amino acid analysis of NADH:ubiquinone oxido-
reductase purified from E. coli membrane particles is in 
agreement with that predicted from the amino acid sequence. 
Together with the results obtained by peptide mapping, it 
has been confirmed that the enzyme is composed of a single 
type of polypeptide chain. The tight binding of the enzyme 
to the membrane cannot be explained simply on the basis of 
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the hydrophobicity of the overall protein. 
Amino acid composition data have been obta ined for 
tryptic peptides and CNBr peptides covering 49.8 % of the 
primary sequence , serving as a check on the n ucleic acid 
sequence. As well , CNBr peptides have been obtained 
covering both the amino and carboxyl-termini, confirming 
(when taken into account with the results of SDS polyacryl-
amide gel electrophresis) the integrity of the polypeptide 
chain , as isolated. 
The sequence of the first 21 residues of the processed 
enzyme has been determined . Unequivocal identification of 
formyl-methionine as the amino _terminus of the unprocessed 
enzyme has not been achieved , and so direct assignment of 
the UUG leucine codon as the initiation codon for the ndh 
gene cannot be made from the protein chemic a l data. 
\ 
CHAPTER 6. 
General Discussion 
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In the experiments de sc ribed in Chapte r 2, crude 
E. coli membrane particles were solubilized with 3% 
0 potassum cholate and lM KCl at Oto 4 . It was hoped that 
by using a gentle solubilization procedure, the NADH: 
ubiquinone oxidoreductase segment of the respiratory chain 
could be solubilized intact. Good recovery of NADH: 
ubiquinone oxidoreductase activity was obtained, and when 
solubilized material from the wild-type strain IY13 was 
chromatographed on hydroxylapatite, a single major peak of 
NADH-dependent ubiquinone reductase activity was · resolved. 
This activity is derived from the respiratory NADH dehydro-
genase complex since it was shown to be absent in ndh 
mutant strains, and therefore the corresponding enzyme 
preparation contains the respiratory NADH dehydrogenase. 
The single-column purification procedure results in 
an increase of 30 to 40-fold in specific activity relative 
to wild-type membrane particles. This is mainly due to 
unusually tight binding of the enzyme to hydroxylapatite 
under the co~ditions used. Further purification of the 
enzyme proved to be difficult however, and large losses of 
activity were incurred with all of the approaches 
subsequently tried. Attempts were therefore made to 
amplify the levels of the enzyme in vivo~ to facilitate 
purification, by using various genetic approaches. 
Durin g attempts to clone the ndh geneontomulticopy 
cloning vectors, two hybrid plasmids were constructed which 
complement the ndh mutant phenotype (Young et al .~ 1978). 
As shown in Chapter 3, strains carrying one of these hybrid 
plasmids, pIYl, possess high levels of NADH:ubiquinone 
1r 
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oxidoreductase in their c ell membranes. The levels of 
the cyanide-sensitive, membrane-bound NADH oxidase activity 
are also increased, which indicates that the enzyme, whose 
levels have been amplified in this manner, can interact 
with the respiratory chain. The amplified enzyme elutes 
in an identical position, during hydroxylapatite column 
chromatography, to the NADH:ubiquinone oxidoreductase 
absent in IY12, and by this criterion, is derived from the 
respiratory NADH dehydrogenase complex. Analysis of the 
enzyme preparation from such genetically-amplified strains 
shows a single polypeptide, subsequently confirmed by the 
protein chemical studies in Chapter 5, of molecular weight 
- 45,000. This polypeptide can therefore be unequivocally 
identified as the respiratory NADH dehydrogenase. 
The cloned DNA fragment in pIYl contains the 
structural gene coding for the respiratory NADH dehydro- . 
genase. This was initially demonstrated when it was shown 
that both the hybrid plasmid and the cloned DNA insert itself 
' 
can direct the synthesis of the 45,000 molecular weight 
polypeptide chain in an E. coli cell-free transcription/ 
translation system (M.I. Poulis, unpublished results). 
These studies also indicated that the promoter region for 
the ndh gene has been cloned intact. A direct proof that 
the ndh gene has been cloned comes ultimately from a 
comparison of the nucleic acid sequence of the insert with 
the amino acid composition and protein sequence data on the 
purified NADH dehydrogenase (see Chapter 5). 
The NADH dehydrogenase preparation has a very high 
activity with ubiquinone as electron acceptor, a 
(relatively) low activity with potassium ferricyanide, and 
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is specific for NADH as elec tron donor. The data 
presented in Chapter 4 indicates that the enzyme contains 
a single molecule of non-covalently-bound FAD per poly-
peptide chain but no Fe or acid-labile S. Other metals 
assayed for but not detected include W, Cu and Mo. This 
suggests that there are no iron-sulphur clusters or other 
metal complexes which could act as electron acceptors and 
participate in catalysis. The only metals not assayed, 
but which have been found in other respiratory enzymes, 
are Se (in enzymes such as formate dehydrogenase, Enoch 
& Lester, 1975) and Zn (found in various D-lactate 
dehydrogenase flavoproteins, O±son & Massey, 1979; Gregolin 
& Singer, 1963). There is also no evidence for ·iron-sulphur 
or haem prosthetic groups from the visible spectrum of the 
pure enzyme. The question which must be asked is whether 
the purified enzyme contains all of the components (poly-. 
peptides and prosthetic groups) involved in electron 
transport between NADH and the endogenous ubiquinone pool, 
or whether the very high ubiquinone reductase activity of 
the preparation is artifactual. 
The amplification in the levels of respiratory NADH 
dehydrogenase causes an increase in the membrane-bound NADH: 
ubiquinone oxidoreductase activity which is consistent with 
that expected from the increase in the ndh gene copy-number. 
This indicates that the ubiquinone reductase activity of 
the NADH dehydrogenase is not generated by solubilization 
or subsequent column chromatography. The demonstration 
that the specific activity of the pure enz yme from 
chloramphenicol-amplified IY35 or IY85 strains is similar 
to that of the IY13 enzyme preparation (assuming one active 
I 
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site per 45,000 molecula r we ight subunit in the latter) is 
good evidence that an alteration in the catalytic 
properties of the enzyme has not occurred as a result of 
amplification. 
All of the ndh mutants isolated so far are defective 
in the respiratory NADH dehydrogenase flavoprotein. The 
failure to detect any other class of mutant defective in 
the respiratory NADH dehydrogenase complex is consistent 
with the assumption that there are no other component 
enzymes located between the primary NADH dehydrogenase and 
the ubiquinone pool, although since only a dozen ndh 
mutants have been isolated so Jar, such evidence may not 
be considered strong, and of course cannot be conclusive. 
It is reasonable to postulate that the respiratory 
NADH:ubiquinone oxidoreductase has been purified intact. 
This rests on the assumption that the measurement of 
exogenous ubiquinone reduction by membrane particles assays 
this segment of the respiratory chain. This assumption has 
been shown to be reasonable in the case of mitochondrial 
membrane particles (Hatefi et al .~ 1962; Ragan & Hinkle , 1975; 
Schatz & Racker, 1966), and energy conservation at site 1, 
linked to the reduction of exogenous ubiquinone-1, has been 
demonstrated in mitochondrial particles (Schatz & Racker, 
1966) and vesicles reconstituted from Complex 1 and 
phospholipid (Ragan & Hinkle, 1973). 
There has been a great deal of controversy in the 
literature concerning the attempts to purify NADH: 
ubiquinone oxidoreductase from mitochondria, and in 
particular whether the various soluble low mo lecular weight 
(type 2) NADH dehydrogenases, which are able to reduce 
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ubiquinone analogues (Pharo et al .~ 1966; Raw et al .~ 1961; 
Kumar et al .~ 1968; Hatefi & Stempel, 1969) are intact 
preparations of this segment of the respiratory chain. 
Singer and co-workers strongly hold the view that such low 
molecular weight dehydrogenases are fragments of . the enzyme 
complex which reduces ubiquinone in vivo, and that the 
ubiquinone reductase activity they possess is an artifact 
of solubilization (for a review of their arguments see 
Singer & Gutman, 1971). The major experimental evidence for 
this assertion comes from the demonstration that these 
soluble ubiquinone reductases can be isolated by treatment 
of high molecular weight (type --1) NADH dehydrogenase, 
which itself has no ubiquinone reductase activity, under 
the same conditions as permits their solubilization from 
mitochondrial particles (Cremona et al.~ 1963; Machinist & 
Singer, 1965; Kaniuga, 1963; Cremona & Kearney, 1963). 
There are major differences in the nature of the 
preparations of E. coli NADH:ubiquinone oxidoreductase 
reported in this work, on the one hand, and the soluble 
type 2 NADH dehydrogenase from mitochondria, on the other. 
The former contains approximately 70 % lipid by weight 
whereas the latter, isolated by harsher procedures, are 
devoid of lipid. The physiological reduction of ubiquinone 
in mitochondrial preparations has been shown to require 
phospholipid, and this may reflect a hydrophobic inter-
action of the substrate with the enzyme (Ragan & Racker, 
1973), therefore this reaction may not be amenable to 
study in a soluble, lipid-free preparation (Singer & 
Gutman, 1971). This suggests that the strategy of trying 
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to purify this segment o f the respiratory chain in a water 
soluble form has been misguided. The strategy used in the 
present work has been to isolate the enzyme as a lipo-
protein complex, similar in nature to Complex 1, by 
using gentle solubilization procedures. The difficulty 
in this approach, as illustrated by the work of Hatefi and 
co-workers, is that large aggregates, which are difficult 
to further resolve, can be solubilized, since the 
relatively strong protein-lipid interactions are not totally 
disrupted. The unique use of genetic engineering techniques 
in the present work has enabled the NADH:ubiquinone oxido-
reductase to be purified to homogeneity without 
delipidation of the preparation at any stage, thereby 
protecting the labile ubiquinone reductase activity. 
Irreversible denaturation of the mitochondrial enzyme 
following delipidation under aerobic conditions has been 
demonstrated (Ohnishi e t al.~ 1974): it appears that this 
is due to oxidation of a sensitive iron-sulphur centre, 
N-2 (Orme-Johnson e t al .~ 1971), which has been postulated 
to be the immediate electron donor to ubiquinone in 
mitochondria. It has recently been possible to study the 
ubiquinone reductase reaction in delipidated preparations 
of mitochondrial succinate:ubiquinone oxidoreductase by 
incorporating this enzyme into triton micelles (Weiss & 
Kolb, 1979; Weiss & Wingfield, 1979). The NADH:ubiquinone 
oxidoreductase preparation described in this work is 
amenable to manipulation, and it should be possible to 
study its catalytic properties in a more defined system 
by incorporating the enzyme into either detergent micelles 
or artificial phospholipid vesicles. 
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It appears that the E. co l i NADH:ubiquinone oxido-
reductase is not an iron-sulphur flavoprotein since, as 
was shown in Chapter 4, no Fe or acid-labile S was 
detected in preparations possessing full ubiquinone 
reductase activity, and although the possibility cannot 
be ruled out that Fe or acid-labile S has been lost during 
solubilization and hydroxylapatite column chromatography 
of the enzyme, it is reasonable to assume that Fe is 
probably not involved in electron transport between NADH 
and ubiquinone in E. coli. 
The structure of the respiratory NADH:ubiquinone 
oxidoreductase bears a strong resemblance to that of the 
microsomal NADH:cytochrome b 5 reductase (Williams, 1976). 
Both enzymes have a single polypeptide chain of 
approximately equal molecular weight, a single non-
covalently-bound FAD per subunit, and no Fe or acid-labile 
S . Both are membrane-bound, reduce membrane bound 
substrates, and are NADH specific. A mechanism has been 
proposed for' NADH:cytochrome b 5 reductase based on 
sequential le transfer to cytochrome b 5 involving an 
intermediate flavosemiquinone (Strittmatter, 1965). It 
may be possible that an analogous mechanism exists in the 
case of the NADH:ubiquinone oxidoreductase with the product 
of the enzyme catalyzed reaction being ubisemiquinone. 
Alternatively the enzyme may catalyze a 2e reduction of 
ubiquinone to the corresponding quinol. If this were so, 
then it is interesting that a similarity exists in the 
amino acid sequence at residues 313 to 320 of the E. coli 
NADH:ubiquinone oxidoreductase and the active-site di-
sulphide region of various soluble disulphide reductases, 
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* particularly the E. c o li thioredoxin reductase . 
E. coli NADH:ubiquinone oxidoreductase 
ile-gly-asp-cys-ala-ser-cys-pro 
(see Chapter 5) 
E. coli thioredoxin reductase 
s s 
I I 
ala-cys-ala-thr-cys-asp-gly-phe 
(Thelander, 1970) 
Thioredoxin reductase, which is a soluble NADPH-
specific enzyme consisting of two identical subunits 
--
of molecular weight 37,700, accepts four electrons per 
subunit when fully reduced (two each by the FAD moiety and 
the disulphide) but alternates between the fully oxidized 
and 2e--reduced forms during catalysis (Williams, 1976). 
The possible involvement of cystine as a second 
electron-accepting prosthetic group in the E. coli NADH: 
ubiquinone ~xidoreductase may be demonstrated by a study 
of the spectral changes of the pure enzyme following 
anaerobic titration with NADH. Consistent with the 
presence of an active site thiol is the finding that the 
NADH:ubiquinone oxidoreductase activity is reversibly 
inhibited by Hg++ ions (H.D. Campbell, unpublished 
results). 
* 
It is possible to imagine a mechanism involving 
This configuration of cysteines is also found in many 
ferredoxins and rubredoxins (Orme-Johnson, 1973) where, 
presumably, it fulfils the geometric requirements for 
co-ordination to Fe/S clusters and Fe atoms 
respectively. 
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either a le or a 2e r eduction of ubiquinone to ubi-
semiquinone or ubiquinol respectively. A study of the 
mechanism of catalysis of ubiquinone reduction by the 
purified enzyme will almost certainly provide information 
as to the mechanism of electron transport in this segment 
of the respiratory chain, e.g. the possible involvement of 
ubisemiquinone. However, there is a danger of extra-
polating such results too far since electron transport 
in vivo may be different, in detail, to that in the pure 
enzyme. Thus even though the purified preparation is 
efficient at catalyzing the reduction of free ubiquinone 
in vitro, the endogenous substrate may be different. 
King and his co-workers have suggested that ubiquinone 
participates in mitochondrial electron transport as a 
protein-bound cofactor, and have isolated a ubiquinone 
binding protein thought to be involved in the succinate: 
ubiquinone oxidoreductase reaction (Yu & Yu, 1980, and 
references therein). They have postulated a similar 
ubiquinone'binding protein for each separate dehydrogenase 
system including the NADH:ubiquinone oxidoreductase 
( Yu e t a Z . ~ 1 9 7 9 ) . 
It is evident from the above discussions that the 
'plasmid-amplified' strains described in this thesis have 
proven to be extremely useful in the purification of the 
E. coli NADH:ubiquinone oxidoreductase. The power of such 
a genetic approach, as used here, is dramatically revealed 
in Figure 2-6 where identical preparations of NADH: 
ubiquinone oxidoreductase, from wild-type and genetically-
amplified strains, are compared. That such approaches 
will prove generally applicable, and useful in the 
..... 
I 
I 
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purification of enzymes present in minor amounts in the 
membrane, is shown by the success in amplifying the 
levels of the respiratory D-lactate dehydrogenase flavo-
protein (see Chapter 3) and, in other work, of phospha-
tidylserine decarboxylase (Tyhach e t a l.~ 1979). 
That the defect in the respiratory NADH dehydro-
genase in ndh mutant strains was corrected by over-
production of the membrane-bound D-lactate dehydro-
genase, in strains carrying the hybrid plasmid pIY2, 
highlights the fact that the considerable elevation _of 
particular enzymes, which can be achieved by gene 
cloning, can give rise to new metabolic routes which are 
not significant in wild-type cells. These results 
suggest that modulation of metabolic pathways using gene 
cloning provides a new approach to studying such aspects 
as regulation and rate-limitation in metabolism, as was 
pointed out elsewhere (Raetz e t al.~ 1977). In this 
context, since the level of NADH is believed to be 
important in the regulation of many areas of intermediary 
metabolism, the plasmids pIYl and pIY2 may provide 
interesting insights into the maintenance of the NADH/ 
NAD+ ratio in the cell. Mention has already been made 
(see Chapter 3) of the demonstration that the NADH and 
D-lactate dehydrogenases are rate-limiting for their 
respective oxidase in wild-type membranes. 
The use of strain IY35, in conjunction with the ndh 
mutant strains, has also proven invaluable to the 
identification of the respiratory NADH dehydrogenase. 
This was complicated by the fact that there are very high 
levels of contaminating NADH dehydrogenase activities in 
II 
II 
Ir 
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E. coli . From the results presented in Chapter 2, it 
was found that about 4% of the total NADH-specific ferri-
cyanide reductase and 20% of the NADH-specific ubi-
quinone-1 reductase activity of crude wild-type extracts 
is recovered in washed membrane particles: most of the 
activity appears in the cytoplasmic fraction. As 
discussed in Chapter 2, there are also multiple NADH 
dehydrogenase activities in the cell membrane, and this 
is illustrated by the several NADH:ferricyanide oxido-
reductase peaks resolved during hydroxylapatite column 
chromatography: for apart from the activity associated 
with the respiratory enzyme, rhere is a group of NADH-
specific ferricyanide reductase peaks eluting in the middle 
of the gradient and a peak, sometimes resolved into two 
peaks (e . g . Figure 2-S(a)) depending upon whether the 
column was washed in equilibration buffer prior to 
commencement of the gradient, at the beginning of the 
column profile. 
As seen from the attempted purification of the 
mitochondrial NADH:ubiquinone oxidoreductase, gross 
changes in the catalytic properties of membrane-bound 
enzymes can accompany their solubilization. Clearly in 
the case of E. coli, where there are multiple NADH 
dehydrogenase activities in the membrane, a means of 
assigning the respiratory enzyme in solubilized 
preparations, which is independent of its catalytic 
properties, is essential. From a consideration of the 
column profiles of ndh mutant (IY12), wild-type (IY13) 
and genetically-amplified (IY35 and IY85) strains, it is 
possible not only to definitively identify the 
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respiratory enzyme from amongst the activities resolved, 
but also to state unequi voc ally that the other 
activities are not linked to the respiratory chain. 
In early attempts to purify the respiratory NADH 
dehydrogenase of E. coli either from crude extracts 
(Wosilait & Nason, 1954; Bragg , 1965) or small particles 
(Kashket & Brodie, 1963(b); Bragg & Hou, 1967(a) & (b); 
Gutman et al.~ 1968) no indications were given as to the 
purity of the preparations, nor were there adequate 
criteria to assign the activities purified to the 
respiratory NADH dehydrogenase. Recently, Dancey et al ., 
(1976) reported the purification of an NADH 
dehydrogenase from E. coli which is active with a variety 
of electron acceptors including DCIP and ferricyanide, 
although no activity towards ubiquinone was reported. The 
most highly purified preparations consisted of a single 
polypeptide, molecular weight 38,000. The enzyme was 
purified 16-fold relative to the activity present after 
solubilization of spheroplasts with 5 % (w/v) Triton X-100. 
The solubilization procedure, however, resulted in the 
loss of most of the activity originally present in the 
spheroplasts. From the data presented (Dancey et al .~ 
1976(a)) it appears that there was only a 5 to 6 % recovery 
of DCIP reductase activity after solubilization. The 
specific activity of the purified enzyme, 0.32 11mol DCIP 
-1 -1 0 
reduced min mg at 30 , pH7 . 5, is only 3-fold higher 
than that of the spheroplasts. As the authors point out, 
relating the purified enzyme to the activity present 
before solubilization, to calculate recovery , is 
complicated by the presence in the membrane of more 
than one NADH dehydro genase . But even so, it is 
,, 
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clear that considerable losses of activity would have to 
have occurred due to their purification procedure. 
Because of the very low specific activity of the 
preparation of Dancey et al .~ (1976) it is possible 
that the enzymic activity resides with a minor component 
in the preparation rather than with the 38,000 molecular 
weight polypeptide itself. This may be unlikely, but is 
supported by two lines of evidence: (1) antibody 
preparations directed against the purified enzyme react 
strongly with an antigen shown to be identical with a 
major structural protein present in outer membranes of 
E. coli (Owen & Kaback, 1979). This protein has been 
shown to have a subunit molecular weight of 37,000 
(Garten et al .~ 1975) and is a major protein component 
of vesicles prepared by osmotic shock. It appears 
therefore to be a contaminant in the preparation of 
Dancey e t a l . and to constitute at least part of the 
38,000 molecular weight polypeptide seen. (2) In a later 
abstract from the same laboratory, Thomson & Shapiro 
(1979·) have described a preparation of NADH:ubiquinone 
oxidoreductase which has a specific activity of 75 umol 
. -1 -1 
min mg with 2,3-dimethoxy-5-methyl-6-n -decyl-1,4-
benzoquinone as electron acceptor, and consists of two 
polypeptides of molecular weight 37,000 and 46,000. The 
authors conclude that the NADH dehydrogenase activity is 
associated with the 37,000 molecular weight polypeptide 
(from their earlier studies) and that the 46,000 molecular 
weight polypeptide confe rs speci f icity for ub i qu i none 
r e duction. Howe ve r i n v i ew of the fin d ing that t he 
,, 
I 
I 
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respiratory enzyme has a n a pparent molecular weight of 
-45 ,000 (this thesis, Young et a l.~ 1978) the possibility 
must at least be considered that the catalytic activity 
lies with the 46,000 molecular weight polypeptide and 
that either small amounts of this are responsible for the 
activity observed in the earlier preparation of Dancey 
et al.~ (1976) or that the 38,000 species is a 
separate enzyme or proteolytic degradation product of the 
respiratory NADH dehydrogenase. 
It is not possible to unequivocally define the 
relationship between the 38 ,000 molecular weight poly-
peptide purified by Dancey e C- al., (1976) and the 
respiratory NADH dehydrogenase, especially in the absence 
of amino acid composition or sequence data on the former. 
The difference in subunit molecular weight estimates by 
SDS gel electrophoresis, even allowing for the different 
gel systems used in the two laboratories, makes it 
unlikely that the two polypeptides are identical. If the 
38,000 species is the respiratory NADH dehydrogenase, 
however, the preparation has grossly altered catalytic 
properties. 
Owen & Kaback (1979) have demonstrated the presence 
of two, or possibly three, antigenically distinct NADH 
dehydrogenases in the inner membrane of E. coli by 
crossed immunoelectrophoresis of spheroplasts prepared by 
osmotic shock (antigens 15 and 19/27 in their nomenclature). 
Two of these (antigens 19 & 27) show lines of partial 
identity and it is not clear whether they represent 
separate enzymes . Owen et al . ~ (1980) have assi gned 
antigen 15 as the respiratory NADH dehydrogenase on the 
I 
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basis that it is located strictly in the membrane. It 
possesses NADH dehydrogenase activity (in zymograms, 
using MTT as electron acceptor) and has also been shown 
to contain Fe (ibid.); the authors note, however, that the 
Fe may not be associated with the NADH dehydrogenase subunit 
itself. The other antigen(s) 19/27 has been identified 
with the enzyme purified by Dancey et al .~ (1976) 
basis that it reacts, albeit weakly, with antisera 
prepared against this enzyme (Dancey et al.~ 1976; 
on the 
Owen & Kaback, 1979; Owen et al .~ 1980). Neither antigen 
19 or 27 contains Fe, and both partition between the 
membrane and cytoplasm. It remains to be seen which of 
these antigens, if any, is the respiratory NADH dehydro-
genase . This question should be answered by comparing 
wild-type and genetically-amplified membrane vesicles by 
crossed irnrnunoelectrophoresis. 
The work presented in this thesis describes the first 
reported purification of the E. coli NADH:ubiquinone 
oxidoreductase, and is possibly the first preparation 
described of a highly purified, and intact, respiratory-
chain-linked NADH:ubiquinone oxidoreductase from any 
source. A system has been characterized and developed 
which may prove a good model for studying the basic 
properties of membrane-bound enzymes. At present the 
most advanced and widely-studied model for intrinsic 
membrane proteins is bacteriorhodopsin, which has recently 
been sequenced (Ovchinnikov et al .~ 1979; Khorana et al .~ 
1979). This protein may not be a good model for intrinsic 
membrane proteins in general , however, since it is found 
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in highly specialized membrane structures, the purple 
patch, containing only the one type of polypeptide 
(Oesterhelt & Stoeckenius, 1971). 
With the recent advances in genetic engineering 
techniques, sequence data is starting to become available 
for intrinsic membrane proteins from DNA sequencing 
(Blichel et al .~ 1980; Hensgens et al.~ 1979; Barrell 
et al.~ 1979). Undoubtedly, structural ·data for intrinsic 
membrane proteins will be derived mainly from gene 
sequencing methods in the future. 
Future studies should address themselves to two 
maJor questions: (1) whether- the assumption, made above, 
that this enzyme contains all the components of the 
membrane-bound NADH:ubiquinone oxidoreductase is valid* 
and (2) what is the biological role of this enzyme. There 
is at the moment no obvious conclusive experimental test 
of the first question: however experiments may be 
designed to show (a) whether the enzyme can reduce 
' 
ubiquinone-8 in artificial membrane vesicles and (b) by 
designing suitable photoaffinity anlogues, whether the 
respiratory NADH dehydrogenase interacts with ubiquinone 
in vivo . With respect to the second question, a direct 
role for this enzyme in energy conservation has yet to be 
demonstrated. Preliminary attempts, in collaboration with 
Dr H.D. Campbell, to demonstrate proton gradient formation 
* Recently a number of respiratory enzymes have been 
purified from microorganisms which are simpler in their 
subunit structure than the corresponding enzyme 
complexes from mitochondria. These include a single 
subunit cytochrome oxidase from P53 (Sone et al .~ 1979) 
and two-subunit cytochrome oxidases from P. denitrifican s 
(Ludwig & Schatz, 1980) and T . the r mophilus (Fee et al .~ 
1980). 
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in phospholipid vesicles in laid with pure enzyme by the 
cholate dialysis procedure (Ragan & Hinkle, 1975) have 
so far failed. Unless a positive result is obtained it 
is not clear whether additional components are required 
for the associated energy conservation reaction or that 
no site of energy transduction exists in this segment of 
the respirato~y chain. 
1 95 . 
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